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Abstract 
The installation of a functional group at a specific site through transition-metal catalysed 
C-H functionalisation has emerged as a powerful tool for the synthesis of complex structures 
in a step-economical manner. In this context, the remote functionalisation through migration 
of a transition-metal catalyst along an alkyl-chain, termed chain-walking, has gained 
significant momentum during the last decade. 
The strategy developed by the group of Baudoin relies on palladium-catalysed 
ligand-controlled chain-walk with enolates or organozinc compounds as nucleophiles, where 
a site-selective reductive elimination is the terminating step. More recently, the group 
reported the development of a regioconvergent functionalisation of a regioisomeric mixture 
of bromoalkanes through a migratory Barbier-Negishi cross-coupling. However, the design of 
a migratory version of the ubiquitous Suzuki-Miyaura cross-coupling has remained elusive, 
although various palladium-catalysed migratory cross-coupling reactions were reported.  
In this optic, we first investigated a one-pot approach for the hydroboration of a regioisomeric 
mixture of linear alkenes and subsequent terminal-selective palladium-catalysed 
Suzuki-Miyaura cross-coupling. The developed reaction conditions furnished excellent 
regioselectivity, but the yields were not satisfactory. 
We then developed a benzylic-selective palladium-catalysed Suzuki-Miyaura cross-coupling 
based on the previous observations made. Excellent regioselectivity for the benzylic position 
of the initial alkene was achieved by the combination of ligand and electrophile. We also 
demonstrated the regioconvergence from regio- and geometrical isomeric mixture of alkenes, 
and long-range migration. Additionally, a mechanistic study was also performed. 
Finally, we also explored the feasibility of combining the previous benzylic-selective migratory 
cross-coupling with a subsequent C(sp2)-H activation in a cascade process. However, our 
findings led to the conclusion that the necessary presence of water for the first step is 
detrimental for the second.  
Keywords: C-C coupling, C-H functionalisation, chain-walking, palladium, regioconvergence, 
remote functionalisation 
Yann Baumgartner 
Group of Prof. Dr. Olivier Baudoin 
Department of Chemistry 
University of Basel 
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1. General Introduction 
1.1. From Vitalism to C-H Functionalisation 
The birth of organic chemistry can be traced back to the nineteenth century with the 
unanticipated preparation of urea from inorganic materials by Friedrich Wöhler in 1828,[1] 
challenging the then generally accepted vitalism doctrine that all organic materials are 
endowed with vital force. In retrospect, the coup de grace of vitalism was arguably the 
synthesis of acetic acid starting from carbon disulphide by Hermann Kolbe in 1845.[2] Since 
then chemists have developed an impressive catalogue of reactions for the synthesis and 
derivatisation of organic compounds, relying on the transformation of functional groups or 
structural features with high chemical reactivity (Scheme 1.1a). The developed methods can 
solve many chemo-, regio-, diastereo- and enantioselectivity issues but generally need pre-
functionalised starting materials, obtained after several iterative steps which often require 
the use of a stoichiometric amount of reagents, in other words with a poor overall synthetic 
efficiency.[3–5] Growing concerns of limited availability of raw materials as well as climate 
change issues incited chemists to develop more efficient and environmental benign 
alternatives. 
 
Scheme 1.1: Different strategies for the functionalisation of organic compounds. 
The development of transition metal-catalysed cross-coupling reactions of organic 
electrophiles and organometallic reagents have emerged since the early 80s as an essential 
synthetic tool, allowing for the efficient combination of a wide range of coupling partners 
(Scheme 1.1b). This approach enhanced considerably the ability of synthetic chemists to 
assemble complex frameworks between functionalised and sensitive substrates, thus 
providing new opportunities in total synthesis, medicinal and process chemistry as well as in 
biology and nanotechnology.[6–8] Prominent among these, palladium-catalysed cross-
couplings witnessed an incredible growth of interest in academia and industry as emphasized 
by the continuously rapidly growing literature and industrial applications in this field. This was 
also proved by the fact that Richard Heck, Ei-ichi Negishi and Akira Suzuki were attributed the 
Nobel Prize in Chemistry 2010 for their roles in the discovery and development of these 
strategies.[9–11] 
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Generally, these type of reactions are initiated by the oxidative addition of a Pd0 complex 1.1 
into a carbon-(pseudo)halide bond generating an electrophilic PdII organometallic species 1.2, 
which then undergoes transmetalation with a nucleophilic organometallic compound 
resulting in the PdII complex 1.3. Reductive elimination of this palladium intermediate 
furnishes the cross-coupled product while regenerating the Pd0Ln catalyst (Scheme 1.2). 
Despite the aforementioned advantages, some limitations such as the pre-functionalisation of 
the starting materials and the generation of stoichiometric, often toxic, metal waste 
remained. Thus, further stimulating chemists to explore the direct functionalisation of C-H 
bonds. 
 
Scheme 1.2: Simplified general catalytic cycle for palladium catalysed cross-coupling reactions. 
The replacement of an unactivated C-H bond with a functional group, termed C-H 
functionalisation, is a highly desirable yet difficult step- and atom-economical synthetic 
approach (Scheme 1.1c), and thus has been under intense investigations in the last two 
decades.[12,13] While C(sp2)-H functionalisation has grown into a mature tool, the extension to 
alkyl C-H bonds has proven to be more challenging due to the ubiquity, which prevents the 
regioselectivity, and lower reactivity of these C-H bonds towards organometallic bond 
cleavage.[14–19] Nevertheless, selective alkyl C-H functionalisation can be facilitated by pre-
complexation strategies where the substrate coordinates to the metal complex prior to the 
selective C-H bond cleavage, resulting in a lower activation barrier. Therefore, the substrate 
becomes ligand, which brings the catalyst in close proximity of the targeted C-H bond. This 
type of metalation can be directed via either a Lewis basic directing group of the substrate 
such as heteroatoms or unsaturated bonds (Scheme 1.3a) or by oxidative addition into a 
carbon-(pseudo)halide bond (Scheme 1.3b).[14] 
 
Scheme 1.3: Different strategies for C-H functionalisation. 
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A different approach consists in the remote functionalisation of alkyl C-H bonds. Originally 
developed for controlling polymer topology,[20–23] olefin isomerisation as a vehicle to enable 
functionalisation at a distant site has recently gained increased attention (Scheme 1.3c).[24–28] 
The progression of a transition metal catalyst along an alkyl chain via dynamic displacement, 
termed “chain-walking”, is often associated with the translocation of a double-bond to a 
terminal position, presumably due to steric effects, or to a resonance-stabilised position such 
as adjacent to an aromatic moiety or functional group. Besides allowing the formal 
functionalisation of C-H bonds, it can also serve as a regioconvergent instrument by 
transforming e.g. a regioisomeric mixture of E- or Z-alkenes selectively to one sole product. 
Thus, various different catalytic systems have already been successfully developed with 
different transition metals such as zirconium, cobalt, nickel, ruthenium and palladium.[24–28] 
The evolution of synthetic organic chemistry follows a clear path towards improved efficiency 
of the overall transformation.[3–5] Moreover, the newly developed methods further expand 
the synthetic toolbox enabling the synthesis of increased complexity. In the next part, we will 
discuss the development of palladium-catalysed cross-coupling with alkylboron reagents as 
well as the development of intentional palladium-catalysed migratory functionalisation, the 
two core-subjects of this thesis. Consequently, the other transition metals used for these types 
of transformations will not be discussed for the sake of conciseness.  
1.2. Palladium-Catalysed Suzuki-Miyaura Cross-Coupling with Alkylboron 
Reagents 
1.2.1. Introduction 
In virtue of broad functional group tolerance, operational simplicity, environmental benign 
nature and thermal stability of the transmetalation agents, the Suzuki-Miyaura cross-coupling 
reaction (SMC) has emerged as a powerful synthetic tool.[29,30] Notably, the B-alkyl adaptation 
has become one of the most popular cross-coupling protocol since the first report in 1986 of 
the cross-coupling reaction between alkylboron reagents and aryl or alkenyl halides.[7,31–34] 
Furthermore, the wide application of organoboron compounds since more than 60 years in 
organic synthesis provides a multitude of methods and ease of preparation and handling as 
well as commercial availability of a multitude of different organoboron reagents.[35,36] 
However, the development of C(sp3)-organometallics in cross-coupling reactions has been 
more challenging than the related C(sp2)-couplings due to several limitations. Some of these 
issues are the spontaneous decomposition of alkyl organometallics via β-elimination or proto-
demetalation,[37] and the preparation of the organometallic reagents without purification as 
they are often not air-stable, translating to superstoichiometric amounts of organometallics 
used. Moreover, compared to their C(sp2)-analogues, the three organometallic processes 
(oxidative addition, transmetalation, reductive elimination) become more critical due to the 
slower respective rates, hence opening new pathways for side-reactions (Scheme 1.4) and 
thereby sometimes requiring various additives.[38–41] 
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Scheme 1.4: Mechanistic features of palladium-catalysed cross-coupling with alkyl-organometallics. 
1.2.2. Mechanistic Aspects of the Suzuki-Miyaura Cross-Coupling Reaction 
The mechanism of oxidative addition[42–47] and reductive elimination[48–53] have been 
thoroughly studied and are now relatively well understood. However, there has been a 
dichotomy of opinion about the transmetalation event in SMC, complicated by the wide range 
of different organoboron reagents (Figure 1.1) and an ever-increasing portfolio of ligands, 
electrophiles, bases, additives and solvent systems. 
 
Figure 1.1: Selected examples of popular boron coupling partners. 
The complexity during the transmetalation event arises from the fundamental properties of 
boron-species. Association of a fourth ligand to the Lewis acidic three-coordinated boronic 
species to generate an “ate” complex (1.5, Scheme 1.5) is required to enable efficient transfer 
of the organic moiety to palladium. The provenance of this fourth ligand is where the opinions 
differ and two distinct pathways are considered. In the so-called “boronate” pathway 
(pathway A, Scheme 1.5) a four-coordinate boronate species is preformed, or generated in 
situ through an equilibrium, which then associates with intermediate 1.2 of the oxidative 
addition to form intermediate 1.5. Alternatively, a hydroxy-palladium intermediate 1.4 is 
obtained after ligand exchange, which then acts as a Lewis base toward a three-coordinate 
boron species, thus only generating intermediate 1.5 upon association with the palladium 
complex 1.4, the so-called “oxo-palladium” pathway (pathway B, Scheme 1.5).[54,55]  
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Scheme 1.5: Simplified generic mechanism for SMC of a boronic acid with an organohalide. 
1.2.2.1. Mechanistic studies on the transmetalation of C(sp2)-boron species 
Several density functional theory (DFT) calculations on different aspects of SMC were reported 
by assuming that the transmetalation proceeds through pathway A.[56–59] Only Maseras and 
co-workers directly compared both pathways A and B.[60–64] Despite similar or even lower 
energetic barrier for the oxo-palladium pathway (B), they could not locate the transition state 
for the necessary displacement of the halide with hydroxide at palladium. Thus, they 
concluded that the boronate pathway (A) is responsible for the formation of the common 
intermediate 1.5 because of lack of ready access to the hydroxy-palladium intermediate 1.4. 
Additionally, the boronate species as well as the palladium-halide complex have both been 
detected in the reaction mixture by ESI-MS,[65–67] but not the hydroxy-palladium complex. 
However, the presence of intermediates does not reveal their reactivity characteristics. 
Instinctively, the isolation of preformed boronate species such as trihydroxyboronate 
salts[68,69] or trialkoxyboronate salts[70–72] and subsequent engagement in base-free SMC was 
further believed to be evidence for the boronate pathway. However, their solubility in the 
coupling-medium is low, and thus it is unclear whether there is an equilibrium during the 
catalytic flux constantly replenishing base and boronic acid/ester in the reaction medium or 
not.  
A HPLC-derived kinetic study by Smith[73] indicated that the rate-limiting step with aryl 
bromide is the oxidative addition, whereas with aryl iodide it is post-oxidative addition. 
Further kinetic modelling of the proposed [L2PdX(Ar)] intermediates (X = Br, I) suggested 
similar reactivity toward transmetalation of both halide complexes. Thus, it was interpreted 
as evidence against the oxo-palladium pathway in which halide substitution precedes 
transmetalation. Furthermore, the reaction failed when bicarbonate was used as base. Typical 
pKa values of aryl boronic acid (8.8) relative to carbonate (10.3) and bicarbonate (6.4) was 
taken as evidence for the formation of boronate species, an essential step for the boronate 
pathway.  
However, it was noted by Miyaura in 2002 that a hydroxy-palladium complex 
[(Ph3P)Pd(OH)(Ph)]2 reacts at room temperature with p-anisylboronic acid to give homo- and 
cross-coupling products in 85% yield, thus demonstrating the possibility of the second step in 
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the oxo-palladium pathway.[74] Further kinetic studies on stoichiometric reactions from the 
groups of Amatore and Jutand,[51] Hartwig[75] and Schmidt[76] provided compelling and 
conclusive evidence that the oxo-palladium pathway is kinetically most favourable, at least for 
the systems tested therein. Amatore and Jutand[51] studied various transmetalation scenarios 
with electrochemical techniques combined with heteronuclear NMR spectroscopy. Their 
findings indicated a very slow transmetalation rate for the boronate 1.7 with the halide 
complex 1.9 (Scheme 1.6). Additionally, halide complex 1.9 was found to be in a rapid 
equilibria with the hydroxy-palladium complex 1.8, which is in direct contrast with the DFT 
calculations,[60–63] and then underwent transmetalation efficiently with the boronic acid 1.6. 
The authors were also able to rule out two alternative transmetalation pathways (1.6 + 1.9 
and 1.7 + 1.8). 
 
Scheme 1.6: Different equilibria for the possible species prior to transmetalation in SMC. 
Hartwig[75] employed 31P-NMR spectroscopy to measure the rate of the stoichiometric 
transmetalation of the halide complex 1.9 with an aryl trihydroxyboronate 1.7 (boronate 
pathway) as well as of an in situ generated hydroxy-palladium complex 1.8 with an aryl boronic 
acid 1.6 (oxo-palladium pathway). The latter was found to be four orders of magnitude faster 
than the prior was. Besides this, they also showed that the populations of palladium halide 
complex 1.9 and hydroxy-palladium complex 1.8 are similar to each other as well as the 
population of boronic acid 1.6 and trihydroxyboronate 1.7 in the presence of water and 
carbonate bases. It is noteworthy however, that these studies were conducted in the presence 
of 18-crown-6, thus attenuating the availability of K+ counterion to 1.7 for halide abstraction 
from Pd in 1.9, and thus impacting its rate. Schmidt[76] further compared the rate of 
stoichiometric homocoupling of phenyl boronic acid by UV analysis under phosphine-free 
conditions. The formation of biphenyl proceeding through two-fold transmetalation was 
found to occur about two times faster when the boronic acid 1.6 was added to an equilibrium 
mixture of [PdII(OAc)2] and NaOAc, than the addition of [PdII(OAc)2] to an equilibrium mixture 
of 1.6 and NaOAc, thus excluding the involvement of a trihydroxyboronate. 
Interestingly, much less controversy exists about the existence of the putative pre-
transmetalation intermediate 1.5 (Scheme 1.5), even though it was never observed or 
characterised by chemists until only recently. Realistically, because of a computationally 
predicted barrier value of 14-22 kcal mol-1,[54] special techniques are required to elucidate the 
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structure of 1.5. One such technique is rapid injection NMR (RI-NMR),[77] which was further 
developed by the group of Denmark.[78]  
With this technique, Denmark was able to detect and characterize different Pd-O-B complexes 
(1.12, 1.15, 1.16, Scheme 1.7).[79,80] During their studies, they made several important 
discoveries. The synthesis of the tricoordinate B complex 1.12 proceeded quantitatively when 
prepared from a hydroxy-palladium complex and an arylboronic acid, but yielded only 10% 
when prepared with a palladium-halide complex and an aryl boronate. However, the 
formation of 1.12 must proceed through a tetracoordinate B intermediate such as 1.16, which 
is formed initially, succeeded by rapid loss of a molecule of water. Further investigations with 
a mono-ligated arylpalladium hydroxy complex lead to a new bridged bis-arylpalladium 
arylboronate complex 1.15, which upon further addition of arylboronic acid 1.11 yielded the 
tetracoordinate B complex 1.16. Kinetic studies of the transfer of the aryl group from boron 
to palladium showed that B complex 1.15 is first converted to B complex 1.16 prior to 
transmetalation. Moreover, an inverse dependence of phosphine ligand for the 
transmetalation of tricoordinate B complex 1.12 supports that a dissociation of a phosphine 
ligand is a pre-equilibrium process that leads to the hypothetical 14-electron palladium 
complex 1.13. 
 
Scheme 1.7: Transmetalation pathways for three different pre-transmetalation Pd-O-B intermediates.  
Hence, for the first time, competent pre-transmetalation species containing Pd-O-B linkages 
that undergo SMC were identified and characterised. However, the observation of 
transmetalation from a tricoordinate boron centre challenges the current belief of boron 
activation by base prior to transmetalation.[79,80] Further investigations revealed two 
competing factors which are crucial for transmetalation to happen.[81] First, the ability to 
access a coordinatively unsaturated palladium centre, and second the nucleophilic character 
of the B-ipso carbon. In this study, they also observed faster transmetalation rate for catechol- 
and glycol arylboronic ester compared to the arylboronic acid, and they demonstrated that 
glycol arylboronic ester reacts under anhydrous catalytic conditions, indicating that a prior 
hydrolysis step is not required, raising further questions. 
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1.2.2.2. Mechanistic studies on the transmetalation of C(sp3)-boron species 
Whereas several mechanistic studies have attempted to determine the pathway of the 
transmetalation of C(sp2)-boron species, only a few studies have addressed the C(sp3) 
analogues. Additionally to the dichotomy between the two pathways, transmetalation of 
C(sp3)-centres may also have different stereochemical consequences due to two possible SE2 
mechanism (retentive or invertive) if a secondary or tertiary alkylboron nucleophile is 
used.[82,83] Woerpel[84] and Soderquist[85] in back to back reports independently studied the 
stereochemical outcome of such a transmetalation with deuterium labelling. Woerpel 
demonstrated that diastereomeric dideuterioalkenes cis-1.17 and trans-1.17 underwent 
hydroboration to the corresponding alkylboranes 1.18 followed by SMC with 
α-iodocyclohexenone. The syn-1.19 coupling product was obtained from the cis-1.17 alkene, 
and the anti-1.19 coupling product from the trans-1.17 alkene respectively, as confirmed by 
1H-NMR analysis of the coupling constants (Ja,b = 5.8 Hz for syn-1.19, Ja,b = 9.1 Hz for anti-1.19). 
Thus, it was concluded that the transmetalation in B-alkyl SMC proceed through retention of 
configuration as the hydroboration is a syn-addition process. This was in agreement with 
Soderquist findings, in which he additionally proposed a four-membered cyclic transition 
state 1.20.[85]  
 
Scheme 1.8: Stereochemistry of the transmetalation of alkylboranes. 
Soderquist further conducted systematic studies on the transmetalation step for the coupling 
of primary alkylboranes 1.21 and alkylborinates 1.25 with bromobenzene and NaOH 
(Scheme 1.9). According to 11B-NMR, the Lewis acidic alkylborane 1.21 readily forms the 
boronate complex 1.22 in presence of the base. The kinetics of the coupling with PhBr were 
found to be first-order in electrophile, and pseudo-zero-order in both alkylboron 1.21 and 
base. In contrast, no hydroxyborinate complex 1.26 was formed in the presence of base, and 
kinetics were found to be pseudo-zero-order in both PhBr and alkylborinate 1.25, but first-
order in NaOH. Moreover, competitive studies demonstrated that when both species are 
present, only alkylboranes 1.21 undergo coupling. Additional difference between the two 
organoboron species was found during stoichiometric study of required NaOH. Alkylboranes 
1.21 necessitate two equivalents to perform efficiently, whereas SMC with alkylborinates 1.25 
still proceeds efficiently with just one equivalent. With these data, it was concluded that 
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alkylboranes 1.21 proceed through the boronate pathway, and alkylborinates 1.25 through 
the oxo-palladium pathway.  
 
Scheme 1.9: Pathways for the transmetalation of alkylboranes. 
Since then several reports on stereospecific Pd-catalysed SMC employing directing groups 
were reported.[86–88] Several of them, however, proceeded under inversion of the 
stereocentre. Suginome further demonstrated that the addition of a Lewis acid could 
completely reverse the pathway of transmetalation from invertive to retentive.[83] 
Interestingly, Biscoe observed that the non-directed SMC of unactivated sec-alkylboron (1.30, 
Scheme 1.10) with a mono-ligated palladium catalyst [PdP(tBu)3] proceeds with inversion of 
configuration,[89] which is in direct contrast to the comparable findings of Woerpel[84] and 
Soderquist.[85]  
To better understand the parameters influencing the mechanism of transmetalation he 
teamed-up with Sigman to conduct a mechanistic study using predictive statistical models.[90] 
They demonstrated, that the outputs could be expressed in two readily interpretable terms 
that discriminate between the two SE2 pathways (Figure 1.2): the π-back bonding represented 
by the average energy of the P-C antibonding orbitals, and the ligand’s σ-donation capability 
represented by the energy of the lone pair orbital of phosphorous. Their results suggest that 
π-back bonding may stabilise the coordination of a π-donor ligand X (e.g. OH-) to Pd, and thus 
favouring a retentive mechanism 1.28. Whereas strong σ-donation from the ligand may 
stabilise a two-coordinate, cationic palladium complex and thus favouring an invertive 
mechanism 1.29. A correlation between the enantiopurity of the product 1.32 (Scheme 1.10) 
and the branched:linear ratio further revealed that the β-hydride elimination is responsible 
for both racemisation and isomerisation to the linear product. They also observed a modest 
trend relating the steric bulk with the branched:linear ratio, which is also consistent with the 
reports of large ligands facilitating reductive elimination over β-hydride elimination.[33] 
 
Figure 1.2: Electronic factors influencing the mechanism of transmetalation of secondary alkylboron 
nucleophiles. 
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The outcome of this study of Biscoe and Sigman suggested that both enantiomers of a cross-
coupling product could be selectively accessed through the use of a single enantioenriched 
alkylboron nucleophile with the proper selection of the phosphine ligand. They identified the 
strongly σ-donating ligand PAd3 (L1.1) to promote the stereoinvertive pathway furnishing 
among others (S)-1.32 in excellent yield and stereoinversion. Whereas strongly π-accepting 
ligand bis-CF3PhXPhos L1.2 promoted the stereoretentive pathway furnishing among others 
(R)-1.32 in excellent yield and stereoretention (Scheme 1.10). 
 
Scheme 1.10: Enantiodivergent SMC using enantioenriched alkylboron nucleophiles.  
1.2.3. Challenges in Suzuki-Miyaura Cross-Coupling with Alkylboron Nucleophiles 
Most of the developments and applications of the B-alkyl SMC have been conducted on 
alkylboranes such as 9-BBN boranes (Figure 1.1) or related, and a broad range of primary alkyl 
moieties were cross-coupled with either C(sp2)- or C(sp3)-electrophiles.[7,32–34,91] Interestingly, 
the boronic acid analogues have witnessed a far minor development despite their superior 
stability and availability. This is due to the fact that their use is bound to slower 
transmetalation rates and side reactions such as protodeboration.[6] A way to overcome this 
issue is to use trifluoroborate salts (Figure 1.1), as they slowly release boronic acid into the 
reaction mixture, hence minimising the concentration of boronic acid and radically slowing 
down the protodeboration. By exploiting this strategy, Molander developed various primary 
alkyl trifluoroborate reagents which undergo efficient SMC.[92,93]  
Further challenges arise when moving from primary to secondary or tertiary alkylborane 
species, as the notoriously difficult to suppress β-hydride elimination becomes a possible side-
reaction. Additionally, the transmetalation becomes even slower due to steric hindrance. Fu 
and Hartwig were the first to report the successful SMC of secondary alkylboronic acid 
(Scheme 1.11).[94,95] Although, they each reported only one example, and considerable 
amount of isomerised product 1.39 was obtained together with the direct SMC product 1.38 
when sec-butylboronic acid 1.36 was employed. 
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Scheme 1.11: Seminal examples of SMC with secondary alkylboronic acids. 
Hoogenband and Molander then independently developed the more general SMC of 
secondary alkyltrifluoroborates (Scheme 1.12a).[96,97] It’s noteworthy to mention that no 
isomerisation to the linear product 1.43 was observed when Hoogenband employed sec-
butyltrifluoroborate 1.40, but only modest yields were obtained.[96] Molander’s system 
provided higher reactivity, but considerable amounts of isomerised SMC product due to 
β-hydride elimination was observed in sterically hindered systems (Scheme 1.12b).  
 
Scheme 1.12: SMC with secondary alkyltrifluoroborates. 
Additionally to the work of Biscoe and Sigman (Scheme 1.10),[89,90] Tang reported a general 
method for the SMC alkylboronic acids with hindered aryl bromides and triflates furnishing 
the desired product in excellent yield and branched/linear ratio with their newly developed 
P,P=O ligand L1.8 (Scheme 1.13).[98,99]  
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Scheme 1.13: General SMC with secondary alkylboronic acids. 
A different approach to achieve selective SMC of sec-alkylboron species is achieved by using 
directing groups which chelate to the catalyst, or by using α-anion stabilising substituents such 
as an additional boron atom or a position adjacent to functional groups,[6,100] but their 
description is outside the scope if this introduction.  
1.2.4. Conclusion  
The SMC is one of the few reactions that have been applied in organic synthesis ranging from 
fundamental research to large-scale manufacturing processes, and is doubtless an essential 
tool in the chemist’s toolbox. The advantages over other cross-couplings are clear. The 
organoboron species are accessible through various paths and generally exhibit stability to air, 
moisture and heat. Furthermore, the SMC generally employs mild reaction conditions and 
therefore tolerates various functional groups, and generates nontoxic boron by-products. 
In-depth mechanistic studies have demonstrated without doubt the existence of two 
transmetalation pathways, depending on the organoboron species and reaction conditions 
used. Recent studies on the pre-transmetalation intermediates further demonstrated the 
impact that a single reaction parameter, such as the amount and nature of ligand or the 
presence of water, can have. Moreover, due to constantly changing reaction conditions due 
to the release of boric acid (B(OH)3) and consumption of base it is possible that both the 
oxo-palladium and the boronate pathways compete during different stages of the SMC. 
Whereas the B-alykl SMC has become a mature and popular tool for primary alkylboranes, the 
adaptation to the secondary or tertiary analogues remains scarce due to competing side-
reactions. 
1.3. Palladium-Catalysed Site-Selective Migratory Functionalisation 
1.3.1. Introduction 
The remote functionalisation through initial interaction at a functionalised site leading to the 
selective activation of an unreactive C-H or C-C bond at a distal position remains one of the 
biggest challenges in organic chemistry with enormous potential. Many advances were made 
by the use of tethers placing a transition metal-catalyst proximal to the reaction site, but they 
often have the drawback of employing high molecular weight linkers.[12–19] Thus, the remote 
functionalisation through transition metal-catalysed chain-walking has been gaining increased 
attention in the last decade and a variety of catalytic systems have been developed.[24–28] 
However, transition-metal complexes are known to isomerise double bonds along an alkyl 
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chain in a statistical manner, therefore it can only be directed if associated with a strongly 
favoured termination step.[101] 
1.3.2. General Mechanistic Aspects 
Olefin isomerisation can proceed through either 1,2- or 1,3-hydrogen shift mechanisms, and 
both pathways can potentially compete with each other.[102,103] In the Inner-sphere 
1,2-hydride shift (Scheme 1.14a), the metal-hydride complex 1.59 undergoes hydrometalation 
with the olefin to furnish the well-defined alkyl-metal species 1.60. Subsequent β-hydride 
elimination gives the isomerised olefin π-complex 1.61, which after rotation and 
hydrometalation gives the isomerised alkyl-metal species 1.62. This process generally leads, 
after several repetition along an alkyl-chain, to the formation of the thermodynamically more 
stable primary organometallic species.[104] 
The 1,3-hydride shift can proceed through either an inner-sphere or outer-sphere mechanism. 
The inner-sphere mechanism (Scheme 1.14b) requires coordinatively unsaturated 
organometallic species possessing two vacant valence orbitals (14 electron species). Oxidative 
addition of the metal to the C-H bond facilitated by agostic interaction of the allylic hydrogen 
and the vacant metal-orbital (1.63) yields a η3-allyl metal-hydride intermediate 1.64. This 
intermediate gives, after rotation and reinsertion of the hydride, the isomerised olefin 1.65. 
The regiochemistry can vary and depends on the temperature and the nature of the catalyst 
and ligands.[105] Alternatively, the outer-sphere mechanism (Scheme 1.14c) can proceed if the 
ligand acts as a base, enabling, after complexation (1.66) the deprotonation to form the π-allyl 
metal complex 1.67 and reprotonation to provide the isomerised olefin 1.68.[106] 
 
Scheme 1.14: General mechanism for the transition metal-mediated olefin isomerisation.  
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Finally, the outer-sphere 1,3-proton shift mechanism can occur with the assistance of a base 
in case of π-acidic transition complex such as cationic palladium or silver complexes. The alkyl 
metal carbonium species 1.69 sufficiently acidifies the allylic proton to enable intermolecular 
deprotonation furnishing the allyl intermediate 1.71. Subsequent protonation cleaves the 
metal-carbon bond and furnishes the isomerised olefin 1.72.[107–109] 
However, palladium catalysed migratory remote functionalisation has been found to proceed 
in most cases through a non-dissociative inner-sphere 1,2-hydride shift, enabling the 
migration through tertiary stereocentres with retention of configuration, and initial 
chemoselectivity between different olefin moieties.[27] 
1.3.3. Key Developments 
Various different initiation and termination processes for palladium-catalysed remote 
functionalisation through chain-walk have already been described despite the short 
development period.  
1.3.3.1. Redox-Relay Remote Functionalisation Involving Chain-Walking 
The first report of a redox-relay Mizoroki-Heck reaction was disclosed in 1976 by Heck, in 
which allyl- and homoallyl alcohols underwent arylation and subsequent chain-walk until 
captured by the alcohol function to give a carbonyl compound.[110] Shortly thereafter, Chalk 
reported a similar approach with unsaturated alcohols.[111,112] It is noteworthy to mention that 
a product containing an aldehyde was observed when 9-decen-1-ol was engaged with 
iodobenzene in the reaction, indicating the ability of the palladium-catalyst to undergo long-
range chain-walk. However, the approach described in these seminal reports provided low 
yields of a mixture of products under harsh conditions. These early examples were then 
generalized and extended to the remote functionalisation of longer-chain olefinic alcohols 
1.73 to yield the corresponding carbonyls 1.75 by Larock in 1989 (Scheme 1.15).[113] This 
approach has, since then, found application in several reports.[114–120] 
 
Scheme 1.15: Seminal reports on the redox-relay Heck reaction. 
Sigman disclosed in 2012 the asymmetric remote functionalisation of allyl- homoallyl- and bis-
homoallyl alcohols 1.76 using a chiral PyrOx ligand L1.9 and aryldiazonium salts 1.77 as 
substrates (Scheme 1.16a).[121] Various ketones and aldehydes products were obtained in high 
yield and excellent stereoselectivity. Importantly, since then, asymmetric Heck reactions have 
been thoroughly investigated, but are generally limited to cyclic alkenes or those creating 
quaternary carbons stereocentres to prevent β-hydride elimination responsible for 
racemisation.[122] Thus, styrene formation and alkene dissociation from the catalyst must be 
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avoided for an enantioselective Heck type reaction. Theoretical studies on the mechanism of 
the asymmetric redox-relay Heck reaction (Scheme 1.16b) indicated a possible, but 
disfavoured β-hydride elimination at the newly created stereocentre 1.82. Instead, the 
palladium catalyst can move back and forth on the alkyl chain without dissociating from the 
alkene intermediates until eventual migration to the thermodynamically stable α-position of 
the hydroxyl group 1.83. Deprotonation then leads to the carbonyl compound 1.78 and 
regeneration of the catalyst 1.79.[123,124] 
 
Scheme 1.16: Asymmetric redox-relay Heck reaction and proposed catalytic cycle thereof. 
This methodology was then further applied to alkenyl triflates[125–127] and alkynyl iodanes[128] 
as well as to the alkenylation of acyclic enol ethers[129] and to the remote styrene formation 
as terminating step.[130] It should also be noted that all-carbon quaternary stereocentres are 
obtainable when tri-substituted alkenes are engaged. Significant extension was also achieved 
with the development of the redox-relay oxidative Heck reaction. Thus, arylboronic acids,[131–
137] indoles derivatives,[138–140] carbamates[141] and phenols[142] were successfully engaged in 
oxidative redox-relay Heck reactions, which were also applied to enelactams[137,143] and 
alkenes possessing a remote carbonyl group providing α,β-unsaturated carbonyl 
compounds.[133] 
Sigman and Uenishi independently demonstrated that tertiary carbon stereocentres are not 
racemised during a non-dissociative chain walking process (Scheme 1.17a, b). [132,144] That 
occurs because the catalyst sticks to the same side of the alkene moiety newly generated 
through the β-hydride elimination, and thus the hydride atom cannot be transferred back to 
the original position from the opposite face. Additionally, Marek developed a redox-relay Heck 
reaction involving site-selective cyclopropane ring opening and isomerisation which provides 
the corresponding ketone product 1.94 maintaining the configuration at the stereogenic 
centres (Scheme 1.17c).[145] 
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Scheme 1.17: Redox-relay Heck reaction of alkenyl alcohols containing a stereocentre on the alkyl chain. 
Alternatively, an in situ generated palladium hydride can also be used to initiate the 
chain-walking, resulting in an overall redox-relay isomerisation of olefinic alcohols. In 2014 
Mazet developed a methodology allowing the isomerisation of mono- to tetra substituted 
alkenyl alcohols (Scheme 1.18a)[146] which he later also adapted to the deconjugative redox-
relay isomerisation starting from α,β-unsaturated carbonyls.[147] Mazet then further combined 
these redox-relay isomerisation reactions with sequential multimetallic catalysis to enable 
subsequent functionalisation at the remote sites.[148,149] Daugulis reported in 2017 a redox-
relay isomerisation from terminal alkenyl silyl ether to silyl enol ethers (Scheme 1.18b).[150] 
Shortly thereafter, Kochi presented a very similar work, in which the selectivity for terminal 
1.99 over internal alkenes 1.100 was additionally described (Scheme 1.18c).[151]  
 
Scheme 1.18: Redox-relay isomerisation of alkenyl alcohols and alkenyl silyl ethers. 
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Instead of relying on the formation of a carbonyl or a conjugated moiety as a terminating step, 
Kochi demonstrated in 2012 that if the substrate contains an additional strategically 
positioned alkene, a subsequent cyclisation of the palladium intermediate gives rise to various 
cyclopentane scaffolds (Scheme 1.19a).[152,153] An asymmetric version was later published 
although with only modest enantioselectivity (Scheme 1.19b).[154] 
 
Scheme 1.19: Chain-walking cycloisomerisation of remote dienes. 
1.3.3.2. Remote Functionalisation through Chain-Walking enabled by Transient Alkenes 
The propensity of a palladium-catalyst to undergo chain-walk along an alkyl chain during cross-
coupling reactions has been generally considered as a side-reaction (see also Section 1.2.3). 
However, if the metal migration can be stopped at a selective site by the reductive elimination 
event, a remote functionalisation through migratory cross-coupling reactions can be achieved.  
In 1996 de Meijere reported the unexpected β-arylation on triquinanedione 1.107 (Scheme 
1.20a).[155] The authors initially proposed that the reaction proceeds through a 
dehydrogenation followed by a Heck reaction at to the newly formed double-bond. However, 
dehydrogenation of ketones normally requires stoichiometric amounts of Pd(OAc)2, or a 
catalytic amount and stoichiometric reoxidant, but such conditions only led to the 
decomposition of the starting material (1.107). Furthermore, no side-product arising from the 
Heck reaction with the already present double-bond in 1.107 was observed. Thus, a migratory 
cross-coupling pathway through chain-walk could also be envisaged for this transformation. 
Hartwig discovered in 2002 that the coupling between methyl isobutyrate (1.111) and 2-
bromothiophene (1.110) gave an unexpected 2:1 mixture of α- vs β-arylation products 1.112 
and 1.113, speculated to arise from reductive elimination of a palladium homoenolate 
obtained after rearrangement from the hindered palladium enolate (Scheme 1.20b).[156]  
In 2010 Baudoin reported a systematic study on the palladium-catalysed β-arylation reaction 
of carboxylic esters with aryl halides (Scheme 1.20c).[157] Whereas a bulky phosphine ligand 
such as P(tBu)3 (L1.3) gave the direct coupling product, more flexible ligands such as DavePhos 
(L1.16) afforded mainly the β-arylated product 1.116. Aryl halides bearing an ortho electron-
withdrawing group or a heteroatom (O, S) at the adjacent position were necessary for 
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high-to-complete selectivity. The asymmetric version was also investigated, but only 
moderate enantioselectivities were obtained. An in-depth mechanistic study by Baudoin and 
Clot gave further insight in the selectivity resulting from the different ligands. A difference of 
ΔΔG# = 3.7 kcal mol-1 was found in favour of the β-arylation pathway over the reductive 
elimination leading to the α-arylated product with DavePhos L1.16, in presence of an ortho-
fluoro-substituted aryl group 1.114 and methyl isobutyrate 1.111 (Scheme 1.20d).[158] Baudoin 
then further developed this migratory cross-coupling reaction for the long-range arylation of 
dibenzyl-protected amino esters where a migration of up to 5 positions was demonstrated,[159] 
as well as for the β-arylation of silyl ketene acetals under milder conditions.[160]  
 
Scheme 1.20: (Asymmetric) β-arylation of carboxylic esters through chain-walk. 
In 2011 Knochel reported a study on the diastereoselective α-arylation of substituted N-Boc-
piperidines via Negishi cross-coupling.[161] Unexpectedly, the β-arylation product 1.126 was 
obtained when the reaction was performed with 2-methyl-piperidine .125 (Scheme 1.21a). In 
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line with previous efforts to develop migratory cross-coupling reactions, Baudoin developed 
the ligand-controlled selective α- or β-arylation of N-Boc-piperidines 1.127 
(Scheme 1.21b),[162] which was then further extended to acyclic N-Boc amines,[163] and to the 
γ-selective arylation of allylic Boc-amines.[164] The selectivity was controlled by bulky and rigid 
phosphine ligands such as P(tBu) (L1.3) or RuPhos (L1.5), which provided the direct α-arylated 
products, whereas more flexible N-phenylazole-based phosphine such as CataCXium PiPr 
(L1.18) gave mainly the β-arylated products. More recently the asymmetric version of this 
migratory Negishi cross-coupling was disclosed using an initial sparteine-mediated 
enantioselective lithiation of Boc-1,3-oxazinanes 1.130 (Scheme 1.21c).[165] A broad range of 
alkenyl- and aryl-(pseudo-)halides were well tolerated and subsequent cleavage of the α- or 
β-arylated Boc-1,3-oxazinanes 1.131 & 1.132 gave β2- and β3-amino acids in good yields and 
excellent enantioselectivities. Baudoin also developed in 2016 a migratory Barbier-Negishi 
cross-coupling reaction for the long-range regioconvergent terminal functionalisation of 
mixtures of secondary alkyl bromides (Scheme 1.21d).[166] 
 
Scheme 1.21: Migratory Negishi-type cross-coupling reactions. 
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1.3.3.3. 1,x-Difunctionalisation (x ≠ 2) of Alkenes involving Chain-Walking 
The interception of Heck-like reaction intermediates after chain-walk can also lead to 
interesting 1,x-difunctionalisation (x ≠ 2) of alkenes through migratory multicomponent cross-
coupling (Scheme 1.22a).[167] Such difunctionalisation can by initiated by either oxidative 
addition or transmetalation, depending on the substrate, followed by migratory insertion into 
the olefin. The obtained alkyl-metal species 1.142 then undergoes chain-walking to a 
stabilised position 1.143 or 1.144. Subsequent oxidative addition or transmetalation followed 
by reductive elimination yields the 1,x-difunctionalised (x ≠ 2) product 1.138 or 1.139. 
Alternatively, the alkyl-metal species can also be trapped by a nucleophile (Scheme 1.22b).  
 
Scheme 1.22: 1,n-Difunctionalisation (n ≠ 2) through chain-walk. 
In 1985 Yoshida disclosed the intramolecular 1,1-aryloxygenation of unsaturated alcohols 
(1.147) to afford substituted tetrahydropyrans (1.149, Scheme 1.23),[168] followed by the 
related 1,1-aryloxygenation of unsaturated amines to afford 2-arylated pyrrolidines and 
piperidines.[169] Since then, significant developments have been made by combining different 
types of substrates. Thus various methods for the 1,1-arylhalogenation,[170–173] 
1,1-aryloxygenation,[174–176] 1,1-diarylation,[177–184] 1,1-vinylarylation[185,186] as well as 
1,1-arylboration[187,188] of alkenes involving chain-walking were disclosed. 
 
Scheme 1.23: Intramolecular 1,1-aryloxygenation of terminal alkenes. 
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In 1991 Larock reported a three-component coupling of aryl-iodides (1.151), non-conjugated 
dienes (1.150) and carbon nucleophiles (1.152) for the synthesis of 
1,x-dicarbofunctionalisation (x ≠ 1,2) products 1.153 (Scheme 1.24).[189] Mechanistically it was 
proposed that the chain-walking was driven by the formation of the stable π-allyl-Pd species 
1.154, which was trapped by the nucleophile 1.152. Soon after, the scope of this reaction was 
extended to a variety of nitrogen nucleophiles,[190,191] as well as to the intramolecular version 
with aryl iodides bearing ortho-substituted nucleophilic groups and 1,4-dienes.[192] During 
these studies Larock also reported the selective 1,3-difunctionalisation of 1,4-
cyclohexadienes.[189,190] Only recently, Yin further reported their the 1,3-arylboration and 
1,3-diarylation of 1,4-cyclohexadienes.[193] 
 
Scheme 1.24: Three-component migratory cross-coupling reaction of nonconjugated dienes. 
During a study in 2004 on the synthesis of N-aryl pyrrolidines, Wolf observed the formation of 
a product issued from migration of the catalyst.[194] Further investigation led to a protocol 
furnishing 5-aryl octahydrocyclopenta[b]pyrroles (1.157) in good yields and excellent 
selectivity starting from alkenyl amine (1.155) and aryl bromide 1.156 when P(tBu)2Me (L1.21) 
was used as a ligand (Scheme 1.25).[195] The effect of the ligand was quit dramatic in selectivity 
and reactivity, as switching to P(tBu)3 (L1.3) completely shut down the reaction. 
 
Scheme 1.25: Synthesis of 5-aryl octahydrocyclopenta[b]pyrroles involving chain-walking. 
The possibility of an asymmetric 1,3-difunctionalisation on a cyclic system was reported by 
Toste in 2017 (Scheme 1.27).[196] The integrated mechanistic study led the authors to conclude 
that the ligand, the aryl boronic acid (1.159) as well as the directing group significantly 
influence the regioselectivity of the reaction. Thus, an increased electrophilic character at 
palladium favoured the formation of the 1,3-product. 
 
Scheme 1.26: 1,3-Arylfluorination of chromenes 
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Kochi also recently disclosed the cycloisomerisation of remote dienes 1.162 initiated by 
hydrosilylation of the terminal alkene enabling further transformation at this end of the chain 
(Scheme 1.27).[197] 
 
Scheme 1.27: Hydrosilylation/cyclisation of remote dienes. 
Finally Lin and Yao disclosed the 1,x-arylamination (x = 3-11) of unactivated alkenyl phenols 
(1.165, Scheme 1.28).[198] They proposed a mechanism initiated by a Heck reaction followed 
by chain-walk to the remote benzylic position. Base-assisted quinone-methide formation 
(1.169) and subsequent aza-michael addition by indoline 1.167 furnishes the product 1.168.  
 
Scheme 1.28: 1,11-Arylamination of unactivated alkenyl phenols. 
1.3.4. Conclusion 
Site-specific remote functionalisation through migration of a palladium-catalyst along an alkyl-
chain has gained significant momentum during the last decade. However, it has not always 
been an easy challenge to identify a terminating step, which selectively occurs at a specific 
site. Nevertheless, a broad range of reactions involving chain-walking have already been 
described. Furthermore, the field of remote functionalisation will surely grow continuously 
due to the large amount of reactions involving an alkyl-palladium species, which could be 
pushed to undergo migration. 
Besides providing interesting scaffolds, it should also be noted that chain-walking further 
enables the regioconvergent functionalisation of positional mixtures of functionalised alkyl-
chains such as fatty-acids or alkenes of interest for industrial valorisation of feed-stock 
chemicals.[25] 
Moreover, in-depth mechanistic studies furnished valuable information on the different 
reaction parameters which influence the selectivity, and thus the researchers already have a 
strong background to rely on for further development. 
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1.4. Aim of this Thesis 
The SMC is doubtless an indispensable tool for the synthesis of chemicals from fundamental 
academic research to large-scale industrial applications. Despite early observations of chain-
walking during B-alkyl SMC and a constantly growing number of migratory cross-coupling 
reactions, the development of an efficient palladium-catalysed migratory version of the SMC 
has remained elusive.  
The aim of this thesis was therefore to design and develop a migratory version of the SMC to 
further broaden the organic chemist’s toolbox as well as to gain additional insights in the 
reaction parameters influencing chain-walking. 
In the first part, we will discuss the efforts made towards a one-pot approach for the 
regioconvergent terminal arylation of regioisomeric mixtures of alkenes. Since lightweight 
alkenes represents a cheap feedstock, this would represent an efficient way to bring some 
molecular complexity in a single step. 
The second part will be dedicated to the development of the benzylic selective migratory SMC 
for the synthesis of 1,1-diarylalkenes starting from alkenes, borane and bromoarenes. 
Finally, attempts towards the development of a cascade reaction involving the benzylic 
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2. Terminal-Selective Palladium-Catalysed Migratory 
Suzuki-Miyaura Cross-Coupling 
2.1. Design Plan 
Linear alkenes are an important feedstock obtained amongst others through cracking of crude 
oil. However, the resulting crude is composed of isomeric mixtures, which leads to tedious 
purification and thus rising the price of the final product.[199] Hence, a method which could 
selectively functionalise a regioisomeric mixture of linear alkenes in a regioconvergent manner 
is highly desirable. As described in Section 1.3, alkenes can readily undergo migratory cross-
coupling. With this in mind, we envisioned that we could exploit terminal-selective palladium-
catalysed migratory SMC for the remote functionalisation of alkenes as shown in Scheme 2.1. 
 
Scheme 2.1: Aim of the project: terminal-selective remote functionalisation through migratory SMC. 
A hypothetic catalytic cycle for this transformation is depicted in Scheme 2.2. Oxidative 
addition of the electrophile 2.2 to a Pd0 catalyst (2.4) followed by ligand exchange gives the 
intermediate 2.6. Transmetalation with the alkylborane 2.7 obtained by alkene hydroboration 
yields the intermediate 2.8 which then undergoes chain-walking until it reaches a terminal 
position yielding the intermediate 2.12. Reductive elimination at this site furnishes the linear 
alkylarene product 2.3 and regenerates the catalyst 2.4.  
 
Scheme 2.2: Hypothetic catalytic cycle. 
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Ideally, all three alkyl moieties of the trialkylborane species 2.7 would undergo 
transmetalation successively. However, previous SMC protocols employing linear 
trialkylborane generally engage an excess amount of the borane species due to side-reactions 
and slow transmetalation rates.[200,201] In order to enhance the reactivity of trialkylboranes, 
Lacôte envisioned to exploit their complexation with an N-heterocyclic carbene (NHC).[202] 
Thus, all three alkyl-substituents of this complex could be successfully transformed to the 
alkylarene product 2.15 when a base was added to the reaction mixture. However, the 
stoichiometric amount of NHC used translates to a poor overall atom-economy (Scheme 2.3). 
 
Scheme 2.3: SMC of NHC-Boranes enables the transfer of all three alkyl moieties of symmetrical 
trialkylboranes. 
More recently, Li and Zhong reported a one-pot procedure for the generation and SMC of 
linear trialkylboranes with aryl halides (Scheme 2.4a).[203] Interestingly, they observed 
isomerisation when the reaction was performed with tri-sec-butylborane 2.7a, yielding a 4:1 
mixture of the direct 2.9a and migratory cross-coupling products 2.3b (Scheme 2.4b). Thus, 
this report served as inspiration for the design as well as proof-of-concept for the idea of a 
terminal-selective migratory SMC. 
 
Scheme 2.4: One-pot procedure for the SMC of terminal alkenes and observed isomerisation for the SMC with 
tri-sec-butylborane. 
2.2. Results & Discussion 
2.2.1. Preliminary Test-Reactions 
We initiated our studies by reproducing the protocol of Li and Zhong[203] with 
CataCXium A (L2.2) or RuPhos (L2.3) as ligand, tri-sec-butylborane (2.7a) and different 
bromoarenes (2.2) to identify the reaction parameters which influence the chain-walking 
process (Table 2.1). As described, the coupling of bromobenzene (2.2a) and 
tri-sec-butylborane (2.7a) with CataCXium A (L2.2) as ligand furnished a mixture of branched 
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and linear product with a linear/branched ratio of ~1:4 (entry 1). A dramatic difference in 
selectivity was observed when the reaction was performed with RuPhos (L2.3) as ligand, 
indicating a strong influence of the ligand on the selectivity (entry 2). Interestingly, the 
electronic parameters of the electrophile 2.2 only had a slight impact (entry 3-5), whereas a 
higher ratio of the linear product 2.3 was observed when 1-bromo-2-fluorobenzene (2.2d) was 
used as electrophile as previously observed (entry 6, 7).[157,166] CataCXium PnBu (L2.4), which 
provided optimal selectivity in previous migratory Negishi cross-couplings,[162–166] gave better 
ratios albeit with low yields and mainly dehalogenated electrophile as side-product 
(entry 8, 9). 
Table 2.1: Preliminary test-reactions. 
 
Entry Ligand ArBr rr[a] 
1 CataCXium A (L2.2) 2.2a 18:82 
2 RuPhos (L2.3) 2.2a 5:95 
3 CataCXium A (L2.2) 2.2b 21:79 
4 RuPhos (L2.3) 2.2b 18:82 
5 CataCXium A (L2.2) 2.2c 32:67 
6 CataCXium A (L2.2) 2.2d 95:5 
7 RuPhos (L2.3) 2.2d 50:50 
8 CataCXium PnBu (L2.4) 2.2b 81:19 
9 CataCXium PnBu (L2.4) 2.2c 66:34 
[a] Regioisomeric ratio (rr) of linear/branched regioisomers were determined by GC-FID analysis. 
 
The high differences in selectivity between the conditions tested indicate a strong influence 
from the ligand, but only minimal influence from the electronic parameters of the 
electrophile. Thus, we reasoned it is possible to identify the right catalyst in order to achieve 
the set goal of a regioisomeric ratio of minimum 9:1 for the linear product 2.3. An additional 
challenge expected to be encountered is the finding of the right conditions to enable the 
efficient transmetalation of all three sec-alkyl moieties of the trialkylborane species 2.7. 
However, an alternative to overcome this problem is the preparation of the sec-alkylboronic 
acid analogue by adjusting the equivalents of borane used for the hydroboration of the alkene 
2.1, as this specie were previously successfully engaged in SMC (see also Section 1.2.3)  
Terminal-Selective Palladium-Catalysed Migratory Suzuki-Miyaura Cross-Coupling 
- 28 - 
2.2.2. Optimisation of the Reaction Conditions  
We initiated our study with the model reaction of 4-bromoanisole (2.2b) and 
tri-sec-butylborane (2.7a) to focus on the migratory SMC, thus avoiding the initial 
hydroboration step. Aiming at identifying a potent family of ligands for our reaction, we 
performed a broad screen of ligands (Table 2.2 and 2.3). Interestingly, a 82:18 regioisomeric 
ratio was observed when JohnPhos (L2.5) was used (entry 1, Table 2.2), but this selectivity was 
lost when the alkyl substituents of the ligand were different (entry 2, 3). DavePhos (L2.8) and 
PhDavePhos (L2.9) roughly gave a 1:1 mixture of products (entry 4, 5). Further phenyl-pyrrole-
type or related ligands were also tested, but yielded only poor regioisomeric ratios 
(entry 6-11).  
Table 2.2: Initial screening of ligands (1/2). 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 JohnPhos (L2.5) 16 82:18 
2 PhJohnPhos (L2.6) 11 57:43 
3 CyJohnPhos (L2.7) 30 39:61 
4 DavePhos (L2.8) 39 44:56 
5 PhDavePhos (L2.9) 19 49:51 
6 CataCXium PtB (L2.10) 6 64:36 
7 CataCXium PNp (L2.11) 20 43:57 
8 CataCXium PCy (L2.12) 21 22:78 
9 CataCXium PiPr (L2.13) 23 36:64 
10 CataCXium PIntB (L2.14) 18 63:37 
11 L2.15 29 13:87 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis.
 
We then continued the ligands screen with smaller phosphines (Table 2.3). Phenyl 
substituents on the phosphine further gave poor selectivity (entry 1, 2), while PCy3 (L2.18) 
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gave an interesting 80:20 ratio, but with only 5% yield (entry 3), which could be increased to 
53% with similar selectivity when the corresponding tetrafluoroborate salt L2.19 was engaged 
(entry 4). The more bulky P(tBu)3∙HBF4 (L2.20) gave mainly the direct coupling product, 
eventually giving us a clue on which parameters of the ligand could influence the selectivity 
(entry 5). However, further trialkyl-phosphines did not clarify if smaller ligands indeed favour 
the chain-walking (entry 6-12). Bidentate ligands further yielded unsatisfying mixtures of the 
coupling products. 
Table 2.3: Initial screening of ligands (2/2). 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 PPh2tBu (L2.16) 55 31:69 
2 PPhCy2 (L2.17) 54 53:47 
3 PCy3 (L2.18) 5 80:20 
4 PCy3∙HBF4 (L2.19) 53 77:23 
5 P(tBu)3∙HBF4 (L2.20) 72 24:76 
6 P(tBu)2Np∙HBF4 (L2.21) 61 73:27 
7 P(iPr)3∙HBF4 (L2.22) 9 83:17 
8 PEt3∙HBF4 (L2.23) - - 
9 CataCXium FBU (L2.24) 11 52:48 
10 CataCXium A (L2.2) 76 19:81 
11 CataCXium AHI (L2.25) 10 21:79 
12 CataCXium ABn (L2.26) 2 46:54 
13 DTBPF (2.27) 29 19:81 
14 DCPF (L2.28) 37 53:47 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis. 
 
As the reaction mostly gave poor overall yields, we decided to enhance the reactivity before 
screening further ligands. Thus, as the base can play a major role in SMC, we tested various 
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inorganic bases which are traditionally used in SMC with the initial reaction conditions 
(Table 2.4). The reaction seemed to work, but without improvement, with hydroxide bases 
(entry 1-3), as well as tert-butoxide bases (entry 4-6). Lithium carbonate completely shut 
down the reaction (entry 7) but potassium carbonate gave 72% combined yield (entry 8). 
Caesium carbonate gave a slightly better yield (entry 9) than the initial conditions with 
potassium phosphate (see also Table 2.3, entry 10), whereas acetates completely killed the 
reactivity (11-13). We retained caesium carbonate as it gave a slight increase in yield, but also 
because it facilitated the filtration over Celite® during the work-up of the reactions. 
Surprisingly, changing the amount of caesium carbonate did not give great differences (entry 
1-3, Table 2.5). 
Table 2.4: Screening of different inorganic bases. 
 
Entry Base Combined Yield (%)[a] rr[b] 
1 LiOH 39 19:81 
2 NaOH 64 19:81 
3 KOH 71 19:81 
4 LiOtBu 50 19:81 
5 NaOtBu 70 19:81 
6 KOtBu 74 19:81 
7 Li2CO3 - - 
8 K2CO3 72 19:81 
9 Cs2CO3 79 19:81 
10 LiOAc - - 
11 NaOAc - - 
12 KOAc - - 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis.  
Table 2.5: Screening of the amount of base. 
 
Entry Amount of Base  Combined Yield (%)[a] rr[b] 
1 1.0 equiv. 71 18:82 
2 1.5 equiv. 75 18:82 
3 3.0 equiv. 80 18:82 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis.  
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We then turned our attention to the reaction temperature (Table 2.6). Interestingly, lowering 
the temperature gave a faintly better selectivity for the linear product (entry 1), whereas 
higher temperature slightly decreased the selectivity (entry 3). However, we decided to keep 
the temperature at 100 °C as we observed decreased reactivity with other phosphines 
at 80 °C. 
Table 2.6: Screening of different temperatures. 
 
Entry Temperature (°C) Combined Yield (%)[a] rr[b] 
1 80 78 21:79 
2 100 79 18:82 
3 120 76 16:84 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis.  
Finally we also tested different solvents (Table 2.7). Ether solvents generally gave a slightly 
better selectivity compared to toluene, but decreased the reactivity (entry 1-5). Acetonitrile 
and 1,2-dichloroethane also lowered the reactivity (entry 7,8), and hexane did not give any 
improvement either (entry 9). Thus, it seemed that a 10:1 mixture of toluene with water was 
the best solvent system. 
Table 2.7: Screening of solvents. 
 
Entry Solvent Combined Yield (%)[a] rr[b] 
1 THF 44 23:77 
2 2-MeTHF 45 22:78 
3 DME 43 24:76 
4 t-BME 45 23:77 
5 1,4-Dioxane 52 23:77 
6 MeCN 38 22:78 
7 DCE 34 28:72 
8 Hexane 69 20:80 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis.  
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With slightly improved conditions at hand, we turned our focus back to the main goal of 
improving the regioselectivity of the reaction. Various N-heterocyclic carbene (NHC) were 
tested, but unfortunately showed no reactivity for this type of reaction (Table 2.8, entry 1-7). 
Table 2.8: Screening of NHC ligands. 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 IBioxMe4∙HOTf (L2.29) - - 
2 IPr∙HCl (L2.30) ~1 60:40 
3 SIPr∙HCl (L2.31) - - 
4 SIMes∙HCl (L2.32) - - 
5 SIAd∙HCl (L2.33) - - 
6 IAd∙HBF4 (L2.34) - - 
7 ICy∙HBF4 (L2.35) - - 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis. 
 
Since PCy3∙HBF4 (L2.19) gave the best results in the previous ligand screenings with similar 
reaction conditions (see also Table 2.3, entry 4), we decided to change one cyclohexyl 
substituent and thus tune the steric properties, which seemed to affect the regioselectivity. 
Therefore, six new PCy2R (L2.36 – L2.40) were successfully synthesized from 
chlorodicyclohexylphosphine (2.16) and the corresponding Grignard reagents 
(2.17, Scheme 2.5). 
 
Scheme 2.5: Synthesis of PCy2R; [a] X = Br, Cl; [b] Prepared from the corresponding lithiate. 
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These newly synthesised ligands were then tested in the model reaction with additional 
commercial ligands (Table 2.9). Surprisingly, a slightly smaller[204] neopentyl substituent 
(L2.36) completely switched the selectivity to the direct coupling product (entry 1), whereas 
in a previous ligand screening the P(tBu)2Np∙HBF4 (L2.21) gave a much better selectivity for 
the linear product than P(tBu)3∙HBF4 (L2.20, see also Table 2.3, entry 5, 6). Linear alkyl 
substituents gave a better selectivity at the expense of reactivity (entry 2) which was more 
pronounced for n-butyl (entry 3). Only small yields and worsened selectivity was observed 
with branched butyl isomers (entry 4, 5). The ferrocene containing phosphine L2.41 gave a 
~1:1 mixture and a similar outcome was obtained when PCy2tBu (L2.42) was tested (entry 8). 
The bidentate DCPE (L2.43) showed no reactivity (entry 9). As we assumed that less steric bulk 
favours the chain-walk we also tested PCyp3 (L2.44), which indeed gave a better selectivity 
than the cyclohexyl analogue (entry 10). 
Table 2.9: Screening of PCy2Alk ligands. 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 PCy2Np (L2.36) 48 26:74 
2 PCy2Et (L2.41) 44 87:13 
3 PCy2nBu (L2.37) 4 88:12 
4 PCy2sBu (L2.38) 17 78:22 
5 PCy2iBu (L2.39) 10 70:30 
6 PCy2Fer (L2.40) 53 51:49 
8 PCy2tBu (L2.42) 70 46:54 
9 DCPE (L2.43) - - 
10 PCyp3 (L2.44) 51 83:17 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis. 
 
Motivated by this promissing result, we assumed that the smaller PCyp2Alk analogues could 
further improve the selectivity and thus we prepared a small library of such phosphines 
(Scheme 2.6). 
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Scheme 2.6: Synthesis of PCyp2Alk; [a] X = Br, Cl. 
The reaction with PCyp2Me (L2.45) did not give any product (entry 1), and the two PCyp2Alk 
phosphines with either an ethyl L2.46 or a n-butyl L2.47 gave comparable results regarding 
selectivity and low yields (entry 2, 3). 
Table 2.10: Screening of PCyp2Alk ligands. 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 PCyp2Me (L2.45) - - 
2 PCyp2Et (L2.46) 38 88:12 
3 PCyp2nBu (L2.47) 5 89:11 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis.  
 
Since, the reactivity with these ligands seemed very delicate, and the tetrafluoroborate salt of 
PCy3 L2.19 previously showed better results in terms of yield (see also Table 2.3, entry 3, 4), 
we decided to prepare the salts of the previously obtained phosphines by simply mixing them 
with aqueous HBF4 in dichloromethane (Scheme 2.7).[205] 
 
Scheme 2.7: Synthesis of the HBF4 salts from the corresponding trialkylphosphines. 
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The obtained ligands L2.49 – L2.53 and L2.54 – L2.57 as well as the commercial L2.58 were 
then engaged in the model reaction to check if the reactivity could be enhanced (Table 2.11). 
Unfortunately, all of the PCy2Alk∙HBF4 ligands L2.49 – L2.53 and L2.58 did not significantly 
improve the yield of the reaction (entry 1-6), whereas the reactions with PCyp2Alk∙HBF4 L2.54 
– L2.57 showed minor improvements (entry 7-10). Interestingly, despite with a very low yield, 
we observed for the first time a selectivity of above 9:1 for the linear product with 
PCyp2Me∙HBF4 L2.55 (entry 7), as well as with P(nBu)3 L2.59 (entry 11). 
Table 2.11: Screening of PCy2Alk and PCyp2Alk tetrafluoroborates. 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 PCy2Np∙HBF4 (L2.49) 60 28:72 
2 PCy2Et∙HBF4 (L2.50) 41 87:13 
3 PCy2nBu∙HBF4 (L2.51) 6 87:13 
4 PCy2sBu∙HBF4 (L2.52) 26 78:22 
5 PCy2iBu∙HBF4 (L2.53) 19 69 
6 PCy2tBu∙HBF4 (L2.58) 56 46:54 
7 PCyp2Me∙HBF4 (L2.54) ~1 93:7 
8 PCyp2Et∙HBF4 (L2.55) 44 88:12 
9 PCyp2nBu∙HBF4 (L2.56) 36 87:13 
10 PCyp2iPr∙HBF4 (L2.57) 54 81:19 
11 PnBu3 (L2.59) ~1 95:5 
[a] Yield determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/branched 
regioisomers were determined by GC-FID analysis. 
 
Since we finally had a good regioselectivity, we turned our attention to the reactivity. As we 
observed only trace amounts of product, we started with the investigation of the key steps of 
the migratory SMC. Thus, we tested various additives which we believed could enhance the 
transmetalation e.g. by coordination to the borane (Table 2.12). However, while nitrogen or 
phosphorous Lewis bases did not improve the yield (entry 1, 2), interestingly, silver salts 
showed some minor improvements which could be associated to the removal of the bromide 
in the reaction mixture by forming insoluble silver-halide salts and thus making the palladium 
more cationic (entry 3, 4). A further hint in this direction was the complete absence of product 
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when lithium triflate was used (entry 5). Lithium chloride, which has been observed to 
enhance the reactivity in other cross-couplings,[6] did not increase the yield (entry 6). 
Table 2.12: Screening of different additives. 
 
Entry Additive Combined Yield (%)[a] rr[b] 
1 DABCO (0.4 equiv) - - 
2 PnBu3 (0.4 equiv) ~1 95:5 
3 AgOTf (1 equiv) 11 92:8 
4 AgBF4 (1 equiv) 3 93:7 
5 LiOTf (1 equiv) - - 
6 LiCl (1 equiv) - - 
[a] Yield of 2.3b determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/branched regioisomers were determined by GC-FID analysis. 
We therefore continued our optimisation study by testing the reaction at different 
temperatures and a prolonged reaction time (Table 2.13). Decreasing the temperature was 
detrimental (entry 1, 2), and prolonged reaction time not beneficial (entry 1-3). A higher 
temperature was also not improving the yield (entry 4). 
Table 2.13: Longer reaction time and different temperatures. 
 
Entry Temp. (°C) Reaction time Combined Yield (%)[a] rr[b] 
1 60 4.5 d 11 94:6 
2 80 4.5 d 31 93:7 
3 100 4.5 d 49 92:8 
4 120 16 h 27 91:9 
[a] Yield of 2.3b determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/branched regioisomers were determined by GC-FID analysis. 
Another possible way of generating more cationic palladium intermediates is to use different 
types of the electrophile. We therefore tested various pseudo-halides (Table 2.14). 
Aryl-tosylate 2.19 and the aryl-mesylate 2.20 showed no reactivity (entry 1, 2). However, the 
aryl-triflate 2.21a gave 49% yield with a high regioisomeric ratio of 92:8 (entry 3) and also the 
aryl-nonaflate 2.22a gave a similar outcome (entry 4). The aryl-diazonium salt 2.23, which 
tends to give a very cationic palladium intermediate upon oxidative addition as well as the 
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generally more reactive aryl-iodide did not react (entry 5, 6). Thus, we continued with the aryl-
triflate 2.21a. 
Table 2.14: Screening of different types of electrophiles. 
 
Entry Electrophile Combined Yield (%)[a] rr[b] 
1 Aryl-Tosylate (2.19) - - 
2 Aryl-Mesylate (2.20) - - 
3 Ar-Triflate (2.21a) 49 92:8 
4 Ar-Nonaflate (2.22a) 42 92:8 
5 Aryl-Diazonium∙HBF4 (2.23) - - 
6 Ar-Iodide (2.24) - - 
[a] Yield of 2.3b determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/branched regioisomers were determined by GC-FID analysis. 
 
We also investigated the palladium-to-ligand ratio, which can have an impact on various 
stages of the reaction as previously described (see also Section 1.2.2.). A 1:1 ratio seemed to 
give a slightly lower yield (entry 1) compared to the previously used 1:2 ratio (entry 2), 
whereas a 1:3 ratio nearly shut down the reactivity (entry 3). Therefore we concluded to 
maintain the original amount of ligand. 
Table 2.15: Screening of the palladium – ligand ratio. 
 
Entry Amount of Ligand Combined Yield (%)[a] rr[b] 
1 5 mol% 40 92:8 
2 10 mol% 50 92:8 
3 15 mol% 6 95:5 
[a] Yield of 2.3b determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/branched regioisomers were determined by GC-FID analysis. 
As the employment of aryl-triflate 2.21a significantly enhanced the yield, we decided to test 
some ligands which previously either did not give any product, or showed interesting 
selectivity but with low yield (Table 2.16). Symmetrical trialkylphosphines gave modest yield 
with good selectivity (entry 1-3), and the ethyl substituted dicycloalkylphosphines showed 
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some conversion with high selectivity (entry 4, 5). The reaction with PCyp2Me, which 
previously gave a yield of 1% (see also Table 2.11, entry 7) now furnished 47% of the product 
in a 91:9 ratio (entry 6). Other substituents did not improve the results (entry 7, 8), but 82% 
yield with a ratio of 88:12 was obtained when P(tBu)2Me L2.60 was engaged (entry 9). Finally, 
the reaction with NHC ligands also yielded some product, but with a poor selectivity 
(entry 10,11). 
Table 2.16: Screening of ligands with aryl triflate 2.21b. 
 
Entry Ligand source Combined Yield (%)[a] rr[b] 
1 PCy3 (L2.10) 34 78:22 
2 PiPr3∙HBF4 (L2.22) 38 82:18 
3 PEt3∙HBF4 (L2.23) 36 93:7 
4 PCy2Et (L2.37) 49 87:13 
5 PCyp2Et (L2.45) 33 89:11 
6 PCyp2Me (L2.46) 47 91:9 
7 PCyp2nBu (L2.47) 15 88:12 
8 PCyp2iPr (L2.48) 36 82:18 
9 P(tBu)2Me (L2.60) 82 88:12 
10 IPr∙HCl (L2.30) 11 53:47 
11 SIPr∙HCl (L2.31) 2 44:56 
[a] Yield of 2.3b determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/branched regioisomers were determined by GC-FID analysis. 
 
An additional screening of different solvents was then performed in a final attempt of reaching 
the set goal of a 9:1 ratio in favour of the linear product with P(tBu)2Me L2.60 (Table 2.17). 
Amide solvents slightly improved the selectivity at the expense of the yield (entry 1-3). Other 
polar aprotic solvents also decreased the yield of the reaction (entry 4, 5), whereas alcohol 
solvents shut down the reactivity (entry 6, 7). Ether solvents as well as acetonitrile and DCE 
also showed no improvement (entry 8-10).  
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Table 2.17: Screening of solvents. 
 
Entry Solvent Combined Yield (%)[a] rr[b] 
1 DMF 18 90:10 
2 NMP 23 90:10 
3 DMAC 29 90:10 
4 Et3N 62 87:13 
5 EtOAc 43 89:11 
6 iPrOH 1 93:7 
7 EtOH 2 91:7 
8 THF 25 89:11 
9 1,4-Dioxane 48 89:11 
10 DME 61 90:10 
11 MeCN 13 91:9 
12 DCE 9 90:10 
[a] Yield of 2.3b determined by GC-FID analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/branched regioisomers were determined by GC-FID analysis. 
We then performed some test-reactions with different sec-butylborane species to see if the 
reaction conditions are generally applicable (Scheme 2.8). The reaction surprisingly only gave 
4% of product with sec-butylboronic acid 2.25, which is thought to be the species generated 
in situ after two transmetalation starting from the tri-sec-butylborane 2.7a. Furthermore, the 
pinacol ester 2.26 and the trifluoroborate analogues 2.27 did not furnish any product at all. 
 
Scheme 2.8: Test-reactions with different sec-butylboranes. Yield determined by GC-FID analysis with internal 
standard; Regioisomeric ratio (rr) of linear/branched regioisomers were determined by GC-FID analysis. 
As outlined at the beginning of this chapter (see also Scheme 2.1), the aim of this project was 
to start from an olefin which undergoes hydroboration followed by migratory SMC. Initial 
Terminal-Selective Palladium-Catalysed Migratory Suzuki-Miyaura Cross-Coupling 
- 40 - 
attempts for the hydroboration of trans-3-hexene 2.1b using the same protocol as reported 
by Li and Zhong[203] surprisingly yielded no product. However, after minor modifications we 
were pleased to find that adding the alkene to a 2 M BH3∙DMS solution in toluene at room 
temperature and letting the reaction mixture stir for 1 hour at 50 °C efficiently transformed 
the olefin to the tri-3-hexyl-borane 2.7b. With the hydroboration working we then tested the 
whole sequence (Scheme 2.9). The reaction starting with trans-3-hexene 2.1b furnished 56% 
yield of 2.3c, but with a modest 72:28 regioisomeric ratio for the linear product over the sum 
of the branched isomers. The drop in selectivity, and to some extend the lower yield, can be 
rationalised by the longer migration distance necessary to reach the terminal position of the 
alkyl-chain. This also means, that the yield and selectivity would possibly further drop if the 
reaction is performed with longer linear alkene chains.  
 
Scheme 2.9: One-pot alkene hydroboration/migratory SMC test-reaction. The initial position of the alkene is 
highlighted in orange. Yield determined by GC-MS analysis with internal standard; Regioisomeric ratio (rr) of 
linear/sum of branched regioisomers were determined by GC-MS analysis. 
We therefore had to perform further optimisation, but this time starting from 
tri-3-hexyl-borane 2.7b in order to adapt our reaction conditions to longer branched chains. 
Thus, different classes of ligands were again tested, to see whether we could identify another 
ligand platform suitable for the migratory SMC (Table 2.18). Unfortunately, the biphenyl-type 
ligands performed only poorly (entry 1, 3), even though JohnPhos L2.5 gave a better selectivity 
of 83:17 (entry 1). Phenyl-pyrrole or related ligands also showed only little reactivity and 
selectivity (entry 4-7). Other N-aromatic phosphines as well as BrettPhos L2.4 were also not 
performing well (entry 8-12). 
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Table 2.18: Screening of ligands with 2.26. 
 
Entry Ligand source Yield (%)[a] rr[b] 
1 JohnPhos (L2.5) 16 83:17 
2 PhJohnPhos (L2.6) 10 45:55 
3 CyJohnPhos (L2.7) 10 41:59 
4 CataCXium PnBu (L2.4) 17 64:36 
5 CataCXium PNp (L2.11) - - 
6 CataCXium PCy (L2.12) 6 21:79 
7 CataCXium PiPr (L2.13) 7 48:52 
8 L2.61 2 57:43 
9 L2.62 6 14:86 
10 L2.63 3 51:49 
11 L2.64 28 75:25 
12 BrettPhos (L2.65) 4 27:73 
13 PCyp3∙HBF4 (L2.19) 21 78:22 
[a] Yield of 2.3c determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/sum 
of branched regioisomers were determined by GC-MS analysis.
 
Since we could not identify a better catalyst system to achieve a higher regioselectivity, we 
then turned our attention towards the electrophile. As the chain-walking process occurs after 
oxidative addition and transmetalation, the electrophile is ligated to the palladium during the 
migration of the catalyst along the alkyl-chain, and thus can influence the steric and electronic 
properties of the catalyst (see also Scheme 2.2). Electron withdrawing substituents in 
ortho-position to the electrophilic centre generally disfavours the reductive elimination 
electronically, and therefore favour the chain-walk as observed for the initial test-reactions 
(see also Table 2.1, entry 6, 7) as well as in previous reports from the Baudoin group.[157,166] 
We engaged different electrophiles to gain further insight and identify a potential substituent, 
which could serve as a directing group (Table 2.19). An electron withdrawing substituent such 
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as a trifluoromethyl in para-position (2.21b) gave a 88:12 ratio for the linear product (entry 
1), whereas an electron donating substituent such as a methoxy at the same position (2.21a) 
gave an 72:28 ratio (entry 2) and a methyl (2.21c) led to a 80:20 ratio (entry 3). A 
trifluoromethyl group in meta-position (2.21d) further slightly improved the selectivity 
(entry 4). To our delight, a methoxy substituent in ortho-position (2.21e) gave rise to an 
excellent selectivity of >99:1 (entry 5), as with a trifluoromethyl substituent (2.21f) (entry 6). 
An ortho-methyl (2.21g) on the other hand furnished a 95:5 ratio (entry 7). These results 
indicated that the steric influence of a substituent in ortho-position is sufficient under the 
optimised reaction conditions to achieve the linear cross-coupling product through migratory 
SMC with an excellent selectivity. In pursuit of identifying an easily removable directing group, 
we further tested the reaction with an ortho-chloride substituted electrophile (2.21h), 
obtaining the linear product with an excellent regioisomeric ratio but only 15% yield (entry 8). 
Table 2.19: Investigating the influence of the electrophile on the regioselectivity. 
 
Entry Electrophile Yield (%)[a] rr[b] 
1 para-CF3 2.21b n.d. 88:12 
2 para-OMe 2.21a 56 72:28 
3 para-Me 2.21c n.d. 80:20 
4 meta-CF3 2.21d n.d. 91:9 
5 ortho-OMe 2.21e n.d. >99:1 
6 ortho-CF3 2.21f n.d. >99:1 
7 ortho-Me 2.21g 58 95:5 
8 ortho-Cl 2.21h 15 >99:1 
[a] Yield of 2.3 determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/sum 
of branched regioisomers were determined by GC-MS analysis. 
 
As the electronic parameters can also influence the other stages of the reaction we tested 
different 2-chloro substituted electrophiles (Table 2.20). The linear product 2.3d was obtained 
in 32% yield with 1-bromo-2-chlorobenzene 2.2e (entry 1), and in 19% with 1,2-
dichlorobenzene 2.28 (entry 2) as electrophiles with a >99:1 ratio. As expected, the 2-
chlorophenyl nonaflate 2.22b (entry 3) did not improve when compared to the reaction with 
2-chlorophenyl triflate 2.21h (entry 4). A possible reason for the low yield for the reaction with 
2-chlorophenyl triflate 2.21h could be the formation of benzyne. 
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Table 2.20: Screening of different types of electrophiles. 
 
Entry Electrophile Yield (%)[a] rr[b] 
1 Ar-Bromide 2.2e 32 >99:1 
2 Ar-Chloride 2.28 19 >99:1 
3 Ar-Nonaflate 2.22b 7 >99:1 
4 Ar-Triflate 2.21h 15 >99:1 
[a] Yield of 2.3d determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/sum 
of branched regioisomers were determined by GC-MS analysis. 
 
We then moved on to see whether we could increase the reactivity with higher temperature 
(Table 2.21). To avoid overpressure in the reaction system we decided to uses xylenes as 
solvent instead of toluene. The reaction gave a similar yield at 100 °C (entry 1), demonstrating 
the viability of the new solvent. Increasing the temperature to 120 °C significantly increased 
the yield to 69% (entry 2). Further increase in temperature only gave slightly higher yield 
(entry 3, 4) so we decided to retain 120 °C as the best compromise between the harshness of 
the reaction conditions and yield. 
Table 2.21: Screening of higher temperatures with xylenes instead of toluene. 
 
Entry Temperature (°C) Yield (%)[a] rr[b] 
1 100 32 >99:1 
2 120 69 >99:1 
3 130 72 >99:1 
4 140 75 >99:1 
[a] Yield of 2.3d determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/sum 
of branched regioisomers were determined by GC-MS analysis.  
With these conditions in hand we moved on to see how the reaction proceeds with additional 
substituents on the electrophile (Table 2.22). Intriguingly the reaction performed poorly with 
methoxy substituted 1-bromo-2-chlorobenzenes (entry 1-3) as well as with methyl benzoates 
(entry 4-7). 
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Table 2.22: Reactivity check with substituted 1-bromo-2-chlorobenzenes. 
 
Entry Electrophile Yield (%)[a] rr[b] 
1 Aryl-bromide 2.2f 20 >99:1 
2 Aryl-bromide 2.2g 53 >99:1 
3 Aryl-bromide 2.2h 2 >99:1 
4 Aryl-bromide 2.2i - - 
5 Aryl-bromide 2.2j 32 >99:1 
6 Aryl-bromide 2.2k 34 >99:1 
7 Aryl-bromide 2.2l - - 
[a] Yield of 2.3 determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/sum 
of branched regioisomers were determined by GC-MS analysis. 
 
Changing the amount of borane used for the hydroboration and therefore generating different 
sec-alkyl borane species of trans-3-hexene 2.1b only slightly improved the yield with the 
4-methoxy substituted electrophile 2.2f, indicating that the species of the organoborane is not 
an issue of the reaction (Table 2.23). 
Table 2.23: Screening of the amount of borane used. 
 
Entry Amount of BH3∙DMS Yield (%)[a] rr[b] 
1 0.4 28 >99:1 
2 0.8 26 >99:1 
3 1.2 30 >99:1 
 [a] Yield of 2.3e determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of 
linear/sum of branched regioisomers were determined by GC-MS analysis.  
As the reactions were conducted at a quite high temperature, we hypothesized that maybe 
the transient alkenes generated during the chain-walking process could dissociate from the 
catalyst and evaporate in the gaseous phase. Thus we prepared various protected alkenyl 
alcohols to see if heavier substrates would lead to increased yields (Table 2.24). The reaction 
with the pivalate 2.1c did not produce any product (entry 1), but the THP 2.1d and benzyl 
protected 2.1e substrates gave slightly improved yields (entry 2, 3) compared to 
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trans-3-hexene 2.1b. Additionally, the silyl protected 2.1f and the free alkenyl alcohol 2.1g 
gave no product (entry 4, 5). 
Table 2.24: Testing less volatile substrates.  
 
Entry Olefin Yield (%)[a] rr[b] 
1 2.1c - - 
2 2.1d 55 >99:1 
3 2.1e 53 >99:1 
4 2.1f - - 
5 2.1g - - 
 [a] Yield of 2.3 determined by GC-MS analysis with internal standard; [b] Regioisomeric ratio (rr) of linear/sum 
of branched regioisomers were determined by GC-MS analysis. 
 
We then investigated alkenyl arenes as substrates. Interestingly, we observed a competition 
between the formation of the linear product 2.3e and the 1,1-diarylalkane product 2.29a 
when the reaction was performed with the alkenyl arene 2.1h (Scheme 2.10). It seemed that 
the reductive elimination was considerably enhanced at the benzylic position and thus 
favouring the remote functionalisation at the benzylic site. It is also noteworthy to mention 
that the catalyst was able to undergo migration over a tertiary position as observed when the 
reaction was performed with alkenyl arene 2.1i. 
 
Scheme 2.10: One-pot alkene hydroboration/migratory SMC test-reactions. Yield not determined; 
Regioisomeric ratio (rr) of linear/benzylic regioisomers were determined by GC-MS analysis. 
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Additional optimisation efforts finally led to some minor changes to the reaction conditions. 
Thus, more stable and reproducible results were obtained by employing Pd(OAc)2 as palladium 
source, which is reduced in situ by one equivalent of the phosphine ligand in a 3:1 ratio with 
the palladium and three equivalents of the base. However, only modest yields were obtained 
for the terminal-selective migratory SMC of protected alkenyl alcohols (Scheme 2.11).  
 
Scheme 2.11: Examples of the linear selective SMC. The initial position of the alkene is highlighted in orange. 
Yields refer to the isolated product. Regioisomeric ratio (rr) of linear/sum of branched regioisomers were 
determined by GC-MS analysis of the crude reaction mixture. 
With these results we decided to discontinue this project and went on to design a different 
approach for the development of a migratory SMC. 
2.3. Conclusion 
In summary, the goal of converting a regioisomeric mixture of alkenes to alkyl arenes in a 
regioconvergent manner through a sequence of hydroboration and migratory SMC only gave 
unsatisfactory yields, despite the excellent achieved regioselectivity. 
Considerable efforts were made through intensive screening of various parameters of the 
reaction conditions and valuable insights were gained for future projects. Despite the ability 
of palladium catalysts to undergo efficient reductive elimination at a terminal position as 
disclosed by a multitude of direct as well as some migratory cross-coupling protocols, it 
appears that the changes made during the optimisation to favour the migration of the catalyst 
was detrimental to the overall reactivity. 
Late results with alkenyl arenes showed an interesting competition for the reductive 
elimination, furnishing mainly the product issued from the reductive elimination at the 
benzylic site. Therefore, we decided to discontinue this project and proceed with the 
development of a benzylic-selective migratory SMC, which will be discussed in the following 
chapter. 
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3. Benzylic-Selective Palladium-Catalysed Migratory 
Suzuki-Miyaura Cross-Coupling 
3.1. Design Plan 
As described at the end of Chapter 2 (Scheme 2.10), when we investigated alkenyl arenes in 
our reaction, we observed a competition for the reductive elimination between the terminal 
and the benzylic site, yielding mainly the product arylated in benzylic position. With this in 
mind we envisioned that we could exploit benzylic-selective migratory SMC for the remote 
functionalisation of alkenyl arenes at the benzylic site yielding 1,1-diarylalkanes as shown in 
Scheme 3.1. 
 
Scheme 3.1: Aim of the project: benzylic-selective remote functionalisation through migratory SMC. 
A hypothetic catalytic cycle, analogous to the terminal-selective palladium catalysed 
migratory SMC is depicted in Scheme 3.2. Oxidative addition of the electrophile 3.2 to a Pd0 
catalyst (3.4) followed by ligand exchange gives the intermediate 3.6. Transmetalation with 
the alkylboranonic acid 3.7 obtained by alkene hydroboration yields the intermediate 3.8 
which then undergoes chain-walking until it reaches a benzylic position yielding the 
intermediate 3.12. Reductive elimination at this site furnishes the 1,1-diarylalkane 3.3 and 
regenerates the catalyst 3.4. 
 
Scheme 3.2: Hypothetic catalytic cycle. 
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The unsymmetrically substituted 1,1-diarylalkane structural motif is present in natural as well 
as synthetic bioactive molecules (Figure 3.1),[206–210] but only a few examples of direct 
palladium catalysed cross-coupling of benzylic organoboranes exist.[83,211–215] Besides recent 
reports on nickel-catalysed benzylic-selective migratory arylations[216–218] and a selective 
migratory allylic arylation reaction,[219] to the best of our knowledge this work represents the 
first example of a palladium-catalysed benzylic-selective SMC of B-alkyl boronic acids and aryl 
halides.  
 
Figure 3.1: Bioactive 1,1-diarylalkanes. 
3.2. Results and Discussion 
3.2.1. Preliminary Test-Reactions 
We initiated our studies with the preparation of alkenyl arenes 3.1 bearing a group which 
would block the chain-walking of the catalyst, and thus favour the selective formation of 
1,1-diarylalkanes 3.3, with a minimal distance of two methylene bonds for the chain-walking. 
The alkene 3.1a bearing a tert-butyl blocking group was obtained through a Wittig reaction of 
triphenylphosphonium bromide 3.13a and pivaldehyde (Scheme 3.3a). Additionally, a more 
extended alkene 3.1b with a protected alcohol moiety as a blocking group was prepared 
through reduction and protection of the carboxylic acid 3.16, obtained through a modified 
Knoevenagel condensation of the aldehyde 3.15 generated by a Swern oxidation of 
4-phenylbutanol (3.14a, Scheme 3.3b). 
 
Scheme 3.3: Synthesis of 3.1a and 3.1b. 
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The obtained substrates 3.1a and 3.1b were then engaged in the one-pot alkene 
hydroboration/migratory SMC with 1-bromo-2-chlorobenzene (3.2a). Delightfully, we 
observed exclusive benzylic regioselectivity for both substrates when using P(tBu)2Me∙HBF4 
(L3.1) as ligand, furnishing the products 3.3a and 3.3b in decent yields (Scheme 3.4). Notably, 
either geometry of the initial alkene, Z for 3.1a and E for 3.1b, yielded the corresponding 
intermediate alkylboronic acid species 3.7 efficiently. 
 
Scheme 3.4: Test-reactions with different blocking groups for the terminal position. 
3.2.2. Optimisation of the Reaction Conditions 
We then moved on with the optimisation of the reaction conditions with (Z)-(5,5-dimethylhex-
3-en-1-yl)benzene (3.1a) together with ortho-substituted aryl electrophile 3.2a and 
P(tBu)2Me∙HBF4 (L3.1) as ligand. We retained the borane dimethylsulfide complex as cheap 
and easy-to-handle hydroboration agent since the regioselectivity of the initial hydroboration 
step does not affect the outcome of the reaction. 
We started by performing the reaction at different temperatures (Table 3.1). The reactivity 
decreased significantly with lower temperatures (entry 1, 2), and slightly lower yields were 
obtained when toluene (entry 3) was replaced by xylenes (entry 4), but without affecting the 
regioselectivity. 
Table 3.1: Screening of the reaction temperature. 
 
Entry Temperature Yield (%)[a] rr[b] 
1 90 32 >99:1 
2 100 65 >99:1 
3 120 78 >99:1 
4[c] 120 71 >99:1 
[a] Yield of 3.3a determined by 1H-NMR using CH2Br2 as the internal standard; [b] Regioisomeric ratio (rr) of 
benzylic/sum of other regioisomers were determined by GCMS analysis; [c] Xylenes were used instead of 
toluene. 
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When comparing different bases (Table 3.2) to the initial conditions with caesium carbonate 
(entry 1), we only obtained 50% of the product with potassium phosphate (entry 2). Sodium 
hydroxide gave only 24% of the product (entry 3), but switching the alkali counterion to 
potassium increased the yield (entry 4). Barium hydroxide showed no improvement (entry 5), 
whereas the reactions with tert-butoxide bases were sluggish (entry 6, 7), and triethylamine 
completely shut down the reaction (entry 8). Potassium acetate gave only 8% (entry 9) and 
potassium carbonate gave a modest 54% yield (entry 10). Even though potassium hydroxide 
gave a 1% higher yield, we decided to use the milder caesium carbonate. 
Table 3.2: Screening of the base. 
 
Entry Base Yield (%)[a] rr[b] 
1 Cs2CO3 78 >99:1 
2 K3PO4 50 >99:1 
3 NaOH 24 >99:1 
4 KOH 79 >99:1 
5 Ba(OH)2∙8H2O 51 >99:1 
6 NaOtBu 16 >99:1 
7 KOtBu 41 >99:1 
8 Et3N - - 
9 KOAc 8 >99:1 
10 K2CO3 54 >99:1 
[a] Yield of 3.3a determined by 1H-NMR using CH2Br2 as the internal standard; [b] Regioisomeric ratio (rr) of 
benzylic/sum of other regioisomers were determined by GCMS analysis. 
Table 3.3: Screening of the amount of the base. 
 
Entry Amount of Base Yield (%)[a] rr[b] 
1 1.0 equiv 33 >99:1 
2 1.5 equiv 54 >99:1 
3 2.0 equiv 68 >99:1 
4 2.5 equiv 75 >99:1 
5 3.0 equiv 78 >99:1 
[a] Yield of 3.3a determined by 1H-NMR using CH2Br2 as the internal standard; [b] Regioisomeric ratio (rr) of 
benzylic/sum of other regioisomers were determined by GCMS analysis. 
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We also checked the necessary equivalents of base (Table 3.3). Only 33% of the product was 
obtained when just one equivalent was used (entry 1), which could be raised to 54% with 1.5 
equivalents (entry 2). Further increasing the amount of the base also increased the yield 
(entry 3, 4), and three equivalents of caesium carbonate gave the best result (entry 5). 
We then tested different palladium sources to see if we could further increase the yield 
(Table 3.4). Moving from palladium acetate (entry 1) to palladium trifluoroacetate (entry 2) 
gave a slight increase in yield. Lower yields were obtained with palladium pivalate and 
acetylacetonate (entry 3, 4), whereas as comparable outcome to palladium acetate was 
observed with palladium chloride (entry 5). Additionally, ligated palladium chloride species 
led to a decrease of the yield (entry 6, 7) which was less pronounced for the palladium 
(π-cinnamyl) chloride dimer (entry 8). Interestingly, significantly lower yields were also 
observed when Pd2(dba3)∙CHCl3 was used (entry 9). 
Table 3.4: Screening of the palladium source. 
 
Entry Pd source Yield (%)[a] rr[b] 
1 Pd(OAc)2 78 >99:1 
2 Pd(TFA)2 82 >99:1 
3 Pd(OPiv)2 62 >99:1 
4 Pd(acac)2 56 >99:1 
5 PdCl2 76 >99:1 
6 PdCl2(MeCN)2 17 >99:1 
7 PdCl2(cod) 10 - 
8 [PdCl(π-cin)]2 65 >99:1 
9 Pd2(dba)3∙CHCl3 (2.5 mol%) 37 >99:1 
[a] Yield of 3.3a determined by 1H-NMR using CH2Br2 as the internal standard; [b] Regioisomeric ratio (rr) of 
benzylic/sum of other regioisomers were determined by GCMS analysis. 
As the reaction seemed to have reached a maximum yield of 82%, we decided to inverse the 
role of the limiting partner. Thus, we engaged a slight excess of the alkene and one equivalent 
of the electrophile (Scheme 3.5). Satisfyingly, the product 3.3a was obtained exclusively and 
in quantitative yield with these conditions.  
 
Scheme 3.5: Electrophile as limiting coupling partner; Yield of 3.3a determined by 1H-NMR using CH2Br2 as the 
internal standard; Regioisomeric ratio (rr) of benzylic/sum of other regioisomers were determined by GCMS 
analysis. 
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Since none of the aforementioned reaction parameters had an impact on the regioselectivity, 
we wanted to validate the necessity of the ortho-substituent on the electrophile (Table 3.5). 
Somewhat unexpectedly due to the previous investigations (see also Section 2.2.2), an 
excellent yield and regioselectivity of 96:4 was obtained when using simple bromobenzene 
(3.2b, entry 1). A big difference of the outcome was observed when different ligands were 
tested (entry 2-5), confirming the need of a small and electron rich ligand.[220] Notably, 
CataCXium PiPr (L3.5), which gave optimal selectivity in previous migratory Negishi cross 
couplings[162–166] gave only a 21:79 ratio supressing the migration (entry 5), thus highlighting 
the different behaviour of the catalyst between the different types of migratory cross-
couplings. Unfortunately, a non-negligible drop in regioselectivity was observed when the 
alkyl chain was elongated by just one methylene unit on both sides of the alkene (3.1c, entry 
6). Apparently, the steric bulk of the tert-butyl group on alkene 3.1a is sufficiently close to 
push the chain-walk to the benzylic position, but this effect weakens with a longer chain (3.1c). 
However, the loss in regioselectivity could be recovered when the ortho-substituted aryl 
bromide 3.2a was used, furnishing the exclusive 1,1-diarylalkane product 3.3c in high yield 
and excellent regioselectivity (entry 7). 
Table 3.5: Testing the influence of the ligand and ortho-substituent. 
 
Entry Variation from conditions ArBr Alkene Yield (%)[a] rr[b] 
1 - 3.2b 3.1a 96 96:4 
2 ligand: CataCXium A (L3.2) 3.2b 3.1a 9 7:93 
3 ligand: RuPhos (L3.3) 3.2b 3.1a 27 78:22 
4 ligand: PCy3 (L3.4) 3.2b 3.1a 18 49:51 
5 ligand: CataCXium PiPr (L3.5) 3.2b 3.1a 10 21:79 
6 - 3.2b 3.1c 77 84:16 
7 - 3.2a 3.1c 70 >99:1 
[a] Yield of 3.3 determined by 1H-NMR using CH2Br2 as the internal standard; [b] Regioisomeric ratio (rr) of 
benzylic/sum of other regioisomers were determined by GCMS analysis; [c] Yield of the isolated product.
 
Finally, other ortho-dihalobenzenes were tested (Table 3.6). The reaction still proceeds 
efficiently with ortho-dichlorobenzene (3.2c, entry 1), but would presumably lead to a mixture 
of regioisomers if further substituted. Additionally, a drop in reactivity was observed with 
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1-chloro-2-iodobenzene (3.2d, entry 2) which was even more pronounced with ortho-
dibromobenzene (3.2e, entry 3). 
Table 3.6: Test-reactions with different electrophiles. 
 
Entry ArBr Yield (%)[a] rr[b] 
1 3.2c 91 >99:1 
2 3.2d 74 >99:1 
3 3.2e 37 >99:1 
[a] Yield of 3.3 determined by 1H-NMR using CH2Br2 as the internal standard; [b] Regioisomeric ratio (rr) of 
benzylic/sum of other regioisomers were determined by GCMS analysis. 
 
3.2.3. Scope and Limitations 
With optimal reaction conditions in hand, we turned our attention to investigate the 
generality of our reaction. Thus, various alkenyl arenes were synthesized with a variety of 
substituents at different positions on the aryl moiety. A general approach starting from 
carboxylic acids, or commercial intermediates, is shown in Scheme 3.6. The carboxylic acids 
3.18 are reduced to the alcohols 3.14 which are then substituted in an Appel reaction yielding 
the alkyl bromides 3.19. A nucleophilic substitution with lithiated tert-butylacetylene gives the 
alkynes 3.20, which are then partially reduced to the predominantly (Z)-alkenes 3.1d - 3.1k 
using the Lindlar catalyst and hydrogen gas with modest E/Z ratios. 
 
 Scheme 3.6: Synthesis of the different alkenyl arenes 3.1d – 3.1k. 
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Further alkenyl arenes with longer alkyl chains 3.1c and 3.1l, or different blocking group 3.1m 
from the model substrate 3.1a, were obtained through a Wittig reaction (Scheme 3.7a). 
Substrates with different functional groups 3.1n - 3.1p that could efficiently block the 
chain-walking, were obtained through derivatisation of the previously described alkenyl 
alcohol 3.17 (see also Scheme 3.3) by either a Dess-Martin oxidation and successive 
acetalisation of the obtained aldehyde 3.21, or by a Mitsunobu reaction (Scheme 3.7b). Finally 
a cyclic alkene 3.1q was prepared by a Grignard reaction (Scheme 3.7c) to see if our reaction 
proceeds efficiently when a tertiary carbon is on the path to the benzylic position. 
 
Scheme 3.7: Synthesis of alkenyl arenes 3.1c, 3.1l – 3.1q. 
We then evaluated the scope of the alkenes with 1-bromo-2-chlorobenzene (3.2a) as the 
electrophile (Scheme 3.8). Both, electron-donating and electron-withdrawing substituents, 
were well tolerated in ortho- (3.3c, 3.3d), meta- (3.3e, 3.3f) and para-position (3.3g, 3.3h) as 
well as a disubstituted 1,2-methylenedioxybenzene (3.3i). Importantly, the initial geometry of 
the alkene had no noticeable impact as pure (Z)- (3.3a, 3.3c, 3.3m, 3.3n), (E)-alkenes (3.3b) or 
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E/Z mixtures (3.3d - 3.3l) underwent hydroboration and successive migratory SMC efficiently 
and selectively. Remarkably, excellent results were obtained when a longer-chain alkene was 
used as starting material, furnishing product 3.3j in high yield and perfect regioselectivity with 
a migratory distance of ten positions with respect to the initial alkene site. The reaction also 
proceeds with a cyclohexyl (3.3l) or a tert-butyl ether (3.3b) as blocking group, for the latter 
enabling further functional group transformation at this end of the alkyl chain. We additionally 
demonstrated the practicability of our protocol by performing the reaction on a ten-fold larger 
scale (5.0 mmol) and without need of using the glovebox for the synthesis of the model 
compound 3.3a. The reaction proceeded efficiently with excellent regioselectivity and a 
slightly lower yield mainly due to difficult purification. Furthermore, the reaction also 
performed well yielding 75% of 3.3a when the amount of borane was decreased to 0.45 
equivalents, thus leading to the formation of tri-sec-alkylborane. It is noteworthy to mention 
that our system is able to react with the three secondary alkyl moieties of this trialkylborane, 
which is to date unmet in a general protocol. [200–203]  
 
Scheme 3.8: Scope of alkenes of the migratory SMC. The geometry of the initial alkenes is indicated in 
parenthesis, and the initial positions of the alkenes is highlighted in orange. Scale of the reactions: 0.50 mmol. 
Yields refer to the isolated product. Regioisomeric ratio (rr) of benzylic/sum of other regioisomers were 
determined by GCMS analysis of the crude reaction mixture. [a] Performed on a 5.0 mmol scale; [b] 0.45 equiv 
of BH3∙DMS used; [c] Isolated as the C-H arylation products (3.25a, 3.25b), yield over two steps, see also 
Scheme 3.11b. 
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Additionally, very high regioselectivity and yield were obtained without ortho-substituent on 
the aryl bromide when the terminal position was blocked with a bulky tert-butyl group and 
the migration distance was short (3.3m, 3.3n). Unfortunately, the reaction did not tolerate 
some of the blocking groups (Figure 3.2). The reaction furnished only isomerised alkene when 
3.1m was engaged, presumably due to easy decoordination of the palladium-hydride 
intermediate from the in situ formed trisubstituted alkene, and the reaction with 3.1n 
completely decomposed the substrate. Somewhat surprisingly, the presence of a nitrogen 
seemed to inhibit the hydroboration as the starting materials 3.1o and 3.1p were mainly 
recovered from the reaction mixture.  
 
Figure 3.2: Unsuccessful examples of alkenes. 
We then explored the scope of the electrophiles with the tert-butyl ether alkene 3.1b 
(Scheme 3.9). We first evaluated various substituted 1-bromo-2-chlorobenzenes. Electron 
donating and electron withdrawing substituents in para- (3.3o - 3.3r) and both meta-positions 
(3.3s - 3.3v) with respect to the formed bond were well tolerated. Furthermore, trisubstituted 
as well as heteroaromatic electrophiles were also tolerated as shown with 
1,2-methylenedioxybenzene (3.3w), indole (3.3x) and pyridine (3.3y) although a slight drop in 
regioselectivity was observed with the latter. An additional ortho-substituent furnished only 
25% of 3.3z, presumably due to the increased steric hindrance. Notably, as also previously 
observed (see also Table 2.19), the ortho-chloride can also be replaced with a methyl (3.3aa), 
a methoxy (3.3ab) of a trifluoromethyl group (3.3ac) to obtain ortho-substituted products in 
high yield and perfect selectivity. 
 
Scheme 3.9: Scope of electrophiles of the migratory SMC. The geometry of the initial alkenes is indicated in 
parenthesis, and the initial positions of the alkenes is highlighted in orange. Scale of the reactions: 0.50 mmol. 
Yields refer to the isolated product. Regioisomeric ratio (rr) of benzylic/sum of other regioisomers were 
determined by GCMS analysis of the crude reaction mixture. 
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3.2.4. Deprotection and Postfunctionalisation  
We then further transformed the products to demonstrate the versatility of the products 
obtainable with our reaction. First, the ortho-chloride substituent, which we used as a 
removable directing group for the majority of the examples, was efficiently cleaved by 
palladium-catalysed dehalogenation to obtain 3.22 in a quantitative yield (Scheme 3.10a).[221] 
It should be noted that traditional hydrogenation with palladium on charcoal and hydrogen 
gas did not furnish 3.22. The alcohol was also rapidly deprotected by simply stirring 3.3b in 
trifluoroacetic acid to obtain the terminal free alcohol 3.23 (Scheme 3.10b). Milder conditions 
for the cleavage of tert-butyl ethers also exist,[222] if labile functional group were to be present 
on the substrate. 
 
Scheme 3.10: Removal of the directing and protecting groups. 
The aryl-chloride was also employed to perform further transformations as demonstrated by 
the SMC with para-anisylboronic acid yielding the biphenyl 3.24 in excellent yield 
(Scheme 3.11a),[223] or by the C-H arylation to obtain the 9-n-alkyl-fluorene 3.25 (Scheme 
3.11b).[224] Two other fluorenes (3.25a, 3.25b, Scheme 3.8) were also synthesized from the 
corresponding migratory SMC products for easier purification. 
 
Scheme 3.11: SMC and C-H arylation with the ortho-Chloride. 
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One of the most powerful feature of migratory functionalisation is their ability to transform 
regio- and stereoisomers into one single product (see also Section 1.3). Besides already shown 
for the convergence of (E)- and (Z)-alkenes (see also Scheme 3.8) we further demonstrated 
this by engaging a one-to-one mixture of two positional isomers 3.1a and 3.1i, which, as 
expected, furnished 3.3a in quantitative yield and perfect regioselectivity (Scheme 3.12). 
 
Scheme 3.12: Regioconvergent coupling through migratory SMC. 
3.2.5. Mechanistic Considerations. 
We then performed a mechanistic study to gain additional insights in the factors influencing 
the regioselectivity and mechanism. We started with the synthesis of an alkenyl arene (3.1r) 
bearing at each end of the alkyl chain either an electron rich or an electron poor aryl moiety 
at the same distance from the alkene, with a similar approach to the one previously used 
(Scheme 3.13). The analogous compound was then also prepared with deuterium atoms on 
the olefin (3.1r-D2) for an isotopic labelling experiment. 
 
Scheme 3.13: Synthesis of alkenyl arenes 3.1r and 3.1r-D2. 
To investigate the electronic properties of the electrophilic partner, we performed the 
migratory SMC reaction with para-bromobenzotrifluoride and para-bromoanisole 
(Scheme 3.14). An electron poor electrophile (3.3ad) provided a slightly better selectivity than 
the electron rich electrophile (3.3ae). Additionally, we already showed that excellent 
regioselectivity was achieved regardless of the electronic nature of the ortho-substituent 
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(3.3aa - 3.3ac, Scheme 3.9). Furthermore, a statistical one-to-one ratio of products 3.3af and 
3.3ag was observed for alkene 3.1r, clearly indicating that the aryl group on the alkylboronic 
acid partner has no influence on the selectivity (Scheme 3.14). These findings indicate that 
steric factors have a more pronounced influence than the electronic effects, similar to the 
migratory Negishi cross-coupling.[166] 
 
Scheme 3.14: Influence of the substituents on both partners on the regioselectivity. 
Next, we wanted to determine whether the chain-walk proceeds through a non-dissociative 
pathway or if the transient palladium-hydride can dissociate from the transient alkene. 
Therefore, we performed a crossover experiment by simply adding olefin 3.1j to the reaction 
mixture after the hydroboration of 3.1a (Scheme 3.15). The complete absence of 3.3g and 
quantitative yield for 3.3a is clearly indicative for a non-dissociative chain-walk process (see 
also Section 1.3.2), similar to other migratory cross-couplings investigated by the Baudoin 
group.[157–160,162–166]  
 
Scheme 3.15: Crossover experiment. 
Finally the deuterated alkene 3.1r-D2 was engaged in the migratory SMC reaction to elucidate 
if deuterium scrambling occurs along the alkyl chain, and to what positions (Scheme 3.16). As 
for the non-deuterated analogue, a statistical mixture of both possible 1.1-diarylalkane 
products 3.3af-D2 and 3.3ag-D2 was obtained.  
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Scheme 3.16: Isotopic labelling experiment. 
Remarkably, no deuterium was observed in any of the benzylic positions (a, d, Figure 3.3), 
indicating that the catalyst migration to the benzylic position is irreversible, which is consistent 
with the observation that the electronic properties of the benzylic position does not influence 
the regioselectivity (see also Scheme 3.14). Additionally, only little incorporation of deuterium 
was measured in α-position (b) of the newly formed bond (~5%), whereas all the remaining 
methylene groups bear to some extend deuterium atoms. These results show that a reversible 
and statistical chain-walk occurs until the catalyst reaches the benzylic position, where the 
benzylpalladium intermediate acts as a thermodynamic sink within the migration pathway and 
thus furnishing the products in excellent regioselectivity. 
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To identify the generated alkylboron species, we simply engaged the alkene 3.1a to 
hydroboration under the same conditions of the whole sequence and stopped after the 
evaporation of the volatiles (Scheme 3.17). 
 
Scheme 3.17: Interrupted reaction sequence for the determination of the organoborane species. 
A clear and sharp peak at 19.49 ppm was observed in the 11B-NMR spectrum of 3.7a, which is 
in the range of organoboronic acids (~15 – 35 ppm), compared to organoborinic acids 
(~40 – 60 ppm) and triorganoboranes (~80 – 90 ppm).[225] Additionally, the absence of a 
second peak slightly upfield, despite using deuterated water as solvent, is indicative for the 
absence of organoboroxine, as this specie would partially be hydrolysed to the boronic acid 
analogue in presence of water. Thus we concluded, that the sec-alkylboronic acid species 3.7 
is generated and active in our reaction. 
 
Figure 3.4: 11B-NMR (D2O, 160 MHz) of 3.7a. 
With the combined results in hand, we confirm the initialy proposed catalytic cycle for the 
current migratory SMC (Scheme 3.18). Oxidative addition of the electrophile 3.2 to the in situ 
generated Pd0 catalyst 3.4 and successive ligand exchange gives hydroxy-palladium species 
3.6. Transmetalation with the sec-alkylboronic acid 3.7 obtained by hydroboration of the 
alkene 3.1 yields the intermediate 3.8. A small and electron rich ligand L as well as an 
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ortho-substituted Ar1 group significantly increases the activation barrier of the reductive 
elimination as proposed by DFT calculations for related cross-couplings,[157,158] and thus the 
alkylpalladium species 3.8 undergoes chain-walking through a series of non-dissociative 
β-hydride elimination/π-bond rotation/insertion steps until the catalyst eventually reaches a 
benzylic position 3.12. Reductive elimination at this site furnishes the benzylic cross-coupling 
product 3.3 at the expense of other regioisomers, while regenerating the Pd0 catalyst 3.4. 
 
Scheme 3.18: Proposed catalytic cycle. The generation of the active Pd0 was omitted for clarity. 
A closer look at the different energies for the steps of the final catalyst-migration, represented 
in qualitative energy profile format based on DFT calculations for related cross-
couplings,[157,158] is displayed in Figure 3.5. The chain-walk of the catalyst towards the benzylic 
position 3.12 (blue path) is energetically favoured compared to the two unwanted side 
reaction leading to regioisomer 3.9 and isomerised starting material 3.1’ (red paths). The 
reductive elimination at the benzylic position is favoured over the back-migration, and thus a 
perfect regioselectivity for the product 3.3 is achieved. 
 
Figure 3.5: Qualitative energy profile on the selectivity of the site of reductive elimination. 
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3.3. Conclusion 
In summary, we have developed the first palladium-catalysed migratory SMC of 
sec-alkylboronic acid, obtained by hydroboration of alkenes, and bromoarenes for the 
synthesis of a variety of 1,1-diarylalkanes. The developed one-pot procedure for the 
generation of sec-alkylboronic acids and their subsequent migratory SMC avoids the 
often-difficult purification and isolation of these intermediates. Excellent regioselectivity and 
high yields are achieved by employing a small, electron rich ligand and ortho-substituted 
electrophiles. Particularly, using an ortho-chloro substituent on the electrophile, or a 
protected alcohol at the other end of the alkyl chain of the alkenyl arene, allowed for a broad 
diversity of substitution patterns and postfunctionalisations. The regioconvergent nature as 
well as a long-range example further demonstrated the power of this palladium-catalysed 
migratory Suzuki-Miyaura cross-coupling. Furthermore, a mechanistic study indicates a 
partially reversible non-dissociative catalyst migration along the alkyl chain until the stabilised 
benzylic position, where reductive elimination is facile. 
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4. Benzylic-Selective Palladium-Catalysed Migratory Suzuki-Miyaura 
Cross-Coupling ─ C(sp2)-H Activation Cascade 
4.1. Design Plan 
The products (4.4) obtained through the one-pot alkene hydroboration/migratory 
palladium-catalysed SMC which is described in Chapter 3 are ideal precursors for the synthesis 
of 9-n-alkyl-fluorenes (4.3) through a C(sp2)-H activation (see also Scheme 3.11). As the 
reaction conditions used for the migratory SMC are similar for the two reactions, we 
envisioned a possible cascade process combining the one-pot alkene 
hydroboration/migratory palladium-catalysed SMC and the C(sp2)-H activation as shown in 
Scheme 4.1a. 
 
Scheme 4.1: Preparation of 9-n-alkyl-fluorene (4.3) through a migratory SMC/C(sp2)-H activation cascade. 
A hypothetical working principle is depicted in Scheme 4.1b. The 1,1-diarylalkane product 4.4 
is obtained in the same way as elaborated previously in Scheme 3.18 (Cycle A). In a second 
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catalytic cycle, oxidative addition of the obtained migratory SMC product 4.4 with the 
regenerated Pd0 catalyst 4.5 furnishes intermediate 4.11, which then undergoes ligand 
exchange with a carbonate to yield 4.12. This intermediate then undergoes C-H activation 
through a concerted metalation-deprotonation (CMD) mechanism, which yields the 
palladacycle 4.14. Reductive elimination furnishes the 9-n-alkyl-fluorene product 4.3 and 
regenerates the catalyst. 
Employing substituted 1-bromo-2-chlorobenzene (4.2) would furnish the products with 
predictable substitution pattern on the fluorene moiety (Scheme 4.2) as the oxidative addition 
of a Pd0 catalyst is kinetically favoured for the bromide compared to chloride. Thus, the bond 
formed through the migratory SMC would take place at the ipso-position of the bromide, and 
the C-H activation at the ipso-position of the chloride. Only a meta-substituent on the aryl of 
the starting alkene (R1, 4.1) could possibly lead to selectivity issues, but the steric hindrance 
(4.13) would presumably lead to the product 4.4 where the substituent is in para-positions of 
the formed bond. 
 
Scheme 4.2: Substitution pattern is predictable. 
However, a major challenge is expected for the two distinct ligand exchange steps 
(Scheme 4.1). The developed migratory SMC employs a mixture of toluene and water as a 
solvent system, and thus the carbonate base is predominantly solvated in the aqueous phase. 
This does not only dramatically decrease the concentration of the carbonate present in the 
organic phase, but also means that hydroxide ions will be competing with the carbonate.  
The products obtainable through the proposed cascade process, i.e. methylene-bridged 
polyarenes, have become an important class of compounds in materials science such as 
light-emitting diodes or semiconductor,[226–228] among which, fluorene is the most 
representative structural motif.[229–233] Thus, the proposed approach would furnish highly 
valuable products in a single sequence starting from cheap and readily available substrates. 
4.2. Results & Discussion 
4.2.1. Preliminary Test-Reactions 
We first encountered the formation of 9-n-alkyl-fluorenes (4.3) during our investigation of the 
migratory SMC in presence of carbon monoxide. We used the two-chamber reactor developed 
by Skrydstrup[234] where a solid CO precursor (COgen, 4.15) is used to generate a controlled 
amount of carbon monoxide (Scheme 4.3). Instead of a CO-containing product, we observed 
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an unexpected 79:21 mixture of the fluorene product 4.3a together with the migratory SMC 
product 1,1-diarylalkane 4.4a.  
 
Scheme 4.3: Unexpected formation of 9-n-alkyl-fluorene product 4.3a. Ratio of 4.3/4.4 determined by 
GCMS analysis. 
Unknowing of the effect that carbon monoxide had on the reaction, we performed the same 
reaction but with a balloon of CO gas instead of the more expensive COgen two-chamber 
system (Scheme 4.4). The fluorene product 4.3a was again observed, but this time in a roughly 
one-to-one ratio with 4.4a.  
 
Scheme 4.4: Test-reaction with a CO balloon instead of COgen. Ratio of 4.3/4.4 determined by GCMS 
analysis. 
Aiming at identifying a suitable model reaction for further optimisation we conducted the 
reaction with alkene 4.1b and two different electrophiles in the two-chamber reactor as the 
ratio was higher in favour of the desired product 4.3 (Scheme 4.5). The obtained ratios were 
comparable with the first reaction (Scheme 4.4). 
 
Scheme 4.5: Test-reactions with different electrophiles (4.2a, 4.2b) on alkenyl arene 4.1b. Ratio of 4.3/4.4 
determined by GCMS analysis. 
Still unknowing of the effect that CO had, we decided to check whether CO acts as a ligand. 
We therefore decided to test the reaction without the phosphine ligand, as well as with 
different catalyst loading to see if this affects the reactivity of the system (Table 4.1). The 
reaction without ligand showed no reaction (entry 1), indicating the necessity of a phosphine 
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ligand, at least for the migratory SMC. Decreasing to 5 mol% of the catalyst showed only 
minimal traces of the products (entry 2). Surprisingly, we also observed only trace amounts of 
the products when the reaction was conducted under the same conditions as 
previously (entry 3), indicating a lack of reproducibility. 
Table 4.1: Different catalyst loading. 
 
Entry Amount of Pd Amount of L Ratio 4.3/4.4[a] 
1 10 mol% - n.r. 
2 5 mol% 10 mol% traces 
3 10 mol% 20 mol% traces 
[a] Ratio of the cascade product (4.3) and migratory SMC product (4.4) determined by GC-MS analysis. 
As we could not identify the role of the carbon monoxide, we decided to do a bottom-up 
optimisation without CO, starting from the same model-reaction as used for the optimisation 
of the migratory SMC (see also Section 3.2.2) 
4.2.2. Optimisation of the Reaction Conditions 
As mentioned, we expect the carbonate necessary for the migratory SMC to be mainly in the 
aqueous phase. Thus, we started with the screening of different carboxylates, which have a 
higher solubility in the organic solvent due to an organic back-bone (Table 4.2). The reaction 
with caesium pivalate, which is often employed in C-H activation reactions, furnished 
surprisingly only a very small amount of the product (entry 1). Caesium acetate as well as in 
situ generated adamantly carboxylate gave a slightly better yield, but still less good than the 
one previously obtained.  
Table 4.2: Screening of additives known to favour the CMD. 
 
Entry Additive Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 CsOPiv (30 mol%) 5 75 
2 CsOAc (30 mol%) 16 70 
3 AdCO2H (30 mol%) 24 56 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard. 
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As the palladium catalyst has a bigger workload for this cascade process, we then tested higher 
catalyst loading (Table 4.3). The reaction with 10 mol% of the catalyst gave 61% of the product 
4.4 (entry 1) which was gratifying, but the yield decreased when more catalyst was added 
(entry 2, 3). So we decided to keep running the reaction with 10 mol% of catalyst. 
Table 4.3: Screening of the catalyst loading. 
 
Entry Amount of Pd Amount of L Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 10 mol% 20 mol% 61 29 
2 15 mol% 30 mol% 39 47 
3 20 mol% 40 mol% 37 47 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard. 
As the PdII is presumably reduced by one equivalent of the phosphine ligand, we decided to 
test the reaction with the precatalyst (4.16, 4.17) developed by Buchwald[235,236] which 
generates in situ a Pd0L catalyst together with 1-adamantanecarboxylic acid (Table 4.4). The 
catalyst were reactive and showed nearly complete conversion of the initial boronic acid 
obtained from the alkene 4.1a, but with unsatisfying ratios of the products (entry 1, 2). 
Table 4.4: Screening of Buchwald’s precatalyst with L = P(tBu)2Me. 
 
Entry Additive Precat. Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 AdCO2H (30 mol%) 4.16 42 49 
2 AdCO2H (30 mol%) 4.17 36 57 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard. 
  
As we could still not define the parameters that were detrimental for the reaction, we decided 
to do some test-reactions by arbitrarily variating some of the conditions (Table 4.5). The 
reaction with P(tBu)3∙HBF4 (L4.2) as ligand showed hardly any conversion (entry 1), whereas 
an interesting ratio was obtained with PCy3∙HBF4 (L4.3, entry 2). Raising the temperature to 
140 °C gave a high yield and good ratio (entry 3) as for the reaction with less water (entry 4). 
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Surprisingly, we also observed the formation of 78% of the product 4.3a with a very good ratio 
when the reaction was performed without water (entry 5). However, when the reaction was 
repeated, we only observed some of the intermediate product 4.4a and no 4.3a at all (entry 
5, results in parenthesis), confirming the non-reproducibility of the reaction. Additionally, the 
reaction with caesium pivalate instead of caesium carbonate showed no conversion at all. 
Table 4.5: Further screening of reaction conditions. 
 
Entry Variation from std. conditions Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 ligand: P(tBu)3∙HBF4 0 7 
2 ligand: PCy3∙HBF4 54 24 
3 temperature: 140 °C 77 3 
4 H2O: 5.5 equiv 77 11 
5 without H2O 78 (0)[b] 8 (53)[b] 
6 base: CsOPiv - - 
7 base: CsOPiv; without H2O - - 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard; [b] Yield in parenthesis obtained when 
the reaction was performed a second time. 
 
It seemed from the obtained results, that the presence of water is detrimental for the second 
step to occur. This could also explain why the results are not reproducible, as the small amount 
of water in the catalysis tube can partially evaporate over the long reaction time. To confirm 
this, we engaged in the final step of our sequence the isolated intermediate 4.4a with and 
without water (Table 4.6). The reaction yielded 94% of the product in the absence of water 
(entry 1), whereas only 1.2 equivalents of water were enough to drop the yield to 61% (entry 
2). 
  
Results & Discussion 
- 73 - 
Table 4.6: C(sp2)-H activation starting from the 1,1-diarylakane 4.4a. 
 
Entry Amount of H2O Yield 4.3a (%)[a] 
1 0 equiv 94 
2 1.2 equiv 61 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard 
This confirmed our supposition that water inhibits the second cycle of the cascade process. 
However, a certain amount of water is necessary for the migratory SMC to occur. In order to 
identify the precise amount necessary, which after consumption would not disturb the C-H 
activation, we prolonged the evaporation time succeeding the hydroboration and screened 
different amounts of water. (Table 4.7). The reaction with 1.1 equivalents of water furnished 
74% of the migratory SMC product 4.4a, but no fluorene product 4.3a at all (entry 1), which 
was surprising as the water would have been nearly completely consumed at this stage. 
Doubling the amount of water yielded 49% of the product 4.3a, but a consequential 37% 
amount of intermediate 4.4a also remained (entry 2). Further increasing the amount of water 
lead to better results in terms of yield and ratio (entry 3, 4), thus refuting our assumption. 
Table 4.7: Screening of the amount of water after prolonged evaporation time. 
 
Entry Amount of H2O Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 1.1 equiv 0 74 
2 2.2 equiv 49 37 
3 5.6 equiv 72 13 
4 11.1 equiv 75 4 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard 
We then continued by comparing palladium acetate with palladium pivalate (Table 4.8). 
However, the reaction with Pd(OAc)2 only furnished 22% of the product 4.3a with a lot of the 
intermediate remaining (entry 1). Pd(OPiv)2 gave a better yield and ratio (entry 2), although 
better results were previously obtained. 
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Table 4.8: Testing a different palladium source. 
 
Entry Pd source Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 Pd(OAc)2 22 43 
2 Pd(OPiv)2 38 18 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard 
As the ratio between the palladium and ligand had a big impact on the outcome of the 
migratory SMC (see also Table 2.15) we wanted to check if this could favour the formation of 
the fluorene product 4.4 (Table 4.9). A slight increase of the catalyst loading showed better 
reactivity (entry 1), but reducing the amount of ligand was detrimental (entry 2, 3). 
Table 4.9: Screening of the catalyst loading and Pd/L ratio. 
 
Entry Amount of Pd Amount of L Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 15 mol% 30 mol% 56 10 
2 10 mol% 15 mol% 36 34 
3 10 mol% 10 mol% 21 56 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard. 
In the last attempt, we decided to check if the whole reaction could be performed in a protic 
solvent (Table 4.10). However, no conversion was observed when methanol or isopropanol 
were used (entry 1, 2).  
Table 4.10: Screening of different protic solvents. 
 
Entry Solvent Yield 4.3a (%)[a] Yield 4.4a (%)[a] 
1 MeOH - - 
2 iPrOH - - 
[a] Yield determined by 1H-NMR using CH2Br2 as the internal standard. 
Conclusion 
- 75 - 
As the reaction was not reproducible, giving different results at every attempt, we decided to 
discontinue this project.  
4.3. Conclusion 
In summary, the goal of developing a cascade reaction consisting of a migratory SMC and a 
C(sp2)-H activation was unsuccessful despite promising early results. Considerable efforts 
were made through screening of reaction conditions and analysis of the different reaction 
parameters, but the results were not reproducible. Possible reasons could be the prolonged 
reaction time, which can be challenging for palladium-phosphine catalysts, as well as 
conflicting presence of water. Thus we decided to discontinue this project, as the fluorene 
products can be readily obtained in an additional step from 1,1-diarylalkanes.  
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5. General Conclusion & Outlook 
An impressive range of reactions have been accomplished for the migratory transition-metal 
catalysed remote C(sp3)-functionalisation just over the last decade. This new approach 
constitutes an interesting and powerful extension to the organic synthesis toolbox, providing 
access to molecular complexity in a step- and atom-economical manner. On this basis, the 
present PhD thesis was directed towards the identification and development of novel 
transition-metal catalysed migratory functionalisation, with emphasis on the Suzuki-Miyaura 
cross-coupling.  
The initial goal to develop the terminal-selective remote functionalisation of linear alkenes 
through a migratory Suzuki-Miyaura cross-coupling was encountered with unsatisfactory 
yields despite excellent regioselectivity. However, we observed a considerable preference for 
the developed palladium-catalyst to undergo reductive elimination at a benzylic site when 
different substrates were tested. Thus, we decided to exploit this behaviour in the 
optimisation of a novel project. 
Therefore, we proceeded with the development of the benzylic-selective remote 
functionalisation through a migratory Suzuki-Miyaura cross-coupling (Scheme 5.1). Linear 
alkenyl arenes were successfully converted to 1,1-diarylalkanes in up to quantitative yields, 
and in most cases with perfect regioselectivity. The designed one-pot procedure avoids the 
difficult purification and isolation of the sec-alkylboronic acid intermediates. We also 
demonstrated the regioconvergent nature of this type of reaction as well as the long-range 
migration up to ten positions, and mechanistic experiments indicated a partially reversible, 
non-dissociative palladium migration along the alkyl chain until the benzylic position is 
reached, where reductive elimination is favoured. 
 
Scheme 5.1: One-Pot Alkene Hydroboration/Palladium-Catalysed Migratory Suzuki-Miyaura Cross-Coupling. 
Further efforts of extending the reaction to a cascade process involving a C(sp2)-H activation 
for the preparation of 9-n-alkyl fluorenes were in vain, as the role of the required water for 
the migratory Suzuki-Miyaura cross-coupling was unclear for the C-H activation. 
The field of migratory cross-coupling is rapidly and continuously growing due to the synthetic 
potential, and a multitude of approaches were already disclosed. Elegant examples of 
enantioselective Heck-type reactions as well as stereospecific transformations were already 
reported. However, asymmetric examples remain scarce, especially for enantioselective 
terminating steps, although its feasibility was disclosed in the initial report of the Baudoin 
group in 2010. We therefore expect a great expansion in this field of migration in the future 
research. 
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6. Experimental Section 
6.1. General Information 
6.1.1. Techniques 
All reactions involving air-sensitive materials were carried out in pre-dried glassware under an 
argon atmosphere by using Schlenk techniques employing double-line argon-vacuum lines 
and working in an argon-filled glovebox. Analytical thin layer chromatography (TLC) was 
performed using pre-coated Merck silica gel 60 F254 plates (0.25 mm). Visualization of the 
developed chromatogram was performed by UV absorbance (254 nm) or TLC stains (KMnO4 
and Phosphomolybdic acid). Flash column chromatography (FCC) was performed using 
Silicycle SiliaFlash P60 (230-400 mesh) with the indicated solvent system.  
6.1.2. Chemicals 
Anhydrous solvents were obtained from a solvent purification system equipped with activated 
alumina and copper columns. The solvents were degassed by three cycles of freeze-pump-
thaw and storing in single-necked flasks equipped with a J-Young PTFE valve (or similar) when 
necessary. Chemical reagents were purchased from Merck (Sigma-Aldrich), Acros Organics, 
AlfaAesar Apollo scientific and Fluorochem and used as received without further purification 
unless otherwise stated.  
6.1.3. Instrumentation: 
GC-MS analyses were performed with a Shimadzu QP2010SB GCMS apparatus on a Rtx®-5ms-
Low-Bleed column lined with a mass (EI) detection system. Melting points were obtained on 
a Büchi melting point M-565, and are uncorrected. IR spectra were recorded on an ATR Varian 
Scimitar 800 and are reported in reciprocal centimetres (cm-1). Nuclear magnetic resonance 
spectra were recorded on a Bruker Advance 400 (400 MHz), Advance 500 (500 MHz) and 
Advance 600 (600 MHz) in deuterated chloroform (residual peaks 1H δ 7.26 ppm, 13C δ 77.16 
ppm) unless otherwise noted. 19F NMR spectra were referenced to external CFCl3, 11B NMR 
spectra were referenced to external BF3∙Et2O and 31P NMR spectra were referenced to 
external H3PO4. Data are reported in parts per million (ppm) as follows: chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintuplet, sept = septuplet, 
m = multiplet and bs = broad singlet), coupling constant in Hz and integration. High resolution 
mass spectra were recorded by Dr. M. Pfeffer (Department of Chemistry, University of Basel) 
on a Bruker maXis 4G QTOF ESI mass spectrometer with addition of AgNO3 [1 mM] in difficult 
cases. Microwave reactions were performed with a Biotage® Initiator+ System. 
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6.2. Terminal Selective Migratory SMC 
6.2.1. Synthesis of electrophiles 
All electrophiles tested were either purchased from a commercial supplier, or were already 
available in the group library and described in previous thesis, except for the following 
electrophiles. 
 
4-Methoxyphenyl trifluoromethanesulfonate (2.21a) 
 
4-Methoxyphenol (5.38 g, 43.3 mmol, 1.0 equiv) was dissolved in pyridine (21 mL) and cooled 
to 0 °C. Trifluoromethanesulfonic anhydride (8.0 mL, 47.6 mmol, 1.1 equiv) was added 
dropwise to the reaction mixture, and then stirred at 25 °C for 14 h. Et2O (50 mL) was added, 
the organic layer was washed with 1 M aq. HCl (3x 30 mL), dried over MgSO4 and the volatiles 
removed under reduced pressure. The crude product was purified by FCC (20% DCM in 
pentane) to obtain 4-methoxyphenyl trifluoromethanesulfonate (11.0 g, 43.0 mmol, 99%) as 
a colourless oil. Spectroscopic data are consistent with those previously reported.[237]  
 
Rf = 0.3 (20% DCM in pentane) 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.23 – 7.17 (m, 2H), 6.95 – 6.89 (m, 2H), 3.82 (s, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 159.3, 143.2, 122.5, 118.9 (q, J = 320.9 Hz), 115.2, 
55.8. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) -72.83 
 
2-Chlorophenyl trifluoromethanesulfonate (2.21h) 
 
2-Chlorophenol (2.48 g, 19.3 mmol, 1.0 equiv) was dissolved in pyridine (9.3 mL) and cooled 
to 0 °C. Trifluoromethanesulfonic anhydride (3.6 mL, 21.2 mmol, 1.1 equiv) was added 
dropwise to the reaction mixture, and then stirred at 25 °C for 14 h. Et2O (30 mL) was added, 
the organic layer was washed with 1 M aq. HCl (3x 20 mL), dried over MgSO4 and the volatiles 
removed under reduced pressure. The crude product was purified by FCC (15% DCM in 
pentane) to obtain 2-Chlorophenyl trifluoromethanesulfonate (4.80 g, 18.4 mmol, 95%) as a 
colourless oil. Spectroscopic data are consistent with those previously reported.[238] 
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Rf = 0.4 (15% DCM in pentane) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.58 – 7.49 (m, 1H), 7.41 – 7.30 (m, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 145.9, 131.5, 129.4, 128.5, 127.5, 123.2 (q, J = 1.0 Hz), 
118. (q, J = 320.5 Hz). 
19F{1H}-NMR (376 MHz, CDCl3): δ (ppm) -73.45 
 
Methyl 4-bromo-3-chlorobenzoate (2.2i) 
 
A drop of conc. sulfuric acid was added to a solution of 4-bromo-3-chlorobenzoic acid (4.99 g, 
21.2 mmol, 1.0 equiv) in MeOH (20 mL, 494 mmol, 23.3 equiv) and the reaction mixture was 
stirred at 50 °C for 1 h. The volatiles were removed under reduced pressure and methyl 4-
bromo-3-chlorobenzoate (4.74 g, 19.0 mmol, 90%) was obtained as an off-white solid. 
Spectroscopic data are consistent with those previously reported.[239] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 8.10 (d, J = 2.0 Hz, 1H), 7.77 (dd, J = 8.3, 2.0 Hz, 1H), 7.70 
(d, J = 8.3 Hz, 1H), 3.92 (s, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 165.5, 135.1, 134.0, 131.4, 130.8, 128.8, 128.2, 52.7. 
IR (neat): ν (cm-1) 2953.0, 1728.5, 1588.6, 1435.0, 1376.7, 1287.8, 1240.0, 1104.7, 1021.7, 
757.7. 
MP: 62.7 °C. 
HRMS (ESI): Calcd for C8H6BrClO2Na [M+Na]+: 270.9132, found 270.9128 
 
Methyl 2-bromo-3-chlorobenzoate (2.2l) 
 
A drop of conc. sulfuric acid was added to a solution of 2-bromo-3-chlorobenzoic acid (500 
mg, 2.12 mmol, 1.0 equiv) in MeOH (2 mL, 49.4 mmol, 23.3 equiv) and the reaction mixture 
was stirred at 50 °C for 1 h. The volatiles were removed under reduced pressure and methyl 
2-bromo-3-chlorobenzoate (455 mg, 1.82 mmol, 86%) was obtained as colourless oil.  
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.60 – 7.53 (m, 2H), 7.30 (t, J = 7.9 Hz, 1H), 3.94 (s, 3H). 
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13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 166.8, 136.7, 135.8, 132.8, 128.6, 128.1, 121.5, 53.0. 
IR (neat): ν (cm-1) 2952.3, 1732.6, 1431.9, 1283.2, 1199.5, 1136.8, 1032.8, 967.0, 756.8. 
HRMS (ESI): Calcd for C8H6BrClO2Na [M+Na]+: 270.9132, found 270.9131 
 
6.2.2. Synthesis of alkenes 
General procedure A: Wittig reaction 
The triphenylphosphonium-bromide salt (1.0 equiv) was suspended in THF (2.4 mL/mmol) 
under inert conditions. n-BuLi (1.6 M in hexanes, 1.1 equiv) was added dropwise at 0 °C and 
the reaction mixture was left to stir at 0 °C for 1 h. The aldehyde (1.0 equiv) was then added 
dropwise to the reaction mixture. After removal of the cooling bath and stirring for 14 h under 
reflux the reaction mixture was slowly quenched with water, extracted with cyclohexane, 
dried over MgSO4 and concentrated in vacuo. The crude product was purified by FCC. 
 
(E)-hex-3-en-1-yl pivalate (2.1c) 
 
(E)-3-Hexen-1-ol (0.5 mL, 4.08 mmol, 1.0 equiv) and DMAP (49.8 mg, 0.408 mmol, 0.1 equiv) 
were dissolved in DMC (8.0 mL). Et3N (1.1 mL, 8.16 mml, 2.0 equiv) and pivaloyl chloride (0.6 
mL, 4.90 mmol, 1.2 equiv) where then added and the reaction mixture was stirred for 15 h at 
25 °C before water (10 mL) was added. The aqueous phases was extracted with DCM (3x 20 
mL) and the combined organic layers dried over MgSO4. The volatiles were removed under 
reduced pressure and the crude product purified by FCC (5% EtOAc in Cy) to obtain (E)-hex-3-
en-1-yl pivalate (527 mg, 2.86 mmol, 70%) as a colourless oil. Spectroscopic data are 
consistent with those previously reported.[240] 
 
Rf = 0.3 (5% EtOAc in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 5.61 – 5.47 (m, 1H), 5.44 – 5.29 (m, 1H), 4.06 (t, J = 6.7 Hz, 
2H), 2.36 – 2.25 (m, 2H), 2.07 – 1.95 (m, 2H), 1.18 (s, 9H), 0.96 (t, J = 7.4 Hz, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 178.7, 135.1, 124.4, 64.0, 38.9, 32.2, 27.3, 25.8, 13.9. 
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(E)-2-(hex-3-en-1-yloxy)tetrahydro-2H-pyran (2.1d) 
 
3,4-Dihydro-(2H)-pyran (1.1 mL, 12.2 mmol, 3.0 equiv) was added to a solution of (E)-3-Hexen-
1-ol (0.5 mL, 4.08 mmol, 1.0 equiv) in DCM (10 mL). Then, a catalytic amount of p-
toluenesulfonic-acid was added and the reaction mixture stirred for 1.5 h at 25 °C. The 
reaction mixture was diluted with DCM (30 mL) and washed with sat. aq. Na2CO3 (25 mL), 
brine (25 mL) and water (25 mL). The organic layer was dried over MgSO4 and the volatiles 
removed under reduced pressure. The crude product was purified by FCC (5% Et2O in 
cyclohexane) to obtain (E)-2-(hex-3-en-1-yloxy)tetrahydro-2H-pyran (465 mg, 2.52 mmol, 
62%) as a colourless liquid. Spectroscopic data are consistent with those previously 
reported.[241] 
 
Rf = 0.34 (5% Et2O in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 5.60 – 5.47 (m, 1H), 5.47 – 5.35 (m, 1H), 4.59 (s, 1H), 3.87 
(s, 1H), 3.77 – 3.69 (m, 1H), 3.53 – 3.45 (m, 1H), 3.45 – 3.37 (m, 1H), 2.33 – 2.24 (m, 2H), 2.05 
– 1.95 (m, 2H), 1.88 – 1.76 (m, 1H), 1.75 – 1.65 (m, 1H), 1.64 – 1.45 (m, 4H), 0.96 (t, J = 7.5 Hz, 
3H). 





Sodium hydride (60% in mineral oil, 196 mg, 4.90 mmol, 1.2 equiv) was added portionwise to 
a solution of (E)-3-Hexen-1-ol (0.5 mL, 4.08 mmol, 1.0 equiv) in THF (9.0 mL) at 0 °C and stirred 
for 15 min. TBAI (15.1 mg, 0.049 mmol, 0.01 equiv) and benzyl bromide (0.54 mL, 4.49 mmol, 
1.1 equiv) were added, and the reaction mixture stirred for 4 h at 25 °C. The reaction was 
quenched with water (5.0 mL), extracted with Et2O (3x 25 mL) and the combined organic layers 
were dried over MgSO4. The volatiles were removed under reduced pressure and the crude 
product purified by FCC (5% Et2O in cyclohexane) to obtain (E)-((hex-3-en-1-
yloxy)methyl)benzene (722 mg, 3.79 mmol, 93%) as a colourless oil. Spectroscopic data are 
consistent with those previously reported.[242] 
 
Rf = 0.31 (5% Et2O in Cy) 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.40 – 7.31 (m, 4H), 7.33 – 7.24 (m, 1H), 5.63 – 5.50 (m, 
1H), 5.50 – 5.34 (m, 1H), 4.52 (s, 2H), 3.54 – 3.45 (m, 2H), 2.38 – 2.26 (m, 2H), 2.09 – 1.96 (m, 
2H), 1.02 – 0.93 (m, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 138.7, 134.3, 128.5, 127.8, 127.6, 125.3, 73.0, 70.4, 
33.2, 25.8, 13.9. 
(E)-tert-butyl(hex-3-en-1-yloxy)dimethylsilane (2.1f) 
 
tert-Butyldimethylsilyl chloride (0.9 mL, 5.30 mmol, 1.3 equiv) was added to a solution of (E)-
3-Hexen-1-ol (0.5 mL, 4.08 mmol, 1.0 equiv) and imidazole (0.7 mL, 10.2 mmol, 2.5 equiv) in 
DMF (2.1 mL) and the reaction mixture was stirred for 18 h at 25 °C. The reaction mixture was 
diluted with cyclohexane (20 mL) and the organic layer washed with half-saturated brine (5x 
20 mL) and dried over MgSO4. The volatiles were removed under reduced pressure and the 
crude product purified by FCC (5% Et2O in cyclohexane) to obtain (E)-tert-butyl(hex-3-en-1-
yloxy)dimethylsilane (809 mg, 3.77 mmol, 93%). Spectroscopic data are consistent with those 
previously reported.[243] 
 
Rf = 0.3 (2.5% Et2O in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 5.57 – 5.45 (m, 1H), 5.45 – 5.32 (m, 1H), 3.61 (t, J = 6.9 Hz, 
2H), 2.26 – 2.15 (m, 2H), 2.07 – 1.94 (m, 2H), 0.96 (t, J = 7.5 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 6H). 




The title compound was obtained following general procedure A from 
propyltriphenylphosphonium bromide (6.47 g, 16.0 mmol, 1.0 equiv) and 
hydrocinnamaldehyde (2.4 mL, 18.1 mmol. 1.1 equiv). The crude product was purified by FCC 
(cyclohexane) to obtain (Z)-hex-3-en-1-ylbenzene (1.17 g, 7.29 mmol, 46%, E/Z = 21:79)as a 
colourless oil. Spectroscopic data are consistent with those previously reported.[244] 
 
Rf = 0.8 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.34 – 7.27 (m, 2H), 7.25 – 7.17 (m, 3H), 5.44 – 5.36 (m, 
2H), 2.74 – 2.63 (m, 2H), 2.42 – 2.30 (m, 2H), 2.07 – 1.97 (m, 2H), 0.98 (E-min, t, J = 7.4 Hz), 
0.92 (Z-maj, t, J = 7.5 Hz, 3H). 
Terminal Selective Migratory SMC 
- 85 - 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.4 (E-min), 142.3 (Z-maj), 132.8 (E-min), 132.5 (Z-
maj), 128.6 (E-min), 128.6 (Z-maj), 128.5 (E-min), 128.4 (Z-maj), 128.4 (E-min), 128.2 (Z-maj), 
125.9 (Z-maj), 125.8 (E-min), 36.3 (E-min), 36.2 (Z-maj), 34.61 (E-min), 29.2 (Z-maj), 25.7 (E-
min), 20.7 (Z-maj), 14.4 (Z-maj), 14.1 (E-min). 
IR (neat): ν (cm-1) 3027.1, 2962.8, 1604.0, 1453.8, 1304.7, 1072.2, 967.6, 905.3. 




The title compound was obtained following general procedure A from 
isopentyltriphenylphosphoniumbromid  (4.02 g, 9.25 mmol, 1.0 equiv) and 
hydrocinnamaldehyde (1.4 mL, 10.5 mmol. 1.1 equiv). The crude product was purified by FCC 
(cyclohexane) to obtain (Z)-(6-methylhept-3-en-1-yl)benzene (1.31 g, 6.98 mmol, 75%, E/Z = 
20:80) as a colourless oil. 
 
Rf = 0.78 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.33 – 7.27 (m, 2H), 7.24 – 7.17 (m, 3H), 5.53 – 5.38 (m, 
2H), 2.73 – 2.64 (m, 2H), 2.42 – 2.30 (m, 2H), 1.95 – 1.85 (m, 2H), 1.59 (dhept, J = 7.0, 6.5 Hz, 
1H), 0.89 (Z-maj, d, J = 7.0 Hz, 6H) 0.87 (E-min, d, J = 7.0 Hz). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.3, 130.6 (E-min), 130.0 (E-min), 129.5 (Z-maj), 
129.5 (Z-maj), 128.6 (E-min), 128.6 (Z-maj), 128.4 (Z-maj), 128.4 (E-min), 125.9 (Z-maj), 125.8 
(E-min), 42.1 (E-min), 36.5 (Z-maj), 36.3 (E-min), 36.2 (Z-maj), 34.6 (E-min), 29.4 (Z-maj), 28.8 
(Z-maj), 28.6 (E-min), 22.5 (Z-maj), 22.4 (E-min). 
IR (neat): ν (cm-1) 3027.1, 2954.7, 1604.2, 1454.8, 1383.3, 1076.3, 1030.6, 969.4, 827.2. 




Prepared according to an adapted reported procedure.[245] Anhydrous magnesium perchlorate 
(121 mg, 0.50 mmol, 0.1 equiv) was first dried in vacuo while heating using a heat gun and 
then was dissolved with (Z)-3-hexenol (0.6 mL, 5.00 mmol, 1.0 equiv) in dichloromethane (7.5 
mL). Di-tert-butyl dicarbonate (2.6 mL, 11.5 mmol, 2.3 equiv) was added and the reaction 
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mixture was then stirred under reflux for 14 h. The mixture was first allowed to cool to 25 °C 
and water (25 mL) was added. The aqueous phase was extracted with DCM (3 x 25 mL) and 
then the combined organic layers were dried over MgSO4. The solvent was removed under 
reduced pressure and the crude was purified by FCC (2.5% Et2O in PET) to (Z)-1-(tert-
Butoxy)hex-3-ene (689 mg, 4.41 mmol, 88%) as a colourless oil. Spectroscopic data are 
consistent with those previously reported.[246] 
Rf = 0.41 (2.5% Et2O in PET). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 5.47 – 5.41 (m, 1H), 5.37 – 5.29 (m, 1H), 3.32 (t, J = 7.3 Hz, 
2H), 2.29 – 2.22 (m, 2H), 2.10 – 2.00 (m, 2H), 1.18 (s, 9H), 0.95 (t, J = 7.5 Hz, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 133.5, 125.3, 72.7, 61.6, 29.0, 28.0, 20.7, 14.4. 
 
6.2.3. Synthesis of ligands 
All ligands tested were either purchased from a commercial supplier, or were already available 
in the group library and described in previous thesis, except for the following phosphine 
ligands. 
General procedure B: Grignard reaction with dialkylchlorophosphine  
The whole procedure was carried out under inert atmosphere due to the pyrophoric nature 
of the starting material as well as product. The Grignard reagent (1.1 equiv) was added 
dropwise to a solution of PR2Cl (1 equiv) in Et2O [0.2 M] at -78 °C. The reaction mixture was 
stirred overnight allowing to warm to 25 °C. The resulting suspension was filtered through a 
Schlenk-frit and the volatiles were removed under reduced pressure. The crude product was 
purified by distillation at 5*10-1 mbar using a heat gun to gradually increase the temperature 
to obtain the trialkylphosphine.  
General procedure C: Preparation of the tetrafluoroborate salts of trialkylphosphines 
Performed according to a literature procedure.[205] HBF4 (48 wt% aqueous solution, 8 equiv) 
was added to a solution of trialkylphosphine (1 equiv) in DCM [0.1 M] and the resulting mixture 
was stirred vigorously for 5 min. The organic layer was then separated, dried over MgSO4 and 
the volatiles removed under reduced pressure, providing the tetrafluoroborate salt of the 
phosphine. 
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Dicyclohexyl(neopentyl)phosphine (L2.36) 
 
Neopentyl bromide (0.5 mL, 3.38 mmol, 0.25 equiv) was added to a suspension of magnesium 
turnings (361 mg, 14.9 mmol, 1.1 equiv) and a crystal of iodine in Et2O (7.0 mL), and the 
reaction mixture was carefully heated to 40 °C until the exothermic reaction initiated. 
Neopentyl bromide (1.5 mL, 10.1 mmol, 0.75 equiv) was then added dropwise to the reaction 
mixture, which was stirred under reflux for 14 h. The obtained Grignard reagent was then used 
in the next step. 
The title compound was obtained following general procedure B from 
chlorodicyclohexylphosphine (1.00 g, 4.30 mmol, 1.0 equiv) and neopentylmagnesium 
bromide (1.47 M, 3.2 mL, 4.73 mmol, 1.1 equiv) to obtain dicyclohexyl(neopentyl)phosphine 
(498 mg, 1.86 mmol, 43%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1.82 – 1.64 (m, 10H), 1.52 – 1.43 (m, 2H), 1.29 (d, J = 6.2 
Hz, 2H), 1.27 – 1.08 (m, 10H), 0.95 (s, 9H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 36.2 (d, J = 19.8 Hz), 33.6 (d, J = 11.5 Hz), 31.1 (d, J = 
8.6 Hz), 30.4 (d, J = 16.8 Hz), 30.3 (d, J = 13.4 Hz), 28.9 (d, J = 8.9 Hz), 27.6 (d, J = 10.9 Hz), 27.5 
(d, J = 7.7 Hz), 26.8 (d, J = 1.1 Hz). 




The title compound was obtained following general procedure B from 
chlorodicyclohexylphosphine (1.00 g, 4.30 mmol, 1.0 equiv) and n-butylmagnesium chloride 
(2 M, 2.4 mL, 4.73 mmol, 1.1 equiv) to obtain butyldicyclohexylphosphine (802 mg, 3.14 mmol, 
73%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1.86 – 1.66 (m, 10H), 1.54 – 1.45 (m, 2H), 1.43 – 1.31 (m, 
6H), 1.28 – 1.13 (m, 10H), 0.90 (t, J = 6.9 Hz, 3H). 
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13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 33.5 (d, J = 12.3 Hz), 30.9 (d, J = 18.5 Hz), 30.5 (d, J = 
14.3 Hz), 29.2 (d, J = 7.9 Hz), 27.6 (d, J = 11.4 Hz), 27.5 (d, J = 7.8 Hz), 26.7 (d, J = 1.1 Hz), 24.8 
(d, J = 12.1 Hz), 21.1 (d, J = 15.8 Hz), 14.0. 




The title compound was obtained following general procedure B from 
chlorodicyclohexylphosphine (1.00 g, 4.30 mmol, 1.0 equiv) and s-butylmagnesium chloride 
(1.85 M, 2.6 mL, 4.73 mmol, 1.1 equiv) to obtain sec-butyldicyclohexylphosphine (302 mg, 
27.4 mmol, 27%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (250 MHz, CDCl3): δ (ppm) 1.85 – 1.47 (m, 14H), 1.36 – 1.14 (m, 11H), 1.08 (dd, J = 
10.4, 7.0 Hz, 3H), 0.96 (t, J = 7.2 Hz, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 32.3 (d, J = 33.4 Hz), 28.5 (d, J = 34.6 Hz), 27.4 (d, J = 
3.9 Hz), 26.7 (d, J = 12.1 Hz), 25.4 (d, J = 4.4 Hz), 24.0 (d, J = 2.8 Hz), 13.7 (d, J = 3.4 Hz), 12.7 
(d, J = 13.6 Hz). 




The title compound was obtained following general procedure B from 
chlorodicyclohexylphosphine (1.00 g, 4.30 mmol, 1.0 equiv) and s-butylmagnesium chloride 
(2 M, 2.4 mL, 4.73 mmol, 1.1 equiv) to obtain dicyclohexyl(isobutyl)phosphine (502 mg, 1.97 
mmol, 46%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1.80 – 1.67 (m, 10H), 1.51 – 1.43 (m, 2H), 1.28 – 1.11 (m, 
13H), 0.98 (d, J = 6.6 Hz, 6H). 
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13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 33.6 (d, J = 11.8 Hz), 31.8 (d, J = 17.1 Hz), 30.4 (d, J = 
14.3 Hz), 28.9 (d, J = 7.9 Hz), 28.1 (d, J = 18.4 Hz), 27.5 (d, J = 20.2 Hz), 24.3 (d, J = 9.3 Hz). 




Ferrocene (407 mg, 2.18 mmol, 1.0 eq.) was dissolved in THF (1.5 mL) and hexane (1.5 mL). At 
0 °C, t-BuLi (2.1 M, 2.1 mL, 4.36 mmol, 2.0 equiv) was slowly added and the solution was stirred 
for 30 minutes. Chlorodicyclohexylphosphine (507 mg, 2.18 mmol, 1.0 equiv) in Et2O (5.0 mL) 
was added dropwise to the reaction mixture. The solution was stirred for 1.5 h at 0 °C followed 
by 1 hour at room temperature. Aqueous NaOH (1 M, 8.0 mL) and brine (8.0 mL) were added, 
the layers were separated and the aqueous layer was extracted with EtOAc (12 mL). The 
combined organic layers were dried over MgSO4 and the volatiles removed under reduced 
pressure. The crude product was purified by FCC (20% Et2O in pnetane), and was then 
recrystallized 3 times from n-heptane to obtain dicyclohexylferrocenylphosphine (114 mg, 
0.298 mmol, 14%) as a yellow solid 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 4.29 (m, 2H), 4.17 – 4.15 (m, 2H), 4.14 (s, 5H), 1.86 – 1.69 
(m, 10H), 1.30 – 1.01 (m, 12H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 71.7 (d, J = 11.2 Hz), 69.3, 33.6 (d, J = 11.4 Hz), 30.4 
(d, J = 7.0 Hz), 30.3, 27.6, 27.5 (d, J = 8.9 Hz), 26.6. 
31P-NMR (202 MHz, CDCl3): δ (ppm) -7.35. 
IR (neat): ν (cm-1) 3096.0, 2948.9, 2892.3, 1461.2, 1381.7, 1026.9, 818.3. 
MP: 44.5 °C. 




The title compound was obtained following general procedure B from 
chlorodicyclopentylphosphine (800 mg, 3.91 mmol, 1.0 equiv) and methylmagnesium 
bromide (2.9 M, 1.5 mL, 4.30 mmol, 1.1 equiv) to obtain dicyclopentyl(methyl)phosphine 
(300 mg, 1.63 mmol, 42%) as a colourless oil. 
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IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1.85 (m, 2H), 1.81 – 1.46 (m, 12H), 1.43 – 1.29 (m, 4H), 
0.94 (d, J = 1.7 Hz, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 37.9 (d, J = 8.8 Hz), 30.9 (d, J = 17.7 Hz), 29.8 (d, J = 
11.7 Hz), 26.7 (d, J = 7.4 Hz), 26.2 (d, J = 6.1 Hz). 




The title compound was obtained following general procedure B from 
chlorodicyclopentylphosphine (800 mg, 3.91 mmol, 1.0 equiv) and ethylmagnesium bromide 
(0.86 M, 5.0 mL, 4.30 mmol, 1.1 equiv) to obtain dicyclopentyl(ethyl)phosphine (297 mg, 1.51 
mmol, 39%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1.89 – 1.77 (m, 6H), 1.69 – 1.49 (m, 8H), 1.47 – 1.30 (m, 
6H), 1.08 (dt, J = 12.5, 7.7 Hz, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 35.7 (d, J = 10.7 Hz), 31.2 (d, J = 16.9 Hz), 30.4 (d, J = 
13.2 Hz), 26.6 (d, J = 7.4 Hz), 26.2 (d, J = 6.6 Hz), 17.3 (d, J = 13.4 Hz), 10.6 (d, J = 11.7 Hz). 




The title compound was obtained following general procedure B from 
chlorodicyclopentylphosphine (800 mg, 3.91 mmol, 1.0 equiv) and n-butylmagnesium chloride 
(2 M, 2.2 mL, 4.30 mmol, 1.1 equiv) to obtain butyldicyclopentylphosphine (604 mg, 
2.65 mmol, 68%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) δ 1.87 – 1.75 (m, 6H), 1.68 – 1.59 (m, 4H), 1.59 – 1.48 (m, 
4H), 1.46 – 1.28 (m, 10H), 0.89 (t, J = 7.1 Hz, 3H). 
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13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 36.2 (d, J = 10.5 Hz), 31.2 (d, J = 16.6 Hz), 30.4 (d, J = 
12.7 Hz), 29.1 (d, J = 12.5 Hz), 26.6 (d, J = 7.3 Hz), 26.2 (d, J = 6.5 Hz), 24.9 (d, J = 10.1 Hz), 24.6 
(d, J = 14.0 Hz), 14.0. 




The title compound was obtained following general procedure B from 
chlorodicyclopentylphosphine (800 mg, 3.91 mmol, 1.0 equiv) and i-propylmagnesium 
chloride (2 M, 2.2 mL, 4.30 mmol, 1.1 equiv) to obtain dicyclopentyl(isopropyl)phosphine 
(498 mg, 2.35 mmol, 60%) as a colourless oil. 
 
IR and HRMS were not measured as the product is not stable towards air. 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1.88 – 1.80 (m, 6H), 1.67 – 1.59 (m, 4H), 1.59 – 1.26 (m, 
9H), 1.12 (dd, J = 10.9, 7.2 Hz, 6H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 34.3 (d, J = 13.4 Hz), 31.9 (d, J = 16.6 Hz), 31.6 (d, J = 
15.9 Hz), 26.4 (d, J = 7.3 Hz), 26.1 (d, J = 7.4 Hz), 24.3 (d, J = 13.2 Hz), 19.9 (d, J = 8.9 Hz). 
31P-NMR (202 MHz, CDCl3): δ (ppm) 14.95. 
 
Dicyclohexyl(neopentyl)phosphine tetrafluoroborate (L2.49) 
 
The title compound was obtained following general procedure C from 
dicyclohexyl(neopentyl)phosphine (L2.36, 100 mg, 0.373 mmol, 1.0 equiv) to obtain 
dicyclohexyl(neopentyl)phosphine tetrafluoroborate (132 mg, 0.370 mmol, 99%) as a white 
solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.60 – 5.49 (m, 1H), 2.56 – 2.40 (m, 2H), 2.08 – 1.79 (m, 
10H), 1.48 – 1.35 (m, 7H), 1.34 – 1.22 (m, 3H), 1.15 (s, 9H). 
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13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 30.9 (d, J = 5.1 Hz), 30.6 (d, J = 6.7 Hz), 29.1 (d, J = 42.3 
Hz), 27.5 (d, J = 3.6 Hz), 27.1 (d, J = 39.7 Hz), 26.7 (d, J = 3.7 Hz), 26.2 (d, J = 6.0 Hz), 26.1 (d, J 
= 5.8 Hz), 25.2 (d, J = 1.8 Hz). 
31P-NMR (202 MHz, CDCl3): δ (ppm) 13.07. 
IR (neat): ν (cm-1) 2936.3, 2859.6, 1451.5, 1053.7. 
MP: 150.4 °C. 
HRMS (ESI): Calcd for C17H34P [M-BF4]+: 269.2393, found 269.2394. 
 
Dicyclohexyl(ethyl)phosphine tetrafluoroborate (L2.50) 
 
The title compound was obtained following general procedure C from 
dicyclohexyl(ethyl)phosphine (100 mg, 0.442 mmol, 1.0 equiv) to obtain 
dicyclohexyl(ethyl)phosphine tetrafluoroborate (139 mg, 0.442 mmol, quant.) as a white solid, 
with impurities araising from the commercial starting material. Spectroscopic data are 
consistent with those previously reported.[247] 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.32 (t, J = 4.8 Hz, 1H), 5.36 (t, J = 4.8 Hz, 1H), 2.04 – 1.81 
(m, 12H), 1.47 – 1.22 (m, 15H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 28.3 (d, J = 42.1 Hz), 27.7 (d, J = 3.5 Hz), 27.1 (d, J = 
3.5 Hz), 26.3 – 25.94 (m), 25.2 (d, J = 1.6 Hz), 8.4 (d, J = 6.0 Hz), 7.7 (d, J = 44.4 Hz). 
31P-NMR (202 MHz, CDCl3): δ (ppm) 27.64. 
IR (neat): ν (cm-1) 2933.2, 2858.1, 1451.4, 1280.0, 1055.0, 903.8, 766.1. 
HRMS (ESI): Calcd for C14H28P [M-BF4]+: 227.1923, found 227.1927. 
 
Butyldicyclohexylphosphine tetrafluoroborate (L2.51) 
 
The title compound was obtained following general procedure C from 
butyldicyclohexylphosphine (L2.37, 100 mg, 0.394 mmol, 1.0 equiv) to obtain 
butyldicyclohexylphosphine tetrafluoroborate (133 mg, 0.388 mmol, 99%) as a white solid. 
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1H-NMR (500 MHz, CDCl3): δ (ppm) 6.53 – 5.21 (m, 1H), 2.55 – 2.45 (m, 2H), 2.19 (dd, J = 5.3, 
3.3 Hz, 2H), 2.12 – 1.76 (m, 10H), 1.74 – 1.61 (m, 2H), 1.57 – 1.24 (m, 12H), 0.98 (t, J = 7.3 Hz, 
3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 28.7, 28.4, 27.7 (d, J = 3.5 Hz), 27.1 (d, J = 3.5 Hz), 26.2 
(d, J = 7.1 Hz), 26.1 (d, J = 13.0 Hz), 25.2 (d, J = 1.7 Hz), 24.2 (d, J = 14.5 Hz), 13.5 (d, J = 42.9 
Hz), 13.5. 
31P-NMR (202 MHz, CDCl3): δ (ppm) 24.53. 
IR (neat): ν (cm-1) 2931.5, 2863.1, 1453.5, 1051.1, 920.6, 868.3. 
MP: 115.7 °C. 
HRMS (ESI): Calcd for C16H32P [M-BF4]+: 255.2236 , found 255.2241. 
 
sec-Butyldicyclohexylphosphine tetrafluoroborate (L2.52) 
 
The title compound was obtained following general procedure C from 
sec-butyldicyclohexylphosphine (L2.38, 100 mg, 0.394 mmol, 1.0 equiv) to obtain 
butyldicyclohexylphosphine tetrafluoroborate (130 mg, 0.380 mmol, 96%) as a white solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.45 – 5.27 (m, 1H), 2.50 (dq, J = 10.4, 3.4 Hz, 3H), 2.11 – 
1.74 (m, 12H), 1.65 – 1.52 (m, 5H), 1.47 – 1.32 (m, 8H), 1.12 (t, J = 7.3 Hz, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 28.5, 28.2, 28.1, 28.1, 28.1, 28.0, 28.0, 28.0, 27.8, 
27.8, 26.5, 26.4, 26.4, 26.4, 26.4, 26.3, 26.3, 26.3, 25.4, 25.4, 25.4, 25.2, 25.2, 25.1, 14.3, 14.30, 
12.3, 12.2. Doublets could not be assigned due to overlapping signals. 
31P-NMR (202 MHz, CDCl3): δ (ppm) 29.98. 
IR (neat): ν (cm-1) 2936.7, 2861.4, 1453.4, 1051.2, 911.0, 728.7, 648.3. 
MP: 151.4 °C. 
HRMS (ESI): Calcd for C16H32P [M-BF4]+: 255.2236 , found 255.2237. 
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Dicyclohexyl(isobutyl)phosphine tetrafluoroborate (L2.53) 
 
The title compound was obtained following general procedure C from 
dicyclohexyl(isobutyl)phosphine (L2.39, 100 mg, 0.394 mmol, 1.0 equiv) to obtain 
dicyclohexyl(isobutyl)phosphine tetrafluoroborate (131 mg, 0.383 mmol, 97%) as a white 
solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) δ 6.39 – 5.29 (m, 1H), 2.52 (dt, J = 11.9, 3.7 Hz, 2H), 2.13 – 
1.95 (m, 7H), 1.94 – 1.84 (m, 4H), 1.83 – 1.74 (m, 2H), 1.54 – 1.36 (m, 8H), 1.29 (dd, J = 12.1, 
3.6 Hz, 2H), 1.14 (dd, J = 6.2, 1.7 Hz, 6H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 28.9, 28.6, 27.6 (d, J = 3.6 Hz), 26.9 (d, J = 3.6 Hz), 26.1 
(d, J = 28.6 Hz), 26.1 (d, J = 1.8 Hz), 25.6 (d, J = 5.1 Hz), 25.2 (d, J = 1.7 Hz), 22.5, 22.2. 
31P-NMR (101 MHz, CDCl3): δ (ppm) 19.29 
IR (neat): ν (cm-1) 2937.7, 2860.5, 1453.3, 1328.4, 1052.0, 912.7, 850.5, 777.2, 670.1. 
MP: 143.8 °C. 
HRMS (ESI): Calcd for C16H32P [M-BF4]+: 255.2236 , found 255.2238. 
 
Dicyclopentyl(methyl)phosphine tetrafluoroborate (L2.54) 
 
The title compound was obtained following general procedure C from 
dicyclopentyl(methyl)phosphine (L2.45, 100 mg, 0.543 mmol, 1.0 equiv) to obtain 
dicyclopentyl(methyl)phosphine tetrafluoroborate (145 mg, 0.533 mmol, 98%) as a white 
solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.90 – 5.25 (m, 1H), 2.77 – 2.59 (m, 2H), 2.28 – 2.05 (m, 
4H), 1.92 – 1.57 (m, 15H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 28.9, 28.8, 28.5, 28.1 (d, J = 1.2 Hz), 26.3 (d, J = 10.9 
Hz), 26.1 (d, J = 10.8 Hz), -0.35 (d, J = 50.9 Hz). 
31P-NMR (202 MHz, CDCl3): δ (ppm) 21.96. 
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IR (neat): ν (cm-1) 2957.9, 1051.9, 912.9, 730.7, 670.1. 
MP: 127.9 °C. 
HRMS (ESI): Calcd for C11H22P [M-BF4]+: 185.1454, found 185.1456. 
 
Dicyclopentyl(ethyl)phosphine tetrafluoroborate (L2.55) 
 
The title compound was obtained following general procedure C from 
dicyclopentyl(ethyl)phosphine (L2.46, 100 mg, 0.504 mmol, 1.0 equiv) to obtain 
dicyclopentyl(ethyl)phosphin tetrafluoroborate (144 mg, 0.503 mmol, 99%) as a white solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.68 – 5.28 (m, 1H), 2.75 – 2.63 (m, 2H), 2.34 (ddd, J = 12.8, 
7.7, 4.8 Hz, 2H), 2.26 – 2.15 (m, 4H), 1.86 – 1.70 (m, 12H), 1.39 (dt, J = 19.2, 7.7 Hz, 3H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 29.1 (d, J = 1.4 Hz), 28.7 (d, J = 1.3 Hz), 28.1 (d, J = 46.7 
Hz), 26.2 (d, J = 10.9 Hz), 26.0 (d, J = 10.9 Hz), 10.5 (d, J = 46.8 Hz), 7.8 (d, J = 5.6 Hz). 
31P-NMR (101 MHz, CDCl3): δ (ppm) 29.96 
IR (neat): ν (cm-1) 2961.4, 1455.2, 1283.0, 1051.3, 913.3, 729.1. 
MP: 171.1 °C. 
HRMS (ESI): Calcd for C12H24P [M-BF4]+: 199.1610, found 199.1614. 
 
Butyldicyclopentylphosphine tetrafluoroborate (L2.56) 
 
The title compound was obtained following general procedure C from 
butyldicyclopentylphosphine (L2.47, 100 mg, 0.442 mmol, 1.0 equiv) to obtain 
butyldicyclopentylphosphine tetrafluoroborate (135 mg, 0.430 mmol, 97%) as a white solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.76 – 5.36 (m, 1H), 2.74 – 2.62 (m, 2H), 2.29 – 2.14 (m, 
6H), 1.88 – 1.66 (m, 14H), 1.51 (h, J = 7.4 Hz, 2H), 0.97 (t, J = 7.3 Hz, 3H). 
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13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 29.2 (d, J = 1.4 Hz), 28.7 (d, J = 1.3 Hz), 28.4 (d, J = 46.8 
Hz), 26.2 (d, J = 11.1 Hz), 26.0 (d, J = 11.0 Hz), 25.6 (d, J = 5.0 Hz), 24.1 (d, J = 14.6 Hz), 16.3 (d, 
J = 45.4 Hz), 13.4. 
31P-NMR (101 MHz, CDCl3): δ (ppm)26.98. 
IR (neat): ν (cm-1) 2961.8, 2873.8, 2361.0, 1455.8, 1050.1, 915.0, 729.5. 
MP: 174.9 °C. 
HRMS (ESI): Calcd for C14H28P [M-BF4]+: 227.1923, found 227.1925. 
 
Dicyclopentyl(isopropyl)phosphine tetrafluoroborate (L2.57) 
 
The title compound was obtained following general procedure C from 
dicyclopentyl(isopropyl)phosphine (L2.48, 100 mg, 0.471 mmol, 1.0 equiv) to obtain 
dicyclopentyl(isopropyl)phosphine tetrafluoroborate (141 mg, 0.0.470 mmol, 99%) as a white 
solid. 
 
1H-NMR (500 MHz, CDCl3): δ (ppm) 6.75 – 5.05 (m, 1H), 2.82 – 2.69 (m, 1H), 2.68 – 2.57 (m, 
2H), 2.27 – 2.15 (m, 4H), 1.88 – 1.72 (m, 12H), 1.44 (dd, J = 17.9, 7.3 Hz, 6H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 29.5 (d, J = 1.5 Hz), 29.4 (d, J = 1.7 Hz), 27.5 (d, J = 44.1 
Hz), 26.1 (d, J = 11.1 Hz), 25.8 (d, J = 11.1 Hz), 21.2 (d, J = 43.8 Hz), 17.5 (d, J = 2.5 Hz). 
31P-NMR (101 MHz, CDCl3): δ (ppm) 35.80. 
IR (neat): ν (cm-1) 2965.2, 2875.1, 1464.0, 1268.8, 1050.7, 890.7, 729.9, 668.0. 
MP: 211.1 °C. 
HRMS (ESI): Calcd for C13H26P [M-BF4]+: 213.1767, found 213.1770. 
 
6.2.4. Palladium catalysed migratory arylation 
General procedure D: Representative procedure for the screening of reaction conditions 
starting from trialkylboranes.  
The reactions were performed on a 0.50 mmol scale. Unless otherwise noted: In a glovebox, 
an oven-dried 10 mL catalysis tube equipped with a stirring bar and septum was charged with 
the indicated palladium source, ligand, base and electrophile (if solid) as well as possible 
additives. Outside the glovebox, the solvent ( 1.0 mL), water (0.1 mL), aryl bromide (if liquid) 
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and the solution of trialkylborane (1 M in THF) were added. The septum was rapidly exchanged 
for a screw cap, the catalysis tube sealed with Teflon-tape, and then placed in a pre-heated 
heating block for 16 h. The reaction tube was then removed from the heating block and let to 
cool to 25 °C. The crude reaction mixture was then filtered over Celite® with EtOAc. Dodecane 
(1.0 equiv) was added to the crude, and an aliquot thereof was measured by GC-FID to 
determine the yield and ratio of the products.  
General procedure E: One-pot hydroboration/migratory SMC  
The reactions were performed on a 0.50 mmol scale. Unless otherwise noted: The olefin 
(0.600 mmol, 1.2 equiv) was charged in an oven-dried 10 mL catalysis tube equipped with a 
stirring bar and septum, and then purged and filled with Argon three times. A borane dimethyl 
sulfide complex solution in toluene (2 M, 0.35 mL, 0.700 mmol, 1.4 equiv) was then added and 
the tube placed in a metal heating block set at 50 °C with stirring, fitted with a balloon. After 
1 h, the reaction tube was cooled to 0 °C with an ice-bath, water (0.10 mL, 5.55 mmol, 11.1 
equiv) was added to the reaction mixture, and the reaction mixture was further stirred at 25 
°C for 1 h. The balloon was then swapped with a line from the Schlenk and the volatiles were 
removed under high vacuum for 1 h. The tube was transferred in a glovebox and Pd(OAc)2 
(5.61 mg, 0.025 mmol, 5 mol%), (tBu)2PMe•HBF4 (18.6 mg, 0.075 mmol, 15 mol%), Cs2CO3 (489 
mg, 1.50 mmol, 3.0 equiv) and aryl bromide (0.500 mmol, 1.0 equiv) (if solid) were charged in 
the catalysis tube. Outside of the glovebox, xylenes (1.0 mL), water (0.1 mL) and the aryl 
bromide (0.500 mmol, 1.0 equiv) (if liquid) were added. The septum was rapidly exchanged 
for a screw cap, the catalysis tube sealed with Teflon-tape and then placed in a heating block 
set at 120 °C with vigorous stirring for 16 h. After this period the reaction mixture was allowed 
to cool to 25 °C and filtered over Celite® with EtOAc. The volatiles were removed under 
reduced pressure and the crude product was analyzed with GC-MS to determine the 




The title compound was obtained following general procedure E from (E)-((hex-3-en-1-
yloxy)methyl)benzene (2.1d, 114 mg, 0.600 mmol, 1.2 equiv) and 4-bromo-3-chloroanisole (79 
µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(benzyloxy)hexyl)-2-chloro-4-methoxybenzene (38.3 
mg, 0.114 mmol, 23%) as a colourless oil. 
 
Rf = 0.45 (2.5% EtOAc in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.37 – 7.31 (m, 4H), 7.31 – 7.26 (m, 1H), 7.09 (d, J = 8.4 Hz, 
1H), 6.90 (d, J = 2.6 Hz, 1H), 6.74 (dd, J = 8.4, 2.6 Hz, 1H), 4.50 (s, 2H), 3.77 (s, 3H), 3.47 (t, J = 
6.6 Hz, 2H), 2.64 (t, J = 7.9 Hz, 2H), 1.67 – 1.54 (m, 4H), 1.43 – 1.27 (m, 4H). 
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13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.4, 138.9, 134.3, 132.4, 130.8, 128.5, 127.8, 127.6, 
114.5, 113.0, 73.0, 70.6, 55.6, 32.8, 30.1, 29.8, 29.3, 26.2. 
IR (neat): ν (cm-1) 2931.5, 2856.2, 1606.4, 1494.8, 1455.8, 1242.8, 1099.8, 1041.7, 840.5. 




The title compound was obtained following general procedure E from (E)-((hex-3-en-1-
yloxy)methyl)benzene (2.1d, 114 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene 
(58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(Benzyloxy)hexyl)-2-chlorobenzene (48.1 mg, 
0.159 mmol, 32%) as a colourless oil. 
 
Rf = 0.41 (2.5% Et2O in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.39 – 7.27 (m, 6H), 7.22 – 7.09 (m, 3H), 4.51 (s, 2H), 3.47 
(t, J = 6.6 Hz, 2H), 2.76 – 2.67 (m, 2H), 1.70 – 1.57 (m, 4H), 1.46 – 1.36 (m, 4H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 140.5, 138.9, 134.0, 130.5, 129.5, 128.5, 127.8, 127.6, 
127.2, 126.8, 73.0, 70.6, 33.7, 29.8, 29.8, 30.0, 26.2. 
IR (neat): ν (cm-1) 2932.0, 2856.9, 1720.6, 1453.8, 1361.8, 1098.9, 906.9, 747.3, 696.7. 




The title compound was obtained following general procedure E from (E)-1-(tert-butoxy)hex-
3-ene (2.1j, 93.8 mg, 0.600 mmol, 1.2 equiv) and 4-bromo-3-chloroanisole (79 µL, 0.500 mmol, 
1.0 equiv) to obtain 1-(6-(tert-butoxy)hexyl)-2-chloro-4-methoxybenzene (32.4 mg, 0.108 
mmol, 22%) as a colourless oil. 
 
Rf = 0.42 (2.5% EtOAc in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) (d, J = 8.4 Hz, 1H), 6.89 (d, J = 2.6 Hz, 1H), 6.73 (dd, J = 8.5, 
2.6 Hz, 1H), 3.77 (s, 3H), 3.32 (t, J = 6.7 Hz, 2H), 2.69 – 2.61 (m, 2H), 1.59 – 1.51 (m, 4H), 1.42 
– 1.36 (m, 4H), 1.18 (s, 9H). 
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13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.3, 134.3, 132.5, 130.8, 114.8, 113.0, 72.6, 61.7, 
55.6, 55.6, 32.8, 30.8, 30.1, 29.3, 26.2. 
IR (neat): ν (cm-1) 2932.8, 2361.6, 1606.6, 1495.4, 1462.2, 1361.6, 1237.8, 1197.4, 1082.0, 
1042.6.  




The title compound was obtained following general procedure E from (E)-1-(tert-butoxy)hex-
3-ene (2.1j, 93.8 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene (58 µL, 0.500 
mmol, 1.0 equiv) to obtain 1-(6-(tert-Butoxy)hexyl)-2-chlorobenzene (41.4 mg, 0.154 mmol, 
31%) as a colourless oil. 
 
Rf = 0.46 (2.5% Et2O in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.32 (dd, J = 7.8, 1.4 Hz, 1H), 7.22 – 7.19 (m, 1H), 7.17 (td, 
J = 7.3, 1.5 Hz, 1H), 7.14 – 7.08 (m, 1H), 3.32 (t, J = 6.7 Hz, 2H), 2.76 – 2.66 (m, 2H), 1.67 – 1.59 
(m, 2H), 1.56 – 1.50 (m, 2H), 1.42 – 1.36 (m, 4H), 1.18 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 140.5, 134.1, 130.4, 129.5, 127.2, 126.8, 72.6, 61.7, 
33.7, 30. 8, 29.9, 29.4, 27.7, 26.2. 
IR (neat): ν (cm-1) 2932.0, 2859.9, 1473.4, 1361.4, 1361.4, 1198.0, 1082.8, 876.5, 748.6. 
HRMS (ESI): Calcd for C16H25ClONa [M+Na]+: 291.1486 , found 291.1484. 
 
6.3. Benzylic Selective Migratory SMC 
6.3.1. Synthesis of alkenes 
General procedure F: Wittig reaction 
The triphenylphosphonium-bromide salt (1.0 equiv) was suspended in THF (2.4 mL/mmol) 
under inert conditions. n-BuLi (1.6 M in hexanes, 1.1 equiv) was added dropwise at 0 °C and 
the reaction mixture was left to stir at 0 °C for 1 h. The aldehyde (1.0 equiv) was then added 
dropwise to the reaction mixture. After removal of the cooling bath and stirring for 14 h under 
reflux the reaction mixture was slowly quenched with water, extracted with cyclohexane, 
dried over MgSO4 and concentrated in vacuo. The crude product was purified by FCC. 
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General procedure G: Sonogashira reaction of unactivated alkyl bromides 
Performed according to a literature procedure.[248] 1,3-bis(l-adamantyl)imidazolium chloride 
or 1,3-bis(l-adamantyl)imidazolium tetrafluoroborate (5.0 mol%), Cul (7.5 mol%), [(n-
allyl)PdCl]2 (2.5 mol% and Cs2CO3 (1.4 equiv) were added in turn to a two-neck flask equipped 
with a stirring bar, a reflux condenser and a Schlenk-bubbler. The flask was then evacuated 
and backfilled with Argon three times. Then a mixture of Et2O and DMF (2:1, 1.0 mL) was 
added, followed by the alkyne (1.3 equiv) and the alkyl halide (1.0 equiv). The heterogeneous 
reaction mixture was stirred vigorously at 45 °C for 14 h. The reaction mixture was allowed to 
cool down to 25 °C and was quenched with sat. aq. NH4Cl. Et2O was added and the organic 
phase was washed 5 times with half-saturated Brine The organic layer was dried over MgSO4 
and concentrated in vacuo. The crude reaction mixture was then purified by FCC or fractional 
distillation. 
General procedure H: Nucleophilic substitution of alkyl bromides 
Performed according to an adapted literature procedure.[249] n-BuLi (1.6 M in hexanes, 1.4 
equiv) was added dropwise to a solution of the acetylene (1.3 equiv) in dry THF [1.0 M] at -78 
°C under inert conditions and was stirred for 20 min at -78 °C. Then the alkylbromide (1.0 
equiv) and HMPA (2.0 equiv) were added sequentially and the reaction mixture was allowed 
to warm to 25 °C while stirring for 4 h. The reaction mixture was then quenched with water, 
the layers seeparates and the aqueous layer was extracted with Et2O (3 x). The combined 
organic layers were dried over MgSO4 and concentrated in vacuo. The crude product was then 
purified by FCC. 
General procedure I: Partial hydrogenation of alkyne 
Lindlar catalyst (10 mol% of Pd) was added to a solution of the alkyne (1.0 equiv) and quinoline 
(0.3 equiv) in cyclohexane [0.05 M]. Argon was bubbled through the solution for 5 minutes, 
followed by two balloons of hydrogen gas. The reaction mixture was then allowed to stir under 
a hydrogen atmosphere for 10 minutes. The reaction mixture was filtered over Celite®, 




The title compound was obtained following general procedure F from (3-phenylpropyl)-
triphenylphosphonium bromide (10.6 g, 23.0 mmol, 1.0 equiv) and 2,2-dimethylpropanal (2.5 
mL, 23.0 mmol. 1.0 equiv). The crude product was purified by FCC (cyclohexane) to obtain (Z)-
(5,5-dimethylhex-3-en-1-yl)benzene (3.75 g, 19.9 mmol, 87%, E/Z = <1:99) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[250] 
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Rf = 0.61 in cyclohexane. 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.32 – 7.26 (m, 2H), 7.23 – 7.16 (m, 3H), 5.36 (dt, J = 12.0, 
1.6 Hz, 1H), 5.22 (dt, J = 12.0, 7.3 Hz, 1H), 2.68 (dd, J = 9.3, 6.5 Hz, 2H), 2.55 – 2.46 (m, 2H), 
1.10 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.2, 140.5, 128.6, 128.4, 127.9, 125.9, 77.5, 77.2, 
76.8, 36.7, 33.3, 31.3, 30.5. 
IR (neat): ν (cm-1) 2955.3, 1604.3, 1454.7, 1361.8, 1204.4, 1079.2, 1029.8, 906.2. 
HRMS (ESI): Calcd for C14H20Ag [M+Ag]+: 295.0610, found 295.0610. 
4-Phenylbutanal (3.15) 
 
A solution of DMSO (10.3 mL, 145 mmol, 2.2 equiv) in dry DCM (66 mL) was added dropwise 
to a solution of oxalyl chloride (7.0 mL, 73.9 mmol, 1.12 equiv) in dry DCM (158 mL) that was 
cooled to −55 °C. After stirring for 5 min, a solution of 4-phenylbutanol (10.2 mL, 66.0 mmol, 
1.0 equiv) in DCM (26 mL) was added dropwise. After additional 15 min of stirring, 
triethylamine (45.7 mL, 33.0 mmol, 5.0 equiv) was added to the reaction mixture, which was 
then allowed to warm to 25 °C and aqueous HCl (1.0 M, 200 mL) was added. The aqueous 
phase was extracted with DCM (3 x 250 mL) and the combined organic phase was washed with 
brine (200 mL) first and then dried over MgSO4. The solvent was removed under reduced 
pressure to obtain 4-phenylbutanal (9.77 g, 66.0 mmol, quant.) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[251] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 9.76 (t, J = 1.6 Hz, 1H), 7.31 – 7.27 (m, 2H), 7.22 – 7.17 (m, 
3H), 2.66 (t, J = 7.52 Hz, 2H), 2.45 (td, J = 7.3 Hz, J = 1.6 Hz, 2H), 1.97 (tt, J = 7.5 Hz, J = 7.3 Hz, 
2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 202.5, 141.4, 128.7, 126.3, 43.3, 35.2, 23.8. 
IR (neat): ν (cm-1) 3027, 2936, 2824, 2722, 1721, 1603, 1496, 1454, 1166, 1073, 912, 747, 699. 
HRMS (ESI): Calcd for C10H12ONH4 ([M+NH4]+): 166.1226, found 166.1224. 
 
(E)-6-Phenyl-3-hexenoic acid (3.16) 
 
Prepared according to a reported procedure.[252] Malonic acid (7.54 g, 72.5 mmol, 1.1 equiv) 
and N-methylmorpholine (8.0 mL, 72.5 mmol, 1.1 equiv) were added to 4-phenylbutanal (3.15, 
9.77 g, 65.9 mmol, 1.0 equiv). The reaction mixture was heated to 95 °C for 14 h and then 
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allowed to cool to 25 °C. A solution of H2SO4 (11 %, 55 mL) was added and the mixture was 
stirred for additional 30 min. The aqueous phase was then extracted with DCM (3 x 60 mL) 
and the combined organic phase was washed with water (80 mL) and dried over MgSO4. The 
solvent was removed under reduced pressure and the crude was purified by FCC (30% EtOAc 
in cyclohexane) to obtain (E)-6-phenyl-3-hexenoic acid (5.51 g, 29.0 mmol, 44%) as a yellow 
oil. Spectroscopic data are consistent with those previously reported.[252] 
 
Rf = 0.4 (30% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.31 – 7.27 (m, 2H), 7.21 – 7.17 (m, 3H), 5.69 – 5.62 (m, 
1H), 5.60 – 5.53 (m, 1H), 3.10 – 3.08 (m, 2H), 2.73 – 2.69 (m, 2H), 2.41 – 2.35 (m, 2H). 





A solution of (E)-6-phenyl-3-hexenoic acid (3.16, 5.51 g, 29.0 mmol, 1.0 equiv) in THF (16 mL) 
was added dropwise to a solution of LiAlH4 (1.65 g, 43.5 mmol, 1.5 equiv) in THF (16 mL) that 
was cooled to 0 °C. The reaction mixture was allowed to warm to 25 °C and stirred for 3 h. 
Et2O (25 mL) was added and the mixture was cooled to 0 °C. Water (1.7 mL), aqueous NaOH 
(1.0 M, 1.7 mL) and water (5.1 mL) again were added sequentially and the reaction mixture 
was stirred at 25 °C for 15 min. MgSO4 was added and the mixture was further stirred for 15 
min, then it was filtrated and the filtered solution was reduced in vacuo. (E)-6-phenyl-3-
hexenol (4.59 g, 26.0 mmol, 90%) was obtained as a yellow oil. Spectroscopic data are 
consistent with those previously reported.[253] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.32 – 7.28 (m, 2H), 7.22 – 7.18 (m, 3H), 5.62 – 5.55 (m, 
1H), 5.42 – 5.34 (m, 1H), 3.58 (t, J = 6.23 Hz, 2H), 2.73 – 2.69 (m, 2H), 2.40 – 2.34 (m, 2H), 2.27 
– 2.22 (m, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 141.9, 133.1, 128.5, 128.4, 126.9, 125.9, 62.0, 36.0, 
35.9, 34.5. 
IR (neat): ν (cm-1) 3332, 3027, 2927, 1604, 1453, 1045, 969, 744, 697. 
HRMS (ESI): Calcd for C12H16ONa ([M+Na]+): 199.1093, found 199.1093. 
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(E)-(6-(tert-Butoxy)hex-3-en-1-yl)benzene (3.1b) 
 
Prepared according to an adapted reported procedure.[245] Anhydrous magnesium perchlorate 
(685 mg, 2.84 mmol, 0.1 equiv) was first dried in vacuo while heating using a heat gun and 
then was dissolved with (E)-6-phenyl-3-hexenol (3.17, 5.01 g, 28.4 mmol, 1.0 equiv) in 
dichloromethane (42.6 mL). Di-tert-butyl dicarbonate (14 mL, 65.3 mmol, 2.3 equiv) was 
added and the reaction mixture was then stirred under reflux for 14 h. The mixture was first 
allowed to cool to 25 °C and water (50 mL) was added. The aqueous phase was extracted with 
DCM (3 x 50 mL) and then the combined organic layers were dried over MgSO4. The solvent 
was removed under reduced pressure and the crude was purified by FCC (2.5% Et2O in PET) to 
obtain (E)-tert-buxoxy-6-phenyl-3-hexene (6.00 g, 25.8 mmol, 91%) as a colourless oil. 
 
Rf = 0.37 (2.5% Et2O in PET). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.31 – 7.27 (m, 2H), 7.21 – 7.17 (m, 3H), 5.60 – 5.53 (m, 
1H), 5.51 – 5.43 (m, 1H), 3.34 (t, J = 7.19 Hz, 2H), 2.71 – 2.67 (m, 2H), 2.36 – 2.30 (m, 2H), 2.26 
– 2.20 (m, 2H), 1.20 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.2, 131.3, 128.6, 128.5, 128.3, 128.3, 127.5, 125.8, 
72.7, 61.8, 36.1, 34.6, 34.1, 27.7. 
IR (neat): ν (cm-1) 2973, 2930, 1740, 1604, 1454, 1362, 1196, 1078, 968, 879, 744, 698. 
HRMS (ESI): Calcd for C16H24ONa ([M+Na]+): 255.1719, found 255.1721. 
 
(4-Phenylbutyl)-triphenylphosphonium bromide (3.13b) 
 
A mixture of triphenylphosphine (7.58 g, 28.9 mmol, 1.0 equiv) and 1-bromo-4-phenylbutane 
(5.1 mL, 28.9 mmol, 1.0 equiv) in toluene (36 mL) was stirred under reflux for 62 h. The 
reaction mixture was then allowed to cool to 25 °C and the precipitate was filtered and washed 
with Et2O to obtain (4-phenylbutyl)-triphenylphosphonium bromide (12.6 g, 26.4 mmol, 91%) 
as a white powder. Spectroscopic data are consistent with those previously reported.[254] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 1H NMR (400 MHz, CDCl3) δ 7.82 – 7.69 (m, 9H), 7.69 – 
7.59 (m, 6H), 7.19 – 7.11 (m, 2H), 7.11 – 7.02 (m, 3H), 3.85 – 3.61 (m, 2H), 2.62 (t, J = 7.4 Hz, 
2H), 1.96 (tt, J = 7.5 Hz, 2H), 1.66 – 1.53 (m, 2H). 
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13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 141.2, 135.0 (d, J = 3.0 Hz), 133.7 (d, J = 10.0 Hz), 130.5 
(d, J = 12.6 Hz), 128.4 (d, J = 18.4 Hz), 125.9, 118.7, 117.8, 34.7, 31.2 (d, J = 15.7 Hz), 22.6 (d, J 
= 50.0 Hz), 21.7 (d, J = 4.6 Hz). 
31P{1H}-NMR (162 MHz, CDCl3): δ (ppm) 24.31. 
IR (neat): ν (cm-1) 3414.4, 3054.0, 2932.5, 2863.6, 1486.1, 1438.2, 1112.0, 996.0, 748.5, 691.9. 
MP 166.4 °C. 




The title compound was following general procedure F from (4-phenylbutyl)-
triphenylphosphonium bromide (3.13b, 2.05 g mg, 4.31 mmol, 1.0 equiv) and 3,3-
dimethylbutanal (541 µL, 4.31 mmol. 1.0 equiv). The crude product was purified by FCC 
(cyclohexane) to obtain (7,7-dimethyloct-4-en-1-yl)benzene (785 mg, 3.63 mmol, 84%, E/Z = 
25:75) as a colourless oil. 
 
Rf = 0.6 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.30 (m, 2H), 7.24 – 7.18 (m, 3H), 5.56 – 5.42 (m, 2H), 2.65 
(m, 2H), 2.14 – 2.05 (m, 2H), 1.96 – 1.87 (m, 2H), 1.76 – 1.66 (m, 2H), 0.91 (Z-maj, s, 9H), 0.90 
(E-min, s). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.8 (E-min), 142.7 (Z-maj), 132.3 (E-min), 130.9 (Z-
maj), 128.6 (E-min), 128.6, 128.4, 128.0 (E-min), 127.3, 125.8 (Z-maj), 125.8 (E-min), 77.5, 77.2, 
76.8, 47.3, 41.3, 35.7, 35.5, 32.4, 31.7, 31.6, 31.4, 31.0, 29.4, 27.0. 
IR (neat): ν (cm-1) 3027.0, 2951.6, 1604.1, 1455.3, 1240.7, 1030.3, 970.6, 906.8, 744.4, 697.3. 




The tile compound was obtained following general procedure G from 2-methylphenethyl 
bromide (0.85 mL. 5.00 mmol, 1.0 equiv) and t-butylacetylene (0.8 mL, 6.50 mmol, 1.3 equiv). 
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The crude product was purified by FCC (cyclohexane) to obtain 1-(5,5-dimethylhex-3-yn-1-yl)-
2-methylbenzene (474 mg, 2.40 mmol, 47%) as a colourless oil. 
 
Rf = 0.45 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.22 – 7.12 (m, 4H), 2.81 (t, J = 7.7 Hz, 2H), 2.41 (t, J = 7.7 
Hz, 2H), 2.35 (s, 3H), 1.20 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 139.4, 136.1, 130.2, 129.3, 126.4, 126.0, 78.0, 33.1, 
31.4, 27.5, 19.9, 19.5. 
IR (neat): ν (cm-1) 2967.0, 1605.0, 1457.1, 1268.0, 1204.7, 1051.1, 909.9, 741.1, 650.6. 




The title compound was obtained following general procedure I from 1-(5,5-dimethylhex-3-
yn-1-yl)-2-methylbenzene (3.20a, 459 mg, 2.29 mmol, 1.0 equiv). The crude product was 
purified by FCC (cyclohexane) to obtain (Z)-1-(5,5-dimethylhex-3-en-1-yl)-2-methylbenzene 
(330 mg, 1.63 mmol, 71%, E/Z =<1:99) as a colourless oil. 
 
Rf = 0.82 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.22 – 7.08 (m, 4H), 5.39 (dt, J = 12.0, 1.6 Hz, 1H), 5.26 (dt, 
J = 11.9, 7.3 Hz, 1H), 2.71 – 2.64 (m, 2H), 2.52 – 2.43 (m, 2H), 2.34 (s, 3H), 1.12 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 140.5, 140.4, 136.0, 130.3, 129.0, 128.1, 126.1, 126.1, 
33.94, 33.3, 31.3, 29.2, 27.1, 19.5. 
IR (neat): ν (cm-1) 2955.3, 1461.2, 1361.8, 1204.6, 1054.4, 908.6, 731.0. 




The tile compound was obtained following general procedure G from 1-(2-bromoethyl)-2-
fluorobenzene (0.70 mL. 5.00 mmol, 1.0 equiv) and t-butylacetylene (0.8 mL, 6.50 mmol, 1.3 
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equiv). The crude product was purified by FCC (cyclohexane) to obtain 1-(5,5-dimethylhex-3-
yn-1-yl)-2-fluorobenzene (334 mg, 1.64 mmol, 33%) as a colourless oil. 
 
Rf = 0.4 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.27 – 7.13 (m, 2H), 7.09 – 6.94 (m, 2H), 2.82 (t, J = 7.9 Hz, 
2H), 2.43 (t, J = 7.4 Hz, 2H), 1.16 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 161.3 (d, J = 245.0 Hz), 131.2 (d, J = 5.0 Hz), 128.0 (d, 
J = 8.1 Hz), 127.9 (d, J = 15.9 Hz), 123.8 (d, J = 3.6 Hz), 115.2 (d, J = 22.1 Hz), 90.1, 77.56, 31.4, 
29.0 (d, J = 2.2 Hz), 27.4, 19.77 (d, J = 1.4 Hz). 
19F{1H}-NMR (376 MHz, CDCl3): δ (ppm) 118.89. 
IR (neat): ν (cm-1) 2967.9, 1585.6, 1492.5, 1361.8, 1230.5, 1100.9, 1064.4, 909.7, 829.0, 753.1, 
669.9. 




The title compound was obtained following general procedure I from 1-(5,5-dimethylhex-3-
yn-1-yl)-2-fluorobenzene (3.20b, 321 mg, 1.57 mmol, 1.0 equiv). The crude product was 
purified by FCC (cyclohexane) to obtain (Z)-1-(5,5-dimethylhex-3-en-1-yl)-2-fluorobenzene 
(233 mg, 1.13 mmol, 72%, E/Z = 32:68) as a colourless oil. 
 
Rf = 0.85 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.24 – 7.11 (m, 2H), 7.11 – 6.95 (m, 2H), 5.46 – 5.16 (m, 
2H), 2.75 – 2.66 (m, 2H), 2.55 – 2.45 (Z-maj, m, 2H), 2.29 (E-min, dt, J = 9.2, 6.6 Hz), 1.08 (Z-
maj, s, 9H), 0.97 (E-min, s). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 160.1 (Z-maj, d, J = 244 Hz), 160.0 (E-min, d, J = 244 
Hz), 142.7 (E-min), 140.8 (Z-maj), 130.9 (E-min, d, J = 5.3 Hz), 130.9 (Z-maj, d, J = 5.3 Hz), 129.0 
(E-min, d, J = 16 Hz), 129.0 (Z-maj, d, J = 16 Hz), 127.7 (Z-maj, d, J = 8.0 Hz), 127.6 (Z-maj) , 
127.5 (E-min, d, J = 8.2 Hz), 124.0 (Z-maj, d, J = 3.6 Hz), 123.8 (E-min, d, J = 3.6 Hz), 123.6 (E-
min), 115.3 (Z-maj, J = 22 Hz), 115.2 (E-min, d, J = 22 Hz), 33.3, 32.9, 31.2, 29.8.  
19F{1H}-NMR (376 MHz, CDCl3): δ (ppm) 118.82 (Z-maj), 118.83 (E-min). 
IR (neat): ν (cm-1) 2955.9, 1585.2, 1492.2, 1362.3, 1229.5, 1102.2, 1035.1, 972.4, 909.0, 847.6. 
HRMS (ESI): Calcd for C14H19FAg [M+Ag]+: 313.0516, found 313.0511. 
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1-(5,5-Dimethylhex-3-yn-1-yl)-3-methoxybenzene (3.20c) 
 
The tile compound was obtained following general procedure G from 1-(2-bromoethyl)-3-
methoxybenzene (1.1 mL. 7.00 mmol, 1.0 equiv) and t-butylacetylene (1.1 mL, 9.10 mmol, 1.3 
equiv). The crude product was purified by fractional distillation (84 °C, 0.089 mbar) to obtain 
1-(5,5-dimethylhex-3-yn-1-yl)-3-methoxybenzene (595 mg, 2.75 mmol, 39%) as a colourless 
oil. 
 
Bp: 84 °C, 0.089 mbar. 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.20 (t, J = 7.8 Hz, 1H), 6.85 – 6.72 (m, 3H), 3.80 (s, 3H), 
2.77 (t, J = 7.6 Hz, 2H), 2.42 (t, J = 7.6 Hz, 2H), 1.19 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 159.7, 142.9, 129.3, 121.1, 114.4, 111.6, 89.9, 78.0, 
55.3, 36.0, 31.5, 27.5, 21.1. 
IR (neat): ν (cm-1) 2966.8, 1601.6, 1454.8, 1361.5, 1262.3, 1152.8, 1050.7, 910.1, 870.0, 778.1. 




The title compound was obtained following general procedure I from 1-(5,5-dimethylhex-3-
yn-1-yl)-3-methoxybenzene (3.20c, 569 mg, 2.63 mmol, 1.0 equiv). The crude product was 
purified by FCC (1% EtOAc in cyclohexane) to obtain (Z)-1-(5,5-dimethylhex-3-en-1-yl)-3-
methoxybenzene (456 mg, 2.09 mmol, 79%, E/Z = 5:95) as a colourless oil. 
 
Rf = 0.25 (1% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.22 (t, J = 7.7 Hz, 1H), 6.81 (d, J = 7.9 Hz, 1H), 6.79 – 6.72 
(m, 2H), 5.36 (dt, J = 11.9, 1.6 Hz, 1H), 5.22 (dt, J = 12.0, 7.2 Hz, 1H), 3.81 (s, 3H), 2.70 – 2.62 
(m, 2H), 2.56 – 2.46 (m, 2H), 1.11 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 159.7, 143.9, 140.5, 129.4, 127.8, 121.0, 114.4, 111.1, 
55.3, 36.7, 33.3, 31.2, 30.4. 
IR (neat): ν (cm-1) 2953.8, 1600.9, 1464.0, 1261.3, 1152.1, 1046.0, 873.5, 775.3. 
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PPh3 (3.15 g, 12.0 mmol, 1.2 equiv) was added portionwise to a solution of 3-(3-
(trifluoromethyl)phenyl)propan-1-ol (2.04 g, 10.0 mmol, 1.0 equiv) and CBr4 (3.98g, 12.0 
mmol, 1.2 equiv) in DCM (20.0 mL) at 0 °C. The reaction mixture was allowed to warm to 25 
°C and stirred for 4 h. The reaction mixture was then filtered over Celite® and the volatiles 
removed under reduced pressure. The crude product was purified by FCC (cyclohexane) to 
obtain 1-(3-bromopropyl)-3-(trifluoromethyl)benzene (2.51 g, 9.39 mmol, 94%) as a colourless 
oil. Spectroscopic data are consistent with those previously reported.[255] 
 
Rf = 0.4 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.51 – 7.44 (m, 2H), 7.44 – 7.37 (m, 2H), 3.40 (t, J = 6.5 Hz, 
2H), 2.86 (t, J = 7.3 Hz, 2H), 2.24 – 2.14 (m, 2H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 141.6, 132.1 (q, J = 1.4 Hz), 131.0 (q, J = 32.0 Hz), 125.3 
(q, J = 4.0 Hz), 124.3 (q, J = 204.2 Hz), 123.3 (q, J = 3.7 Hz), 34.0, 33.9, 32.8. 




The title product was obtained following general procedure H from 1-(3-bromopropyl)-3-
(trifluoromethyl)benzene (3.19a, 0.93 mL, 5.00 mmol, 1.0 equiv), and t-butylacetylene (0.8 
mL, 6.5 mmol, 1.3 equiv). The crude product was purified by FCC (cyclohexane) to obtain 1-
(6,6-dimethylhept-4-yn-1-yl)-3-(trifluoromethyl)benzene (765 mg, 2.85 mmol, 57%) as a 
colourless oil. 
 
Rf = 0.5 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.49 – 7.42 (m, 2H), 7.42 – 7.34 (m, 2H), 2.78 (t, J = 7.5 Hz, 
2H), 2.16 (t, J = 6.9 Hz, 2H), 1.85 – 1.76 (m, 2H), 1.22 (s, 9H). 
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13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 143.0, 132.1 (q, J = 1.4 Hz), 130.8 (q, J = 31.9 Hz), 
128.9, 125.4 (q, J = 3.8 Hz), 124.5 (q, J = 272 Hz), 122.9 (q, J = 3.9 Hz), 90.2, 77.7, 34.6, 31.5, 
30.6, 27.5, 18.2. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) 62.58. 
IR (neat): ν (cm-1) 2969.1, 1451.5, 1327.7, 1123.5, 1073.2, 898.6, 798.9, 702.1, 662.1. 




The title compound was obtained following general procedure I from 1-(6,6-dimethylhept-4-
yn-1-yl)-3-(trifluoromethyl)benzene (3.20d, 751 mg, 2.80 mmol, 1.0 equiv). The crude product 
was purified by FCC (cyclohexane) to obtain (Z)-1-(6,6-dimethylhept-4-en-1-yl)-3-
(trifluoromethyl)benzene (736 mg, 2.72 mmol, 97%, E/Z = 9:91) as a colourless oil. 
 
Rf = 0.8 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.47 – 7.42 (m, 2H), 7.42 – 7.36 (m, 1H), 7.39 – 7.34 (m, 
1H), 5.45 (E-min, dt, J = 15.6, 1.3 Hz), 5.36 (Z-maj, dt, J = 12.0, 1.8 Hz, 1H), 5.17 (dt, J = 12.0, 
7.4 Hz, 1H), 2.70 (Z-maj, d, J = 8.0 Hz, 2H), 2.66 (E-min, t, J = 7.8 Hz), 2.23 (Z-maj, m, 2H), 2.06 
– 2.00 (E-min, m), 1.76 – 1.66 (m, 2H), 1.09 (Z-maj, s, 9H), 1.00 (E-min, s). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 143.5, 140.7, 132.0 (q, J = 1.4 Hz), 130.7 (q, J = 31.9 
Hz), 128.8, 128.0, 125.3 (q, J = 3.8 Hz), 124.5 (q, J = 272 Hz), 122.8 (q, J = 3.9 Hz), 35.5, 33.3, 
31.9, 31.2, 29.9. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) -62.55 (E-min, s, 1F), -62.57 (Z-maj, s, 1F). 
IR (neat): ν (cm-1) 2955.1, 1450.7, 1328.9, 1123.7, 1073.2, 899.3, 798.5, 701.4. 
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1-(5,5-Dimethylhex-3-yn-1-yl)-4-methoxybenzene (3.20e) 
 
The tile compound was obtained following general procedure G from 1-(2-bromoethyl)-4-
methoxybenzene (1.1 mL. 7.00 mmol, 1.0 equiv) and t-butylacetylene (1.1 mL, 9.10 mmol, 1.3 
equiv). The crude product was purified by fractional distillation (79 °C, 0.078 mbar) to obtain 
1-(5,5-dimethylhex-3-yn-1-yl)-4-methoxybenzene (733 mg, 3.39 mmol, 48%) as a colourless 
oil. 
 
Bp: 79 °C, 0.078 mbar. 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.19 – 7.11 (m, 2H), 6.87 – 6.79 (m, 2H), 3.79 (s, 3H), 2.73 
(t, J = 7.5 Hz, 2H), 2.38 (t, J = 7.5 Hz, 2H), 1.19 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.1, 133.4, 129.7, 113.7, 89.9, 78.1, 55.4, 35.0, 31.5, 
27.5, 21.5. 
IR (neat): ν (cm-1) 2966.8, 1612.8, 1512.1, 1458.1, 1361.4, 1244.8, 1177.5, 1107.4, 1037.7, 
910.3, 82..9, 733.4. 




The title compound was obtained following general procedure I from 1-(5,5-dimethylhex-3-
yn-1-yl)-4-methoxybenzene (3.20e, 476 mg, 2.20 mmol, 1.0 equiv). The crude product was 
purified by FCC (cyclohexane to 2% EtOAc in cyclohexane) to obtain (Z)-1-(5,5-dimethylhex-3-
en-1-yl)-4-methoxybenzene (480 mg, 2.20 mmol, quant., E/Z = 1:9) as a colourless oil. 
 
Rf = 0.28 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.18 – 7.06 (m, 2H), 6.90 – 6.80 (m, 2H), 5.46 (E-min, dt, J 
= 15.6, 1.1 Hz), 5.35 (Z-maj, dt, J = 12.0, 1.6 Hz, 1H), 5.21 (dt, J = 12.0, 7.3 Hz, 1H), 3.80 (s, 3H), 
2.67 – 2.57 (m, 2H), 2.53 – 2.42 (Z-maj, m, 2H), 2.30 – 2.23 (E-min, m), 1.10 (Z-maj, s, 9H), 0.99 
(E-min, s). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 157.9, 140.4, 134.3, 129.5, 128.0, 113.8, 55.4, 35.7 (Z-
maj), 35.5 (E-min), 35.0, (E-min) 33.3 (Z-maj), 32.9 (E-min), 31.2 (Z-maj), 30.7 (Z-maj), 29.9 (E-
min). 
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IR (neat): ν (cm-1) 2954.1, 1612.5, 1511.8, 1463.5, 1244.3, 1177.3, 1038.5, 909.2, 824.8, 732.3. 




A solution of 4-(Trifluoromethyl)hydrocinnamic acid (4.36 g, 20.0 mmol, 1.0 equiv) in 
anhydrous THF (11.5 mL) was added dropwise to a solution of LiAlH4 (1.14 g, 30.0 mmol, 1.5 
equiv) in anhydrous THF (11.5 mL) at 0 °C. The reaction mixture was allowed to warm to 25 °C 
and stirred for 4 h. The reaction mixture was then cooled to 0 °C and diluted with Et2O (30 
mL), and then treated sequentially with water (1.2 mL), NaOH (2 M, 2.5 mL), water (3.6 mL), 
warm to 25 °C and stirred for 15 min. Then a copious amount of MgSO4 was added and the 
mixture stirred for further 15 min (Fieser Workup). The slurry was then filtered to remove the 
salts and the filtrate was concentrated under reduced pressure to obtain 3-(4-
(trifluoromethyl)phenyl)propan-1-ol (4.03 g, 19.9 mmol, 99%) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[256] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.59 – 7.49 (m, 2H), 7.35 – 7.27 (m, 2H), 3.67 (t, J = 6.4 Hz, 
2H), 2.77 (t, J = 8.1 Hz, 2H), 1.94 – 1.85 (m, 2H), 1.80 (s, 1H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 146.1 (q, J = 1.3 Hz), 128.9, 128.4 (q, J = 32.3 Hz), 125.4 
(q, J = 3.8 Hz), 124.5 (q, J = 271.7 Hz), 62.0, 34.0, 32.0. 
19F{1H}-NMR (376 MHz, CDCl3): δ (ppm) 62.30. 
IR (neat): ν (cm-1) 3329.3, 2941.6, 1619.2, 1418.7, 1223.3, 1111.6, 1065.1, 911.8, 844.1, 732.9. 
HRMS (ESI): Calcd for C10H11F3ONa [M+Na]+: 227.0654, found 227.0352. 
1-(3-Bromopropyl)-4-(trifluoromethyl)benzene (3.19b) 
 
PBr3 (2.40 g, 8.85 mmol, 0.5 equiv) was added portionwise to a solution of 3-(4-
(trifluoromethyl)phenyl)propan-1-ol (3.14b, 3.64 g, 17.7 mmol, 1.0 equiv) in Et2O (35.5 mL) at 
0 °C. The reaction mixture was allowed to warm to rt and stirred for 14 h. The reaction mixture 
was then cooled to 0 °C and quenched sequentially with water (20 mL) and K2CO3 (1 M, 20 
mL). The organic layer was collected and washed with brine (20 mL), dried over MgSO4 and 
the concentrated under reduced pressure. The crude product was purified by FCC 
(cyclohexane) to obtain 1-(3-bromopropyl)-4-(trifluoromethyl)benzene (2.88 g, 10.8 mmol, 
61%) as a colourless oil. Spectroscopic data are consistent with those previously reported.[257] 
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Rf = 0.4 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.59 – 7.52 (m, 2H), 7.36 – 7.28 (m, 2H), 3.39 (t, J = 6.4 Hz, 
2H), 2.85 (t, J = 7.4 Hz, 2H), 2.18 (tt, J = 7.4, 6.4 Hz, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 144.8 (q, J = 1.4 Hz), 129.0, 128.7 (q, J = 32.4 Hz), 125.6 
(q, J = 3.8 Hz), 124.4 (q, J = 271.8 Hz), 33.9, 33.9, 32.8. 




The tile compound was obtained following general procedure G from 1-(3-bromopropyl)-4-
(trifluoromethyl)benzene (3.19b, 0.55 mL. 3.00 mmol, 1.0 equiv) and t-butylacetylene (0.48 
mL, 3.90 mmol, 1.3 equiv). The crude product was purified by FCC (cyclohexane) to obtain 1-
(6,6-dimethylhept-4-yn-1-yl)-4-(trifluoromethyl)benzene (538 mg, 2.00 mmol, 67%) as a 
colourless oil. 
 
Rf = 0.28 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.56 – 7.51 (m, 2H), 7.33 – 7.28 (m, 2H), 2.78 (t, J = 7.6 Hz, 
2H), 2.16 (t, J = 6.9 Hz, 2H), 1.79 (tt, J = 7.6, 6.9 Hz, 2H), 1.22 (s, 9H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 146.2 (q, J = 1.4 Hz), 129.0, 128.4 (q, J = 32.3 Hz), 125.4 
(q, J = 3.8 Hz), 124.5 (q, J = 271.7 Hz), 90.2, 77.7, 34.6, 31.6, 30.6, 27.5, 18.2. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) 62.29. 
IR (neat): ν (cm-1) 2968.9, 1619.3, 1323.9, 1122.7, 1067.3, 1019.2, 840.8, 734.4. 




The title compound was obtained following general procedure I from 1-(6,6-dimethylhept-4-
yn-1-yl)-4-(trifluoromethyl)benzene (3.20f, 518 mg, 1.93 mmol, 1.0 equiv). The crude product 
was purified by FCC (cyclohexane) to obtain (Z)-1-(6,6-dimethylhept-4-en-1-yl)-4-
(trifluoromethyl)benzene (513 mg, 1.90 mmol, 98%, E/Z = 15:85 as a colourless oil. 
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Rf = 0.96 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.56 – 7.51 (m, 2H), 7.32 – 7.27 (m, 2H), 5.47 (E-min, dt, J 
= 15.6, 1.3 Hz), 5.36 (Z-maj,z dt, J = 12.0, 1.7 Hz, 1H), 5.17 (dt, J = 11.9, 7.4 Hz, 1H), 2.69 (Z-
maj, t, J = 7.6 Hz, 2H), 2.66 (E-min, t, J = 7.7 Hz), 2.23 (tdd, J = 7.5, 7.5 1.7 Hz, 2H), 1.74 – 1.64 
(m, 2H), 1.09 (Z-maj, s, 9H), 1.00 (E-min, s). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 147.0 (E-min, q, J = 1.3 Hz), 146.8 (Z-maj, q, J = 1.3 
Hz), 142.6 (E-min), 140.7 (Z-maj), 128.9 (E-min), 128.9 (Z-maj), 128.3 (Z-maj, q, J = 32.3 Hz), 
128.0, 125.3 (Z-maj, q, J = 3.8 Hz), 124.5 (Z-maj, q, J = 271 Hz), 124.0, 35.5 (Z-maj), 35.3 (E-
min), 33.3 (Z-maj), 33.0 (E-min), 32.2 (E-min), 31.9 (Z-maj), 31.3 (Z-maj), 29.9 (E-min), 27.9 (Z-
maj), 27.1 (E-min). 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) 62.27 (E-min), 62.28 (Z-maj). 
IR (neat): ν (cm-1) 2954.6, 1619.5, 1462.6, 1416.7, 1323.7, 1122.4, 1067.3, 1019.1, 842.4, 
728.7. 




A solution of 3-(benzo[d][1,3]dioxol-5-yl)propanoic acid (2.99 g, 15.4 mmol, 1.0 equiv) in 
anhydrous THF (8.8 mL) was added dropwise to a solution of LiAlH4 (877 mg, 23.1 mmol, 1.5 
equiv) in anhydrous THF (8.8 mL) at 0 °C. The reaction mixture was allowed to warm to 25 °C 
and stirred for 4 h. The reaction mixture was then cooled to 0 °C and diluted with Et2O (30 
mL), and then treated (Fieser Workup) sequentially with water (0.9 mL), NaOH (2 M, 1.9 mL), 
water (2.7 mL), warm to 25 °C and stir for 15 min. Then a copious amount of MgSO4 was added 
and the mixture stirred for further 15 min. The slurry was then filtered to remove the salts and 
the filtrate was concentrated under reduced pressure. The crude product was purified by FCC 
(40% EtOAc in Cyclohexane) to obtain 3-(benzo-dioxol-5-yl)propan-1-ol (2.71 g, 15.1 mmol, 
98%) as a colourless oil. Spectroscopic data are consistent with those previously reported.[258] 
 
Rf = 0.45 (40% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 6.73 (d, J = 7.9 Hz, 1H), 6.69 (d, J = 1.7 Hz, 1H), 6.64 (dd, J 
= 7.9, 1.7 Hz, 1H), 5.91 (s, 2H), 3.65 (t, J = 6.4 Hz, 2H), 2.62 (d, J = 7.5 Hz, 2H), 1.90 – 1.78 (m, 
2H), 1.63 (s, 1H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.7, 145.7, 135.7, 121.2, 109.0, 108.3, 100.9, 62.2, 
34.5, 31.9. 
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IR (neat): ν (cm-1) 3346.5, 2937.7, 2882.0, 1851.8, 1487.2, 1440.7, 1242.1, 1187.3, 1034.0, 
927.6, 808.5. 




Triphenylphosphine (4.75 g, 18.1 mmol, 1.2 equiv) was added portionwise to a solution of 3-
(benzo-dioxol-5-yl)propan-1-ol (3.14c, 2.72 g, 15.1 mmol, 1.0 equiv) and CBr4 (6.01 g, 18.1 
mmol, 1.2 equiv) in dichloromethane (30 mL) at 0 °C. The reaction mixture was then stirred at 
25 °C for 14 h. The solids were removed by filtration and the filtrate concentrated under 
reduced pressure. The crude product was purified by FCC (2% Et2O in cyclohexane) to obtain 
5-(3-bromopropyl)benzo-1,3-dioxole (3.65 g, 15.0 mmol, 99%) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[259] 
 
Rf = 0.4 (2% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 6.74 (d, J = 7.9 Hz, 1H), 6.69 (d, J = 1.7 Hz, 1H), 6.65 (dd, J 
= 7.9, 1.7 Hz, 1H), 5.93 (s, 2H), 3.38 (t, J = 6.6 Hz, 2H), 2.70 (t, J = 7.3 Hz, 2H), 2.12 (t, J = 7.3, 
6.6 Hz, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.8, 146.0, 134.4, 121.5, 109.1, 108.4, 101.0, 34.5, 
33.8, 33.1. 
IR (neat): ν (cm-1) 2890.5, 1487.2, 1441.8, 1235.3, 1188.2, 1037.6, 935.5, 807.6, 731.1. 




The title product was obtained following general procedure H from 5-(3-bromopropyl)benzo-
1,3-dioxole (3.19c, 3.65 g, 15.0 mmol, 1.0 equiv), and t-butylacetylene (2.4 mL, 19.5 mmol, 1.3 
equiv). The crude product was purified by FCC (2% Et2O in cyclohexane) to obtain 5-(6,6-
dimethylhept-4-yn-1-yl)benzo-1,3-dioxole (1.50 g, 6.14 mmol, 41%) as a colourless oil. 
 
Rf = 0.45 (2% Et2O in Cy). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 6.73 (d, J = 7.9 Hz, 1H), 6.69 (d, J = 1.7 Hz, 1H), 6.64 (dd, J 
= 7.9, 1.7 Hz, 1H), 5.92 (s, 2H), 2.63 (t, J = 7.5 Hz, 2H), 2.14 (t, J = 7.0 Hz, 2H), 1.74 (tt, J = 7.5, 
7.0 Hz, 2H), 1.22 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.6, 145.7, 135.9, 121.4, 109.1, 108.2, 100.9, 89.8, 
78.1, 34.5, 31.6, 31.2, 27.5, 18.1. 
IR (neat): ν (cm-1) 2966.9, 1488.3, 1441.8, 1361.1, 1242.6, 1188.3, 1040.0, 938.2, 808.1. 




The title compound was obtained following general procedure I from 5-(6,6-dimethylhept-4-
yn-1-yl)benzo-1,3-dioxole (3.20g, 977 mg, 4.00 mmol, 1.0 equiv). The crude product was 
purified by FCC (1% Et2O in cyclohexane) to obtain (Z)-5-(6,6-dimethylhept-4-en-1-yl)benzo-
1,3-dioxole (962 mg, 3.90 mmol, 98%, E/Z = 28:72) as a colourless oil. 
 
Rf = 0.2 (1% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 6.73 (d, J = 7.9 Hz, 1H), 6.69 – 6.67 (m, 1H), 6.65 – 6.60 (m, 
1H), 5.92 (s, 2H), 5.45 (E-min, dt, J = 15.6, 1.3 Hz), 5.38 – 5.25 (m, 1H), 5.17 (Z-maj, dt, J = 12.0, 
7.3 Hz, 1H), 2.60 – 2.48 (m, 2H), 2.26 – 2.15 (Z-maj, m, 2H), 2.05 – 1.95 (E-min, m), 1.70 – 1.56 
(m, 2H), 1.09 (Z-maj, s, 9H), 0.99 (E-min, s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.6 (Z-maj), 147.6 (E-min), 145.6 (Z-maj), 145.5 (E-
min), 142.2 (E-min), 140.3 (Z-maj), 136.7 (E-min), 136.5 (Z-maj), 128.5 (Z-maj), 124.3 (E-min), 
121.3 (E-min), 121.2 (Z-maj), 109.1 (E-min), 109.0 (Z-maj), 108.2 (Z-maj), 108.2 (E-min), 100.8 
(Z-maj), 100.8 (E-min), 35.5 (Z-maj), 35.2 (E-min), 33.3 (Z-maj), 32.9 (E-min), 32.4 (Z-maj), 32.1 
(E-min), 31.8 (E-min), 31.3 (Z-maj), 30.0 (E-min), 28.0 (Z-maj). 
IR (neat): ν (cm-1) 2953.8, 1488.1, 1441.8, 1361.5, 1242.8, 1188.3, 1040.6, 939.1, 807.9, 732.7. 
HRMS (ESI): Calcd for C16H22O2Ag [M+Ag]+: 353.0665, found 353.0670. 
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(13,13-Dimethyltetradec-11-yn-1-yl)benzene (3.20h) 
 
The title product was obtained following general procedure H from (10-bromodecyl)benzene 
(963 mg, 3.24 mmol, 1.0 equiv), and t-butylacetylene (0.62 mL, 4.21 mmol, 1.3 equiv). The 
crude product was purified by FCC (cyclohexane) to obtain (13,13-dimethyltetradec-11-yn-1-
yl)benzene (770 mg, 2.58 mmol, 80%) as a colourless oil. 
 
Rf = 0.4 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.30 – 7.22 (m, 2H), 7.21 – 7.13 (m, 3H), 2.59 (t, J = 7.6 Hz, 
2H), 2.12 (t, J = 7.1 Hz, 2H), 1.67 – 1.55 (m, 2H), 1.50 – 1.40 (m, 2H), 1.38 – 1.23 (m, 12H), 1.19 
(s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 143.1, 128.5, 128.4, 125.7, 89.1, 78.7, 77.5, 77.2, 76.8, 
36.1, 31.7, 31.6, 29.7, 29.7, 29.7, 29.5, 29.4, 29.3, 28.9, 27.5, 18.8. 
IR (neat): ν (cm-1) 2926.1, 2854.9, 1455.2, 1361.4, 1265.5, 1205.0, 909.1, 733.2. 




The title compound was obtained following general procedure I from (13,13-
dimethyltetradec-11-yn-1-yl)benzene (3.20h, 740 mg, 2.48 mmol, 1.0 equiv). The crude 
product was purified by FCC (cyclohexane) to obtain (Z)-(13,13-dimethyltetradec-11-en-1-
yl)benzene (693 mg, 2.31 mmol, 93%, E/Z = 26:74) as a colourless oil. 
 
Rf = 0.88 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.31 – 7.22 (m, 2H), 7.22 – 7.13 (m, 3H), 5.42 (E-min, dt, J 
= 15.6, 1.3 Hz), 5.34 – 5.24 (m, 1H), 5.15 (dt, J = 11.9, 7.3 Hz, 1H), 2.59 (t, J = 7.6 Hz, 2H), 2.20 
– 2.09 (Z-maj, m, 2H), 2.01 – 1.92 (E-min, m), 1.66 – 1.54 (m, 2H), 1.37 – 1.21 (m, 14H), 1.10 
(Z-maj, s, 9H), 0.98 (E-min, s). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 143.1, 141.6, 139.7, 129.3, 128.5, 128.4, 125.7, 124.9, 
36.2, 33.2, 32.9, 32.8, 31.7, 31.4, 30.5, 30.0, 29.9, 29.8, 29.7, 29.7, 29.7, 29.6, 29.5, 29.5, 29.3, 
28.5. 
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IR (neat): ν (cm-1) 2924.4, 2854.0, 1460.2, 1361.7, 1204.0, 1029.8, 971.7, 908.6. 




The title compound was obtained following general procedure F from (2-phenylethyl)-
triphenylphosphonium bromide (2.30 g, 5.16 mmol, 1.0 equiv) and 3,3-dimethylbutanal (648 
µL, 5.16 mmol, 1.0 equiv). The crude product was purified by FCC (cyclohexane) to obtain 
(Z)-(5,5-dimethylhex-2-en-1-yl)benzene (661 mg, 3.51 mmol, 68%, E/Z = 23:77) as a colourless 
oil. 
 
Rf = 0.62 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.35 – 7.26 (m, 2H), 7.25 – 7.17 (m, 3H), 5.73 – 5.54 (m, 
2H), 3.43 (Z-maj, d, J = 6.6 Hz, 2H), 3.38 (E-min, d, J = 4.5 Hz), 2.12 – 2.05 (Z-maj, m, 2H), 1.93 
(E-min, d, J = 4.3 Hz), 0.96 (Z-maj, s, 9H), 0.91 (E-min,s). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 141.4 (Z-maj), 141.3 (E-min), 131.1 (E-min), 129.6 (Z-
maj), 129.2 (E-min), 128.6 (E-min), 128.5 (Z-maj), 128.5 (Z-maj), 128.5 (E-min), 127.9 (Z-maj), 
126.0 (E-min), 125.9 (Z-maj), 77.5 (E-min), 77.2 (E-min), 76.8 (E-min), 47.2 (E-min), 41.3 (Z-
maj), 39.4 (E-min), 33.7 (Z-maj), 31.5(Z-maj), 31.1 (E-min), 29.5(Z-maj), 29.5 (E-min). 
IR (neat): ν (cm-1) 3026.1, 2954.0, 1603.0, 1472.1, 1364.2, 1240.1, 908.5, 734.4, 696.5. 




The title compound was obtained following general procedure F from (3-phenylpropyl)-
triphenylphosphonium bromide (923 mg, 2.00 mmol, 1.0 equiv) and cyclohexanal (242 µL, 
2.00 mmol. 1.0 equiv). The crude product was purified by FCC (cyclohexane) to obtain (4-
cyclohexylbut-3-en-1-yl)benzene (408 mg, 1.90 mmol, 95%, E/Z = 10:90) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[260] 
 
Rf = 0.65 (cyclohexane). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.31 – 7.24 (m, 2H), 7.22 – 7.14 (m, 3H), 5.42 – 5.17 (m, 
2H), 2.56 (t, J = 7.3 Hz, 2H), 2.41 – 2.25 (m, 2H), 2.24 – 2.11 (m, 1H), 1.71 – 1.45 (m, 5H), 1.30 
– 0.94 (m, 5H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.4 (E-min), 142.3 (Z-maj), 137.3 (E-min), 136.9 (Z-
maj), 128.6 (E-min), 128.6 (Z-maj), 128.4 (Z-maj), 128.3 (E-min), 126.9 (Z-maj), 126.8 (E-min), 
125.9 (Z-maj), 125.8 (E-min), 40.8 (E-min), 36.5 (Z-maj), 36.5 (Z-maj), 36.4 (E-min), 34.7 (E-
min), 33.4 (Z-maj), 33.3 (E-min), 29.5 (Z-maj), 26.4 (E-min), 26.3 (E-min), 26.2 (Z-maj), 26.1 (Z-
maj). 
IR (neat): ν (cm-1) 3024.9, 2950.7, 1600.9, 1364.3, 1249.1, 907.6, 729.9, 649.6. 




(E)-6-Phenyl-3-hexenol (3.17, 0.9 mL, 5.00 mmol, 1.0 equiv) was added to a solution of Dess-
Martin Periodinane (2.55 g, 6.00 mmol, 1.2 equiv) and water (104 µL, 5.75 mmol, 1.15 equiv) 
in dichloromethane (32 mL). The reaction mixture was stirred for 1 h and then carefully 
quenched with sat. aq. NaHCO3 (25 mL) and washed with sat. aq. Na2S2O3 (3 x 25 mL). The 
organic layer was then dried over MgSO4 and the volatiles removed under reduced pressure. 
The crude product was purified by FCC (5% EtOAc in cyclohexane to 10% EtOAc in cyclohexane) 
to obtain (E)-6-phenylhex-3-enal (316 mg, 1.82 mmol, 63%) as a colourless oil. 
 
Rf = 0.3 (10% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 9.63 (t, J = 2.0 Hz, 1H), 7.33 – 7.24 (m, 2H), 7.24 – 7.14 (m, 
3H), 5.72 – 5.60 (m, 1H), 5.60 – 5.48 (m, 1H), 3.16 – 3.08 (m, 2H), 2.71 (t, J = 7.8 Hz, 2H), 2.45 
– 2.34 (m, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 200.4, 141.7, 135.9, 128.6, 128.5, 126.0, 120.1, 47.4, 
35.7, 34.6. 
IR (neat): ν (cm-1) 3027.3, 2925.6, 1722.0, 1495.7, 1453.5, 970.7, 909.2, 730.7. 
HRMS (ESI): Calcd for C12H14ONa [M+Na]+: 197.0937, found 197.0937. 
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(E)-2-(5-Phenylpent-2-en-1-yl)-1,3-dioxolane (3.1n) 
 
Performed according to an adapted literature procedure.[261] Tetra-n-butylammonium 
tribromide (89.1 mg, 0.181 mmol, 0.1 equiv) was added to a solution of (E)-6-phenylhex-3-
enal (3.21, 315 mg, 1.81 mmol, 1.0 equiv) and ethyl orthoformate (0.33 mL, 1.99 mmol, 1.1 
equiv) in ethylene glycol (0.37 mL, 7.24 mmol, 4.0 equiv). The reaction mixture was stirred at 
25 °C for 14 h and then diluted with Et2O (25 mL) and quenched with sat. aq. NaHCO3 (25 mL). 
The aqueous phase was extracted with Et2O (3 x 20 mL), the combined organic layers were 
dried over MgSO4 and the volatiles removed under reduced pressure. The crude product was 
purified by FCC (2.5% EtOAc in cyclohexane) to obtain (E)-2-(5-phenylpent-2-en-1-yl)-1,3-
dioxolane (290 mg, 1.33 mmol, 73%) as a colourless oil. 
 
Rf = 0.18 (2.5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.30 – 7.25 (m, 2H), 7.20 – 7.15 (m, 3H), 5.68 – 5.56 (m, 
1H), 5.53 – 5.42 (m, 1H), 4.86 (t, J = 4.8 Hz, 1H), 4.00 – 3.92 (m, 2H), 3.89 – 3.80 (m, 2H), 2.69 
(t, J = 7.3 Hz, 2H), 2.39 – 2.31 (m, 4H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.1, 133.5, 128.6, 128.4, 125.9, 124.2, 104.3, 65.1, 
37.6, 35.9, 34.6. 
IR (neat): ν (cm-1) 2929.7, 2884.5, 1603.9, 1453.9, 1398.5, 1134.8, 1036.8, 970.1, 746.2, 699.2. 




Diisopropyl azodicarboxylate (0.77 mL, 3.90 mmol, 1.3 equiv) was added dropwise to a 
solution of (E)-6-Phenyl-3-hexenol (3.17, 529 mg, 3.00 mmol, 1.0 equiv), phtalimide (0.47 mL, 
3.90 mmol, 1.3 equiv) and triphenylphosphine (1.02 g, 3.90 mmol, 1.3 equiv) in THF (33 mL) 
and the mixture was stirred at 25 °C for 4 h. The reaction mixture was then quenched with 
water (30 mL) and the aqueous layer extracted with DCM (3 x 30 mL), the combined organic 
layers dried over MgSO4 and the volatiles removed under reduced pressure. The crude 
product was purified by FCC (25% EtOAc in cyclohexane) to obtain (E)-2-(6-phenylhex-3-en-1-
yl)isoindoline-1,3-dione (646 mg, 2.12 mmol, 71%) as a white solid. Spectroscopic data are 
consistent with those previously reported.[262] 
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Rf = 0.3 (25% EtOAc in Cy) 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.88 – 7.80 (m, 2H), 7.75 – 7.66 (m, 2H), 7.25 – 7.19 (m, 
2H), 7.18 – 7.11 (m, 1H), 7.11 – 7.04 (m, 2H), 5.63 – 5.34 (m, 2H), 3.71 (t, J = 7.1 Hz, 2H), 2.54 
(t, J = 9.1, 6.6 Hz, 2H), 2.42 – 2.32 (m, 2H), 2.30 – 2.21 (m, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 168.5, 142.0, 134.0, 132.9, 132.3, 128.5, 128.4, 126.6, 




Diisopropyl azodicarboxylate (0.78mL, 3.99 mmol, 1.1 equiv) was added dropwise to a solution 
of (E)-6-Phenyl-3-hexenol (3.17, 640 mg, 3.63 mmol, 1.0 equiv), N-methyl-p-
toluenesulfonamide (672 mg, 3.63 mmol, 1.0 equiv) and triphenylphosphine (1.05 g, 3.99 
mmol, 1.1 equiv) in THF (3.6 mL) and the mixture was stirred at 25 °C for 4 h. The reaction 
mixture was then quenched with water (30 mL) and the aqueous layer extracted with DCM (3 
x 30 mL), the combined organic layers dried over MgSO4 and the volatiles removed under 
reduced pressure. The crude product was purified by FCC (10% EtOAc in cyclohexane) to 
obtain (E)-N,4-dimethyl-N-(6-phenylhex-3-en-1-yl)benzenesulfonamide (725 mg, 2.11 mmol, 
58%) as a colourless oil. 
 
Rf = 0.47 (10% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.70 – 7.62 (m, 2H), 7.28 (m, 4H), 7.21 – 7.11 (m, 3H), 5.58 
– 5.45 (m, 1H), 5.42 – 5.30 (m, 1H), 2.99 (t, J = 7.3 Hz, 2H), 2.69 (s, 4H), 2.68 – 2.61 (m, 2H), 
2.42 (s, 3H), 2.35 – 2.25 (m, 2H), 2.26 – 2.16 (m, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 143.3, 142.0, 134.9, 132.4, 129.7, 128.6, 128.4, 127.5, 
126.7, 125.9, 50.2, 35.9, 34.9, 34.5, 31.3, 21.6. 
IR (neat): ν (cm-1) 2927.7, 1599.0, 1454.8, 1340.5, 1260.6, 1089.8, 968.8,. 




1-Bromo-3-phenylpropane (1.5 mL, 9.99 mmol, 1.0 equiv) was added slowly to a suspension 
of magnesium turnings (267 mg, 11.0 mmol, 1.1 equiv) and a crystal of iodine in anhydrous 
Et2O (6.7 mL). The reaction mixture was then heated under reflux for 4 h. The reaction mixture 
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was then cooled down to 25 °C and 3-bromocyclohexene (1.3 mL, 9.99 mmol, 1.0 equiv) was 
added to the reaction mixture. The reaction was heated under reflux for 4 h, and then 
quenched with sat. aq. NH4Cl (10 mL). The aqueous layer extracted with Et2O (3 x 10 mL) and 
the combined organic layers dried over MgSO4. The volatiles were removed under reduced 
pressure and the crude product purified by FCC (cyclohexane) to obtain (3-(cyclohex-2-en-1-
yl)propyl)benzene (1.25 g, 6.24 mmol, 63%) as a colourless oil. Spectroscopic data are 
consistent with those previously reported.[263] 
 
Rf = 0.8 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.34 – 7.27 (m, 2H), 7.24 – 7.15 (m, 3H), 5.76 – 5.64 (m, 
1H), 5.64 – 5.54 (m, 1H), 2.63 (t, J = 7.8 Hz, 2H), 2.18 – 2.04 (m, 1H), 2.04 – 1.93 (m, 2H), 1.83 
– 1.66 (m, 4H), 1.58 – 1.22 (m, 4H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.9, 132.2, 128.5, 128.4, 127.0, 125.7, 36.4, 36.2, 
35.2, 29.2, 29.0, 25.5, 21.7. 
IR (neat): ν (cm-1) 3021.8, 2927.0, 2855.6, 1604.0, 1453.3, 745.8, 697.6. 




PPh3 (6.30 g, 24.0 mmol, 1.2 equiv) was added portionwise to a solution of 3-(4-
methoxyphenyl)propan-1-ol (3.32 g, 20.0 mmol, 1.0 equiv) and CBr4 (7.96 g, 24.0 mmol, 1.2 
equiv) in DCM (40.0 mL) at 0 °C. The reaction mixture was allowed to warm to 25 °C and stirred 
for 4 h. The reaction mixture was then filtered over Celite® and the volatiles removed under 
reduced pressure. The crude product was purified by FCC (2.5 % Et2O in cyclohexane) to obtain 
1-(3-bromopropyl)-4-methoxybenzene (4.26 g, 18.6 mmol, 93%) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[264] 
 
Rf = 0.45 (2.5 % Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.17 – 7.08 (m, 2H), 6.90 – 6.79 (m, 2H), 3.80 (s, 3H), 3.39 
(t, J = 6.6 Hz, 2H), 2.73 (t, J = 7.3 Hz, 2H), 2.14 (tt, J = 7.3, 6.6 Hz, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.1, 132.7, 129.6, 114.0, 55.4, 34.5, 33.3, 33.1. 
IR (neat): ν (cm-1) 2934.7, 1612.0, 1511.3, 1460.5, 1241.4, 1177.4, 1034.9, 828.8. 
HRMS (ESI): Calcd for C10H13BrOAg [M+Ag]+: 334.9195, found 334.9196. 
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Triisopropyl(5-(4-methoxyphenyl)pent-1-yn-1-yl)silane (3.26) 
 
The title product was obtained following general procedure H from 1-(3-bromopropyl)-4-
methoxybenzene (3.18d, 1.57 g, 6.86 mmol, 1.0 equiv), and (triisopropylsilyl)acetylen (2.0 mL, 
8.92 mmol, 1.3 equiv). The crude product was purified by fractional distillation (158 °C, 0.03 
mbar) to obtain triisopropyl(5-(4-methoxyphenyl)pent-1-yn-1-yl)silane (1.50 g, 6.54 mmol, 
66%) as a colourless oil. Spectroscopic data are consistent with those previously reported.[265] 
 
Bp: 158 °C, 0.03 mbar. 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.14 – 7.08 (m, 2H), 6.87 – 6.78 (m, 2H), 3.79 (s, 3H), 2.70 
(t, J = 7.6 Hz, 2H), 2.26 (t, J = 6.9 Hz, 2H), 1.80 (tt, J = 7.6, 6.9 Hz, 2H), 1.09 (s, 3H), 1.08 (s, 18H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.0, 134.0, 129.6, 113.9, 108.9, 80.8, 55.4, 33.9, 
31.0, 19.37, 18.8, 11.5. 
IR (neat): ν (cm-1) 2940.1, 2863.7, 2170.1, 1612.5, 1512.1, 1462.4, 1299.9, 1244.9, 1038.3, 
882.9, 660.4. 




Tetrabutylammonium fluoride (1.0 M, 6.8 mL, 6.81 mmol, 1.5 equiv) was added to a solution 
of triisopropyl(5-(4-methoxyphenyl)pent-1-yn-1-yl)silane (3.26, 1.50 g, 4.54 mmol, 1.0 equiv) 
and water (164 µL, 9.08 mmol, 2.0 equiv) in THF (18 mL) and the reaction mixture was stirred 
for 2 h. Sat. aq. NaHCO3 (20 mL) was then added to the reaction mixture and the layers 
separated. The aqueous phase was extracted with Et2O (3 x 30 mL), the combined organic 
layers dried over MgSO4 and the volatiles removed under reduced pressure to obtain 1-
methoxy-4-(pent-4-yn-1-yl)benzene (785 mg, 4.50 mmol, 99%) as a colourless oil. 
Spectroscopic data are consistent with those previously reported.[266] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.17 – 7.08 (m, 2H), 6.88 – 6.79 (m, 2H), 3.80 (s, 3H), 2.68 
(t, J = 7.6 Hz, 2H), 2.20 (td, J = 7.0, 2.6 Hz, 2H), 1.99 (t, J = 2.6 Hz, 1H), 1.82 (tt, J = 7.6, 7.0 Hz, 
2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.0, 133.7, 129.6, 113.9, 84.4, 68.7, 55.4, 33.8, 30.4, 
17.9. 
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IR (neat): ν (cm-1) 3296.3, 2935.2, 1612.0, 1511.8, 1460.7, 1243.4, 1177.6, 1036.6, 909.5, 
732.1, 632.5. 




The title product was obtained following general procedure H from 1-(3-bromopropyl)-4-
(trifluoromethyl)benzene (3.19b, 881 mg, 3.30 mmol, 1.1 equiv), and 1-methoxy-4-(pent-4-
yn-1-yl)benzene (3.27, 523 mg, 3.00 mmol, 1.0 equiv). The crude product was purified by FCC 
(2% Et2O in cyclohexane) to obtain 1-methoxy-4-(8-(4-(trifluoromethyl)phenyl)oct-4-yn-1-
yl)benzene (680 mg, 1.89 mmol, 63%) as a colourless oil. 
 
Rf = 0.3 (2% Et2O in Cy). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.56 – 7.51 (m, 2H), 7.34 – 7.28 (m, 2H), 7.14 – 7.09 (m, 
2H), 6.86 – 6.80 (m, 2H), 3.79 (s, 3H), 2.80 (t, J = 7.7 Hz, 2H), 2.68 (t, J = 7.2 Hz, 2H), 2.24 – 2.16 
(m, 4H), 1.88 – 1.74 (m, 4H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 158.0, 146.1 (q, J = 1.4 Hz), 134.0, 129.5, 129.0, 128.4 
(q, J = 32.3 Hz), 125.4 (q, J = 3.8 Hz), 124.5 (q, J = 271.8 Hz), 113.9, 80.9, 79.9, 55.4, 34.7, 34.1, 
31.1, 30.5, 18.3, 18.3. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) 62.30. 
IR (neat): ν (cm-1) 2935.9, 1614.8, 1512.1, 1323.9, 1244.9, 1162.2, 1119.7, 1067.1, 1037.6, 
836.7. 




The title compound was obtained following general procedure I from 1-methoxy-4-(8-(4-
(trifluoromethyl)phenyl)oct-4-yn-1-yl)benzene (3.28, 338 mg, 0.938 mmol, 1.0 equiv). The 
crude product was purified by FCC (1% Et2O in cyclohexane) to obtain (Z)-1-methoxy-4-(8-(4-
(trifluoromethyl)phenyl)oct-4-en-1-yl)benzene (336 mg, 0.927mmol, 99%, E/Z = <1:99) as a 
colourless oil. 
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Rf = 0.2 (1% Et2O in Cy). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.56 – 7.50 (m, 2H), 7.31 – 7.25 (m, 2H), 7.12 – 7.06 (m, 
2H), 6.86 – 6.80 (m, 2H), 5.49 – 5.35 (m, 2H), 3.80 (s, 3H), 2.67 (t, J = 7.7 Hz, 2H), 2.56 (t, J = 
7.8 Hz, 2H), 2.11 – 1.99 (m, 4H), 1.74 – 1.61 (m, 4H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 157.9, 146.8 (q, J = 1.6 Hz), 134.7, 130.4, 129.5, 129.4, 
128.9, 128.2 (q, J = 32.2 Hz), 125.3 (q, J = 3.8 Hz), 124.6 (q, J = 271.7 Hz), 113.8, 55.4, 35.4, 
34.7, 31.8, 31.2, 26.9, 26.9. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) 62.24. 
IR (neat): ν (cm-1) 2932.2, 2858.1, 1615.0, 1511.9, 1323.9, 1244.4, 1161.8, 1119.1, 1067.2, 
1037.8, 909.3, 839.1, 733.1. 




The title compound was obtained following general procedure I from 1-methoxy-4-(8-(4-
(trifluoromethyl)phenyl)oct-4-yn-1-yl)benzene (3.28, 338 mg, 0.938 mmol, 1.0 equiv) and 
deuterium instead of hydrogen. The crude product was purified by FCC (1% Et2O in 
cyclohexane) to obtain (Z)-1-methoxy-4-(8-(4-(trifluoromethyl)phenyl)oct-4-en-1-yl-4,5-
d2)benzene (342 mg, 0.938mmol, quant., E/Z = <1:99) as a colourless oil. 
 
Rf = 0.2 (1% Et2O in Cy). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.59 – 7.50 (m, 2H), 7.32 – 7.25 (m, 2H), 7.15 – 7.07 (m, 
2H), 6.90 – 6.80 (m, 2H), 3.80 (s, 3H), 2.67 (t, J = 7.8 Hz, 2H), 2.56 (t, J = 7.5 Hz, 2H), 2.13 – 1.99 
(m, 4H), 1.75 – 1.60 (m, 4H). 
2H-NMR (77 MHz, CDCl3): δ (ppm) 4.85 (bs, 22H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 157.9, 146.8 (q, J = 1.4 Hz), 134.7, 129.9 (non-binomial 
t, J = 23.4, 22.2 Hz), 129.4, 129.0 (non-binomial t, J = 23.4, 22.2 Hz), 128.2 (q, J = 32.3 Hz), 125.3 
(q, J = 3.8 Hz), 124.6 (q, J = 271.7 Hz), 113.8, 55.4, 35.4, 34.7, 31.7, 31.2, 26.8, 26.7. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) 62.23. 
IR (neat): ν (cm-1) 2932.6, 2857.8, 1615.2, 1511.9, 1323.9, 1244.7, 1161.7, 1118.6, 1067.0, 
1037.8, 830.5. 
HRMS (ESI): Calcd for C22H23D2F3OAg [M+Ag]+: 471.1028, found 471.1032. 
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6.3.2. Synthesis of aryl-bromides 
4-Bromo-3-chloro-N,N-dimethylaniline (S1a) 
 
4-bromo-3-chloro-N,N-dimethylaniline was prepared according to an adapted reported 
procedure.[267] Sodium cyanoborohydride (960 mg, 14.5 mmol, 2.0 equiv) was added to a 
stirred slurry of 4-bromo-3-chloroaniline (1.50 g, 7.26 mmol, 1 equiv) and paraformaldehyde 
(1.34 g, 14.9 mmol, 2.05 equiv) in glacial acetic acid (10 mL) at 0 °C. The resultant mixture was 
stirred at 0 °C for 25 min whereupon the ice bath was removed and the mixture was heated 
to 65 °C and stirred at that temperature for 3 h. The hot reaction mixture was poured over aq. 
NaOH (5 M, 39 mL, 193 mmol, 1.1 equiv to acetic acid) and then diluted with ethyl acetate (30 
mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (2 × 
30 mL). The combined organic layers were washed sequentially with water (20 mL) and Brine 
(20 mL), and then dried over MgSO4. The dried solution was filtered and concentrated to 
afford 4-bromo-3-chloro-N,N-dimethylaniline (1.46 g, 7.26 mmol, 86%) as an off-white solid. 
Spectroscopic data are consistent with those previously reported.[267] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.37 (d, J = 9.0 Hz, 1H), 6.76 (d, J = 3.0 Hz, 1H), 6.46 (dd, J 
= 9.0, 3.0 Hz, 1H), 2.93 (s, 6H). 




NaH (60% in mineral oil, 521 mg, 13.0 mmol, 3.0 equiv) was added to a solution of 5-bromo-
6-chloro-1H-indole (1.00 g, 4.34 mmol, 1.0 equiv) in dry THF (25 mL). After 30 min, CH3I (0.82 
mL, 13.0 mmol, 3.0 equiv) was added dropwise to the reaction mixture and stirred at 25 °C for 
14 h. The reaction mixture was then quenched with sat. aq. NH4Cl (30 mL), and extracted with 
EtOAc (3 x 30 mL). The combined organic layers were dried over MgSO4 and concentrated in 
vacuo. The crude product was purified by FCC (5% EtOAc in Cyclohexane) to obtain 5-bromo-
6-chloro-1-methyl-1H-indole (797 mg, 3.26 mmol, 75%) as an off-white solid. 
 
Rf = 0.4 (5% EtOAc in Cy). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.85 (s, 1H), 7.42 (d, J = 0.9 Hz, 1H), 7.04 (d, J = 3.1 Hz, 1H), 
6.40 (dd, J = 3.2, 0.9 Hz, 1H), 3.73 (s, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 136.3, 130.8, 128.7, 127.0, 125.1, 112.7, 110.8, 100.7, 
33.2. 
IR (neat): ν (cm-1) 3100.3, 2939.0, 1508.4, 1473.7, 1426.1, 1313.8, 1262.9, 1088.6, 927.0, 
877.8. 
MP: 108.6 °C. 
HRMS (ESI): Calcd for C C9H7BrClNAg ([M+Ag]+) 351.8477, found 351.8479. 
 
Methyl 4-bromo-3-chlorobenzoate (S1c) 
 
A drop of conc. sulfuric acid was added to a solution of 4-bromo-3-chlorobenzoic acid (4.99 g, 
21.2 mmol, 1.0 equiv) in MeOH (20 mL, 494 mmol, 23.3 equiv) and the reaction mixture was 
stirred at 50 °C for 1 h. The volatiles were removed under reduced pressure and methyl 4-
bromo-3-chlorobenzoate (4.74 g, 19.0 mmol, 90%) was obtained as an off-white solid. 
Spectroscopic data are consistent with those previously reported.[239] 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 8.10 (d, J = 2.0 Hz, 1H), 7.77 (dd, J = 8.3, 2.0 Hz, 1H), 7.70 
(d, J = 8.3 Hz, 1H), 3.92 (s, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 165.5, 135.1, 134.0, 131.4, 130.8, 128.8, 128.2, 52.7. 
IR (neat): ν (cm-1) 2953.0, 1728.5, 1588.6, 1435.0, 1376.7, 1287.8, 1240.0, 1104.7, 1021.7, 
757.7. 
MP: 62.7 °C. 




CH3I (0.53 mL, 8.52 mmol, 2.0 equiv) was added to a mixture of 3-bromo-2-chlorophenol (884 
mg, 4.26 mmol, 1.0 equiv) and K2CO3 (1.18 g, 8.52 mmol, 2.0 equiv) in DMF (4.4 mL) and the 
reaction mixture was stirred for 14 h at 50 °C. The reaction mixture was allowed to cool down 
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to 25 °C and diluted with Et2O (50 mL). The organic layer was washed with a 1:1 mixture of 
water and Brine (5 x 30 mL), dried over MgSO4 and the concentrated in vacuo. The crude 
product was purified by FCC (2.5% Et2O in PET) to obtain 1-bromo-2-chloro-3-
methoxybenzene (920 mg, 4.15 mmol, 98%) as a colourless oil. Spectroscopic data are 
consistent with those previously reported.[268] 
Rf = 0.4 (2.5% Et2O in PET). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.23 (dd, J = 8.1, 1.4 Hz, 1H), 7.09 (dd, J = 8.2 Hz, 1H), 6.87 
(dd, J = 8.3, 1.4 Hz, 1H), 3.90 (s, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 156.5, 128.0, 125.5, 124.0, 123.5, 110.7, 56.6. 
2-Bromo-1-chloro-3-methoxybenzene (S1e) 
 
CH3I (0.56 mL, 9.06 mmol, 2.0 equiv) was added to a mixture of 2-bromo-3-chlorophenol (940 
mg, 4.53 mmol, 1.0 equiv) and K2CO3 (1.25 g, 9.06 mmol, 2.0 equiv) in DMF (4.7 mL) and the 
reaction mixture was stirred for 14 h at 50 °C. The reaction mixture was allowed to cool down 
to 25 °C and diluted with Et2O (50 mL). The organic layer was washed with a 1/1 mixture of 
water and Brine (5 x 30 mL), dried over MgSO4 and then concentrated in vacuo. The crude 
product was purified by FCC (2.5% Et2O in PET) to obtain 2-bromo-1-chloro-3-
methoxybenzene (993 mg, 4.49 mmol, 99%) as a colourless oil. 
 
Rf = 0.4 (2.5% Et2O in PET). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.21 (dd, J = 8.2, 8.2 Hz, 1H), 7.09 (dd, J = 8.0, 1.4 Hz, 1H), 
6.79 (dd, J = 8.3, 1.4 Hz, 1H), 3.91 (s, 3H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 157.6, 136.0, 128.5, 122.5, 112.8, 109.9, 56.8. 
IR (neat): ν (cm-1) 2939.9, 1577.7, 1461.8, 1267.5, 1052.7, 767.8, 670.0.  
GCMS (EI): main fragment peak: (m/z) 222. 
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6.3.3. Palladium catalysed migratory arylation of alkenes 
General Procedure J: One-Pot Hydroboration – Migratory Suzuki-Miyaura Coupling 
The olefin (0.600 mmol, 1.2 equiv) was charged in an oven-dried 10 mL catalysis tube equipped 
with a stirring bar and septum, and then purged and filled with Argon three times. A borane 
dimethyl sulfide complex solution in toluene (2 M, 0.35 mL, 0.700 mmol, 1.4 equiv) was then 
added and the tube placed in a metal heating block set at 60 °C with stirring, fitted with a 
balloon. After 1 h water (0.10 mL, 5.55 mmol, 11.1 equiv) was added to the reaction mixture, 
which was further stirred at 60 °C for 1 h. The balloon was then swapped with a line from the 
Schlenk and the volatiles were removed under high vacuum at 60 °C for 1 h. After allowing the 
tube cool down to 25 °C it was transferred in a glovebox and Pd(TFA)2 (8.31 mg, 0.025 mmol, 
5 mol%), (tBu)2PMe•HBF4 (18.6 mg, 0.075 mmol, 15 mol%), Cs2CO3 (489 mg, 1.50 mmol, 3.0 
equiv) and aryl bromide (0.500 mmol, 1.0 equiv) (if solid) were charged in the catalysis tube. 
Outside of the glovebox, toluene (1.0 mL), water (0.2 mL) and the aryl bromide (0.500 mmol, 
1.0 equiv) (if liquid) were added. The septum was rapidly exchanged for a screw cap, the 
catalysis tube sealed with Teflon-tape and then placed in a heating block set at 120 °C with 
vigorous stirring for 48 h. After this period the reaction mixture was allowed to cool to 25 °C 
and filtered over Celite® with EtOAc. The volatiles were removed under reduced pressure and 
the crude product was analyzed with GC-MS to determine the regioselectivity and then 
purified by FCC to yield the corresponding 1,1-diarylalkanes. 
General Procedure K: Large Scale One-Pot Hydroboration – Migratory Suzuki-Miyaura 
Coupling without a glovebox. 
The olefin (6.00 mmol, 1.2 equiv) was charged in two-neck flask equipped with a condenser, 
a Schlenk-bubbler, a stirring bar and a septum and then purged and filled with Argon three 
times. A borane dimethyl sulfide complex solution in toluene (2 M, 3.5 mL, 7.00 mmol, 1.4 
equiv) was then added and the reaction mixture was stirred at 60 °C for 1 h. After 1 h water 
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(1.0 mL, 55.5 mmol, 11.1 equiv) was added to the reaction mixture, which was further stirred 
at 60 °C for 1 h. The volatiles were then carefully removed under high vacuum through the 
Schlenk-Bubbler at 60 °C for 1 h. The septum of the two-neck flask was removed under a flow 
of Argon after allowing the flask to cool down to 25 °C. Pd(TFA)2 (83.1 mg, 0.250 mmol, 5 
mol%), (tBu)2PMe•HBF4 (186 mg, 0.750 mmol, 15 mol%), Cs2CO3 (4.89 g, 1.50 mmol, 3.0 
equiv), aryl bromide (5.00 mmol, 1.0 equiv), toluene (10 mL) and water (2.0 mL) were added 
and open neck closed with a glass-lid. The reaction mixture was then heated to 120 °C under 
vigorous stirring for 48 h. After this period the reaction mixture was allowed to cool to 25 °C 
and filtered over Celite® with EtOAc. The volatiles were removed under reduced pressure and 
the crude product was analyzed with GC-MS to determine the regioselectivity and then 




The title compound was obtained following general procedure J from (Z)-(5,5-dimethylhex-3-
en-1-yl)benzene (1c, 144 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene (58 µL, 
0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(5,5-dimethyl-1-phenylhexyl)benzene (150 mg, 
0.500 mmol, quant.) as a colourless oil. 
 
Large scale and without a Glovebox: The title compound was obtained in a ten-fold bigger 
scale (5.00 mmol) following general procedure K from (Z)-(5,5-dimethylhex-3-en-1-yl)benzene 
(1c, 1.13 g, 6.00 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene (0.58 mL, 5.00 mmol, 1.0 
equiv) to obtain 1-chloro-2-(5,5-dimethyl-1-phenylhexyl)benzene (1.37 g, 4.54 mmol, 91%) as 
a colourless oil.  
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.84 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.35 – 7.26 (m, 5H), 7.26 – 7.14 (m, 3H), 7.14 – 7.06 (m, 
1H), 4.50 (t, J = 7.7 Hz, 1H), 2.07 – 1.91 (m, 2H), 1.29 – 1.18 (m, 4H), 0.82 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 144.0, 142.7, 134.4, 129.8, 128.6, 128.4, 128.3, 127.3, 
127.0, 126.3, 46.8, 44.2, 36.5, 30.5, 29.5, 22.9. 
IR (neat): ν (cm-1) 3027.1, 2951.6, 1600.4, 1470.2, 1364.2, 1249.4, 907.4, 731.0, 670.0. 
HRMS (ESI): Calcd for C20H26Ag [M+Ag]+: 373.1080, found 373.1079. 
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1-Chloro-2-(5,5-dimethyl-1-(o-tolyl)hexyl)benzene (3.3c) 
 
The title compound was obtained following general procedure J from (Z)-1-(5,5-dimethylhex-
3-en-1-yl)-2-methylbenzene (3.1d, 121 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(5,5-dimethyl-1-(o-
tolyl)hexyl)benzene (101 mg, 0.320 mmol, 64%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.48 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.36 – 7.30 (m, 1H), 7.27 – 7.21 (m, 1H), 7.21 – 7.15 (m, 
1H), 7.15 – 7.04 (m, 5H), 4.58 (t, J = 7.5 Hz, 1H), 2.24 (s, 3H), 1.95 – 1.86 (m, 2H), 1.39 – 1.19 
(m, 4H), 0.81 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 142.6, 141.8, 137.1, 134.4, 130.7, 129.6, 129.1, 127.2, 
126.9, 126.9, 126.3, 125.9, 44.4, 43.2, 36.6, 30.5, 29.5, 23.1, 19.8. 
IR (neat): ν (cm-1) 3949.8, 1468.5, 1364.2, 1249.3, 122.7, 1035.2, 909.0, 747.3, 686.7. 




The title compound was obtained following general procedure J from (Z)-1-(5,5-dimethylhex-
3-en-1-yl)-2-fluorobenzene (3.1e, 124 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(1-(2-fluorophenyl)-5,5-
dimethylhexyl)benzene (115 mg, 0.360 mmol, 72%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.48 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 1H NMR (500 MHz, CDCl3) δ 7.33 (dd, J = 7.9, 1.4 Hz, 1H), 
7.31 (dd, J = 7.8, 1.7 Hz, 1H), 7.21 (td, J = 7.6, 1.4 Hz, 1H), 7.18 – 7.09 (m, 3H), 7.07 – 7.02 (m, 
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1H), 7.02 – 6.95 (m, 1H), 4.75 (t, J = 7.7 Hz, 1H), 2.01 – 1.91 (m, 2H), 1.30 – 1.17 (m, 4H), 0.81 
(s, 9H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 161.2 (d, J = 246.1 Hz), 141.5, 134.6, 130.9 (d, J = 14.6 
Hz), 129.8, 129.2 (d, J = 4.6 Hz), 128.8 (d, J = 1.3 Hz), 127.9 (d, J = 8.3 Hz), 127.6, 126.8, 124.0 
(d, J = 3.5 Hz), 115.5 (d, J = 22.8 Hz), 44.2, 40.2 (d, J = 2.0 Hz), 35.8, 30.5, 29.5, 27.1, 22.8. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) -116.63. 
IR (neat): ν (cm-1) 3065.9, 2951.2, 1586.1, 1472.0, 1364.4, 1228.1, 1095.1, 1037.1, 908.0, 
749.6. 




The title compound was obtained following general procedure J from (Z)-1-(5,5-dimethylhex-
3-en-1-yl)-3-methoxybenzene (3.1f, 131 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(1-(3-methoxyphenyl)-5,5-
dimethylhexyl)benzene (105 mg, 0.318 mmol, 64%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.3 (2% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.30 (td, J = 7.9, 1.6 Hz, 2H), 7.23 – 7.14 (m, 2H), 7.08 (td, 
J = 7.6, 1.7 Hz, 1H), 6.86 (d, J = 7.9 Hz, 1H), 6.81 (bs, 1H), 6.71 (dd, J = 8.2, 2.5 Hz, 1H), 4.47 (t, 
J = 7.7 Hz, 1H), 3.75 (s, 3H), 2.03 – 1.91 (m, 2H), 1.27 – 1.17 (m, 4H), 0.81 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 159.7, 145.7, 142.6, 134.4, 129.7, 129.3, 128.6, 127.3, 
127.0, 120.8, 114.5, 111.1, 55.2, 46.7, 44.2, 36.5, 30.5, 29.5, 22.9. 
IR (neat): ν (cm-1) 2951.3, 1599.2, 1469.5, 1255.9, 1153.4, 1047.7, 906.3, 728.0, 649.3. 
HRMS (ESI): Calcd for C21H27ClOAg [M+Ag]+: 437.0796, found 437.0790. 
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9-(5,5-Dimethylhexyl)-2-(trifluoromethyl)-9H-fluorene (3.25a) 
 
The title compound was obtained following general procedure J from (Z)-1-(6,6-dimethylhept-
4-en-1-yl)-3-(trifluoromethyl)benzene (3.1g, 162 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(6,6-dimethyl-1-(3-
(trifluoromethyl)phenyl)heptyl)benzene (3g) as a colourless oil. The crude product was further 
engaged in a cyclization reaction due to impossible separation from the cyclized side product 
as follows.25 1-chloro-2-(6,6-dimethyl-1-(3-(trifluoromethyl)phenyl)heptyl)benzene (3g ,191 
mg, 0.500 mmol, 1.0 equiv), Pd(OAc)2 (3.37 mg, 0.015 mmol, 3 mol%), PCy3 (8.41 mg, 0.030 
mmol 6 mol%) and CsOPiv( 351 mg, 1.50 mmol, 3.0 equiv) were charged in a vial, which was 
purged and filled with Argon three times. THF (2.0 mL) was added and the septum exchanged 
with a cap. The vial was then placed in a heating block set at 120 °C with vigorous stirring for 
12 h. The reaction mixture was then filtered over Celite® and the volatiles removed under 
reduced pressure. The crude product was then purified by FCC (cyclohexane) to obtain 9-(5,5-
dimethylhexyl)-2-(trifluoromethyl)-9H-fluorene (141 mg, 0.407 mmol, 81% over the two 
steps). 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.65 (cyclohexane). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.85 – 7.78 (m, 2H), 7.78 – 7.74 (m, 1H), 7.66 – 7.62 (m, 
1H), 7.59 – 7.54 (m, 1H), 7.43 – 7.38 (m, 2H), 4.04 (t, J = 5.9 Hz, 1H), 2.11 – 1.99 (m, 2H), 1.24 
– 1.12 (m, 4H), 1.12 – 1.07 (m, 2H), 0.83 (s, 9H).  
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 148.4, 148.1, 144.7 (q, J = 1.4 Hz), 139.8, 128.8 (q, J = 
31.8 Hz), 128.1, 127.3, 124.9 (q, J = 271.9 Hz), 124.7, 124.4 (q, J = 3.9 Hz), 121.3 (q, J = 3.8 Hz), 
120.7, 120.0, 47.8, 44.1, 33.0, 30.4, 29.5, 26.7, 25.0. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) -61.58. 
IR (neat): ν (cm-1) 2934.3, 1620.6, 1426.5, 1325.7, 1161.2, 1118.3, 1064.4, 895.8, 834.3, 734.8. 
HRMS (ESI): Calcd for C22H25F3Ag [M+Ag]+: 453.0954, found 453.0947. 
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1-Chloro-2-(1-(4-methoxyphenyl)-5,5-dimethylhexyl)benzene (3.3g) 
 
The title compound was obtained following general procedure J from (Z)-1-(5,5-dimethylhex-
3-en-1-yl)-4-methoxybenzene (3.1h, 131 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(1-(4-methoxyphenyl)-5,5-
dimethylhexyl)benzene (117 mg, 0.354 mmol, 71%) as a colourless oil. 
rr: (benzylic vs. others) >99:1. 
Rf = 0.3 (2% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.33 (dd, J = 7.9, 1.4 Hz, 1H), 7.28 (dd, J = 7.8, 1.8 Hz, 1H), 
7.21 (ddd, J = 7.5, 1.3 Hz, 1H), 7.21 – 7.14 (m, 2H), 7.10 (ddd, J = 7.5, 1.7 Hz, 1H), 6.86 – 6.79 
(m, 2H), 4.43 (t, J = 7.7 Hz, 1H), 3.77 (s, 3H), 1.99 – 1.90 (m, 2H), 1.29 – 1.20 (m, 4H), 0.81 (s, 
9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.0, 143.1, 136.1, 134.3, 129.8, 129.2, 128.5, 127.2, 
127.0, 113.8, 55.3, 45.9, 44.2, 36.7, 30.5, 29.5, 22.9. 
IR (neat): ν (cm-1) 2949.8, 1610.4, 1511.0, 1468.4, 1364.0, 1247.2, 1177.9, 1036.9, 908.3, 
825.0. 




The title compound was obtained following general procedure J from (Z)-1-(6,6-dimethylhept-
4-en-1-yl)-4-(trifluoromethyl)benzene (3.1i, 162 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(6,6-dimethyl-1-(4-
(trifluoromethyl)phenyl)heptyl)benzene (3i) as a colourless oil. The crude product was further 
engaged in a cyclization reaction due to impossible separation from the cyclized side product 
as follows.25 1-chloro-2-(6,6-dimethyl-1-(4-(trifluoromethyl)phenyl)heptyl)benzene (3i, 191 
mg, 0.500 mmol, 1.0 equiv), Pd(OAc)2 (3.37 mg, 0.015 mmol, 3 mol%), PCy3 (8.41 mg, 0.030 
mmol 6 mol%) and CsOPiv (351 mg, 1.50 mmol, 3.0 equiv) were charged in a vial, which was 
purged and filled with Argon three times. THF (2.0 mL) was added and the septum exchanged 
with a cap. The vial was then placed in a heating block set at 120 °C with vigorous stirring for 
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12 h. The reaction mixture was then filtered over Celite® and the volatiles removed under 
reduced pressure. The crude product was then purified by FCC (cyclohexane) to obtain 9-(5,5-
dimethylhexyl)-3-(trifluoromethyl)-9H-fluorene (135 mg, 0.390 mmol, 80% over the two 
steps). 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.65 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 8.01 (bs, 1H), 7.86 – 7.78 (m, 1H), 7.66 – 7.54 (m, 3H), 7.45 
– 7.35 (m, 2H), 4.04 (t, J = 5.9 Hz, 1H), 2.07 (dt, J = 9.8, 5.9 Hz, 2H), 1.28 – 1.20 (m, 2H), 1.20 – 
1.09 (m, 4H), 0.86 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 151.4 (q, J = 1.4 Hz), 147.8, 142.0, 139.9, 129.6 (q, J = 
31.9 Hz), 127.9, 127.3, 124.8 (q, J = 272.2 Hz), 124.7, 124.6, 123.7 (q, J = 3.8 Hz), 120.3, 116.8 
(q, J = 3.8 Hz), 47.8, 44.1, 33.0, 30.4, 29.5, 26.6, 25.0. 
19F{1H}-NMR (376 MHz, CDCl3): δ (ppm) -61.81. 
IR (neat): ν (cm-1) 2934.3, 1427.3, 1322.4, 1265.8, 1120.4, 1061.8, 892.7, 830.5, 737.3, 664.9. 
HRMS (ESI): Calcd for C22H25F3Ag [M+Ag]+: 453.0954, found 453.0948. 
5-(1-(2-Chlorophenyl)-6,6-dimethylheptyl)benzo-1,3-dioxole (3.3i) 
 
The title compound was obtained following general procedure J from (Z)-5-(6,6-Dimethylhept-
4-en-1-yl)benzo-1,3-dioxole (3.1j, 148 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 5-(1-(2-chlorophenyl)-6,6-
dimethylheptyl)benzo-1,3-dioxole (159 mg, 0.443 mmol, 89%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.32 (5% toluene in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.34 (dd, J = 7.9, 1.4 Hz, 1H), 7.31 (dd, J = 7.8, 1.8 Hz, 1H), 
7.23 (td, J = 7.5, 1.4 Hz, 1H), 7.12 (td, J = 7.6, 1.7 Hz, 1H), 6.78 – 6.72 (m, 3H), 5.91 (d, J = 1.7 
Hz, 2H), 4.40 (t, J = 7.7 Hz, 1H), 2.05 – 1.91 (m, 2H), 1.30 – 1.25 (m, 4H), 1.17 – 1.11 (m, 2H), 
0.86 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.7, 145.9, 142.8, 138.0, 134.3, 129.8, 128.4, 127.3, 
127.0, 121.3, 108.7, 108.2, 101.0, 46.5, 44.1, 35.8, 30.4, 29.5, 28.8, 24.6. 
IR (neat): ν (cm-1) 2932.9, 1486.1, 1363.7, 1240.8, 1119.6, 1039.6, 907.3, 806.8, 730.5, 647.8. 
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The title compound was obtained following general procedure J from (Z)-(13,13-
dimethyltetradec-11-en-1-yl)benzene (3.1k, 180 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(13,13-dimethyl-1-
phenyltetradecyl)benzene (159 mg, 0385 mmol, 77%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.7 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.36 – 7.29 (m, 2H), 7.26 (h, J = 2.5 Hz, 4H), 7.24 – 7.14 (m, 
2H), 7.10 (td, J = 7.6, 1.7 Hz, 1H), 4.47 (t, J = 7.7 Hz, 1H), 2.07 – 1.94 (m, 2H), 1.31 – 1.18 (m, 
18H), 1.18 – 1.10 (m, 2H), 0.86 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 144.0, 142.8, 134.4, 129.8, 128.6, 128.4, 128.3, 127.3, 
127.0, 126.3, 46.8, 44.4, 35.6, 30.8, 30.4, 29.9, 29.8, 29.8, 29.8, 29.8, 29.6, 29.6, 27.9, 24.7. 
IR (neat): ν (cm-1) 2925.8, 2854.2, 1468.4, 1363.3, 1036.0, 907.5, 732.6. 
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1-Chloro-2-(7,7-dimethyl-1-phenyloctyl)benzene (3.3k) 
 
The title compound was obtained following general procedure J from (Z)-(7,7-dimethyloct-4-
en-1-yl)benzene (3.1c, 130 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene (58 µL, 
0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(7,7-dimethyl-1-phenyloctyl)benzene (115 mg, 
0.350 mmol, 70%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.78 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.32 (dd, J = 7.9, 1.4 Hz, 1H), 7.29 (dd, J = 7.8, 1.4 Hz, 1H), 
7.29 – 7.24 (m, 4H), 7.23 – 7.14 (m, 2H), 7.09 (dd, J = 7.8, 1.7 Hz, 1H), 4.48 (t, J = 7.7 Hz, 1H), 
2.05 – 1.97 (m, 2H), 1.34 – 1.25 (m, 4H), 1.26 – 1.16 (m, 2H), 1.16 – 1.08 (m, 2H), 0.84 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 144.0, 142.8, 134.4, 129.8, 128.7, 128.5, 128.4, 127.3, 
127.0, 126.3, 46.9, 44.4, 35.7, 30.7, 30.4, 29.6, 28.0, 24.6. 
IR (neat): ν (cm-1) 2932.2, 1470.5, 1036.7, 906.7, 729.7. 




The title compound was obtained following general procedure J from (Z)-(4-cyclohexylbut-3-
en-1-yl)benzene (3.1m, 129 mg, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene (58 µL, 
0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(4-cyclohexyl-1-phenylbutyl)benzene (97 mg, 
0.296 mmol, 59%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.5 (cyclohexane). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.36 – 7.28 (m, 2H), 7.28 – 7.23 (m, 4H), 7.21 – 7.15 (m, 
2H), 7.09 (td, J = 7.6, 1.7 Hz, 1H), 4.48 (t, J = 7.7 Hz, 1H), 2.03 – 1.97 (m, 2H), 1.65 – 1.58 (m, 
4H), 1.35 – 1.07 (m, 9H), 0.88 – 0.76 (m, 2H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 144.0, 142.8, 134.4, 129.8, 128.6, 128.4, 128.3, 127.3, 
127.0, 126.3, 46.8, 37.6, 35.9, 33.5, 33.5, 26.9, 26.5, 25.2. 
IR (neat): ν (cm-1) 2923.1, 2851.3, 1446.9, 1260.3, 1036.5, 906.3, 728.5. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chlorobenzene (58 
µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-phenylhexyl)-2-chlorobenzene (148 
mg, 0.429 mmol, 86%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.45 (2% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.33 (dd, J = 8.0, 1.0 Hz, 1H), 7.31 – 7.28 (m, 1H), 7.28 – 
7.23 (m, 4H), 7.23 – 7.15 (m, 2H), 7.10 (td, J = 7.6, 1.8 Hz, 1H), 4.47 (t, J = 7.7 Hz, 1H), 3.29 (t, J 
= 6.5 Hz, 2H), 2.09 – 1.98 (m, 2H), 1.54 – 1.45 (m, 2H), 1.41 – 1.29 (m, 4H), 1.16 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 143.9, 142.7, 134.4, 129.7, 128.6, 128.4, 128.3, 
127.30, 127.0, 126.3, 72.5, 61.6, 46.7, 35.6, 30.6, 27.7, 27.7, 26.4. 
IR (neat): ν (cm-1) 2930.9, 2859.6, 1601.9, 1469.5, 1361.4, 1197.4, 1083.2, 1035.1, 748.7, 698.3 
HRMS (ESI): Calcd for C22H29ClOAg [M+Ag]+: 451.0952, found 451.0950. 
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1-(5,5-Dimethyl-1-phenylhexyl)-4-(trifluoromethyl)benzene (3.3m) 
 
The title compound was obtained following general procedure J from (Z)-(5,5-dimethylhex-3-
en-1-yl)benzene (1c, 144 mg, 0.600 mmol, 1.2 equiv) and 4-Bromobenzotrifluoride (70 µL, 
0.500 mmol, 1.0 equiv) to obtain 1-(5,5-dimethyl-1-phenylhexyl)-4-(trifluoromethyl)benzene 
(163 mg, 0.0.487 mmol, 98%) as a colourless oil. 
 
rr: (benzylic vs. others) 97:3. 
Rf = 0.78 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.55 – 7.48 (m, 2H), 7.37 – 7.31 (m, 2H), 7.31 – 7.25 (m, 
2H), 7.23 – 7.15 (m, 3H), 3.97 (t, J = 7.8 Hz, 1H), 2.10 – 1.94 (m, 2H), 1.26 – 1.17 (m, 4H), 0.80 
(s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 149.6 (q, J = 1.4 Hz), 144.4, 128.7, 128.5 (q, J = 32.1 
Hz), 128.3, 128.0, 126.6, 125.5 (q, J = 3.8 Hz), 124.5 (q, J = 271.8 Hz), 51.3, 44.2, 36.6, 30.5, 
29.5, 23.0. 
19F{1H}-NMR (376 MHz, CDCl3): δ (ppm) -62.27. 
IR (neat): ν (cm-1) 3028.7, 2951.2, 1619.2, 1323.7, 1122.0, 1068.4, 1018.2, 829.7, 740.5, 698.8. 




The title compound was obtained following general procedure J from (Z)-(5,5-dimethylhex-3-
en-1-yl)benzene (1c, 144 mg, 0.600 mmol, 1.2 equiv) and 4-bromoanisole (63 µL, 0.500 mmol, 
1.0 equiv) to obtain 1-(5,5-dimethyl-1-phenylhexyl)-4-methoxybenzene (117 mg, 0.395 mmol, 
79%) as a colourless oil. 
 
rr: (benzylic vs. others) 92:8. 
Rf = 0.3 (cyclohexane). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.25 – 7.12 (m, 7H), 6.83 – 6.75 (m, 2H), 3.85 (t, J = 7.8 Hz, 
1H), 3.73 (s, 3H), 2.03 – 1.90 (m, 2H), 1.24 – 1.16 (m, 4H), 0.80 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 157.9, 145.9, 137.7, 128.9, 128.5, 127.9, 126.0, 113.9, 
55.3, 50.5, 44.3, 37.0, 30.5, 29.5, 23.0. 
IR (neat): ν (cm-1) 2950.4, 1714.7, 1609.9, 1510.8, 1646.3, 1363.8, 1246.4, 1177.5, 1037.0, 
910.0, 825.0, 731.4, 698.3. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chloro-4-
methoxybenzene (79 µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-phenylhexyl)-
2-chloro-4-methoxybenzene (117 mg, 0.312 mmol, 62%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.14 (3% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.31 – 7.20 (m, 4H), 7.21 – 7.13 (m, 2H), 6.88 (d, J = 2.7 Hz, 
1H), 6.76 (dd, J = 8.7, 2.7 Hz, 1H), 4.38 (t, J = 7.7 Hz, 1H), 3.73 (s, 3H), 3.28 (t, J = 6.6 Hz, 2H), 
2.05 – 1.94 (m, 2H), 1.54 – 1.44 (m, 2H), 1.40 – 1.27 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.2, 144.4, 134.7, 134.7, 129.0, 128.4, 128.1, 126.1, 
114.8, 113.3, 72.5, 61.6, 55.5, 46.0, 35.7, 30.6, 27.7, 27.7, 26.3. 
IR (neat): ν (cm-1) 2935.1, 1605.6, 1493.2, 1362.6, 1233.2, 1195.7, 1079.7, 1041.7, 907.2, 
728.5, 648.4. 
HRMS (ESI): Calcd for C23H31ClO2Ag [M+Ag]+: 483.1052, found 483.1054. 
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1-(6-(tert-Butoxy)-1-phenylhexyl)-2-chloro-4-(trifluoromethyl)benzene (3.3p) 
 
The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chloro-4-
(trifluoromethyl)benzene (74 µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-
phenylhexyl)-2-chloro-4-(trifluoromethyl)benzene (124 mg, 0.300 mmol, 60%) as a colourless 
oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.45 (2% Et2O in Cy). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.62 – 7.58 (m, 1H), 7.48 – 7.42 (m, 1H), 7.42 – 7.38 (m, 
1H), 7.31 – 7.17 (m, 5H), 4.50 (t, J = 7.7 Hz, 1H), 3.28 (t, J = 6.5 Hz, 2H), 2.12 – 1.93 (m, 2H), 
1.54 – 1.44 (m, 2H), 1.40 – 1.25 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (126 MHz, CDCl3): δ (ppm) 146.9 (q, J = 1.3 Hz), 142.8, 134.8, 129.7 (q, J = 33.1 
Hz), 129.1, 128.7, 128.3, 126.8 (q, J = 3.9 Hz), 126.7, 123.8 (q, J = 3.7 Hz), 123.5 (q, J = 272.3 
Hz), 72.5, 61.5, 46.8, 35.4, 30.5, 27.7, 27.6, 26.3. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) -62.62. 
IR (neat): ν (cm-1) 2938.9, 1454.4, 1324.7, 1134.8, 1081.1, 907.7, 734.7, 651.3. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 4-bromo-3-chloro-N,N-
dimethylaniline (S1a, 117 mg, 0.500 mmol, 1.0 equiv) to obtain 4-(6-(tert-butoxy)-1-
phenylhexyl)-3-chloro-N,N-dimethylaniline (75.0 mg, 0.194 mmol, 39%) as a slightly yellow oil. 
 
rr: (benzylic vs. others) >99:1. 
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Rf = 0.2 (2.5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.29 – 7.18 (m, 4H), 7.18 – 7.08 (m, 2H), 6.67 (d, J = 2.7 Hz, 
1H), 6.58 (dd, J = 8.7, 2.7 Hz, 1H), 4.34 (t, J = 7.8 Hz, 1H), 3.28 (t, J = 6.6 Hz, 2H), 2.88 (s, 6H), 
2.05 – 1.93 (m, 2H), 1.54 – 1.43 (m, 2H), 1.41 – 1.26 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 149.6, 145.1, 134.9, 130.0, 128.7, 128.3, 128.1, 125.9, 
113.2, 111.5, 72.5, 61.6, 45.9, 40.5, 35.7, 30.6, 27.8, 27.7, 26.4. 
IR (neat): ν (cm-1) 2933.9, 1609.5, 1507.7, 1444.8, 1360.7, 1197.3, 1078.7, 962.8, 906.9, 728.0, 
648.2. 
HRMS (ESI): Calcd for C24H34ClNOH [M+H]+: 388.2402, found 388.2403. 
 
Methyl 4-(6-(tert-butoxy)-1-phenylhexyl)-3-chlorobenzoate (3.3r) 
 
The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and methyl 4-bromo-3-
chlorobenzoate (S1c, 125 mg, 0.500 mmol, 1.0 equiv) to obtain methyl 4-(6-(tert-butoxy)-1-
phenylhexyl)-3-chlorobenzoate (72.0 mg, 0.179 mmol, 36%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.35 (5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 8.01 (d, J = 1.8 Hz, 1H), 7.86 (dd, J = 8.2, 1.8 Hz, 1H), 7.36 
(d, J = 8.2 Hz, 1H), 7.29 – 7.21 (m, 4H), 7.20 – 7.15 (m, 1H), 4.50 (t, J = 7.7 Hz, 1H), 3.89 (s, 3H), 
3.28 (t, J = 6.5 Hz, 2H), 2.03 (td, J = 7.7, 2.5 Hz, 2H), 1.51 – 1.48 (m, 2H), 1.42 – 1.35 (m, 4H), 
1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 166.0, 147.9, 143.0, 134.6, 130.9, 129.4, 128.6, 128.6, 
128.3, 128.1, 126.6, 72.5, 61.5, 52.4, 47.0, 35.4, 30.5, 27.7, 27.7, 26.3. 
IR (neat): ν (cm-1) 2934.5, 1724.2, 1453.9, 1391.8, 1256.4, 1195.6, 1117.0, 978.1, 908.6, 729.2, 
648.0 
HRMS (ESI): Calcd for C24H31ClO3Na [M+Na]+: 425.1854, found 425.1846. 
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1-(6-(tert-Butoxy)-1-phenylhexyl)-2-chloro-3-(trifluoromethyl)benzene (3.3s) 
 
The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chloro-3-
(trifluoromethyl)benzene (73 µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-
phenylhexyl)-2-chloro-3-(trifluoromethyl)benzene (125 mg, 0.302 mmol, 61%) as a colourless 
oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.15 (3% Et2O in Cy). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.54 (dd, J = 7.8, 1.6 Hz, 1H), 7.48 (dd, J = 7.8, 1.6 Hz, 1H), 
7.32 – 7.26 (m, 3H), 7.26 – 7.18 (m, 3H), 4.60 (t, J = 7.7 Hz, 1H), 3.28 (t, J = 6.5 Hz, 2H), 2.10 – 
1.98 (m, 2H), 1.52 – 1.45 (m, 2H), 1.40 – 1.28 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (151 MHz, CDCl3): δ (ppm) 145.3, 143.1, 132.1, 129.0 (q, J = 30.6 Hz), 128.6, 
128.3, 126.63, 126.6, 125.6 (q, J = 5.6 Hz), 123.2 (q, J = 273.2 Hz), 72.6, 61.5, 46.5, 35.7, 30.5, 
30.5, 27.7, 26.3. 
19F{1H}-NMR (470 MHz, CDCl3): δ (ppm) -62.36. 
IR (neat): ν (cm-12934.1, 2862.1, 1586.3, 1430.2, 1315.5, 1137.8, 1095.0, 698.5. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-chloro-3-
methoxybenzene (S1d, 111 mg, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-
phenylhexyl)-2-chloro-3-methoxybenzene (136 mg, 0.362 mmol, 73%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.35 (5% EtOAc in Cy). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.27 – 7.24 (m, 4H), 7.20 – 7.13 (m, 2H), 6.92 (dd, J = 7.9, 
1.4 Hz, 1H), 6.77 (dd, J = 8.2, 1.4 Hz, 1H), 4.53 (t, J = 7.7 Hz, 1H), 3.87 (s, 3H), 3.28 (t, J = 6.5 Hz, 
2H), 2.07 – 1.98 (m, 2H), 1.49 – 1.30 (m, 6H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 155.3, 144.4, 144.0, 128.4, 128.3, 127.0, 126.3, 122.8, 
120.5, 109.6, 72.5, 61.6, 56.3, 46.8, 35.6, 30.6, 27.8, 27.7, 26.4. 
IR (neat): ν (cm-1) 2935.5, 1574.1, 1362.5, 1269.7, 1196.7, 1071.1, 908.0, 728.5, 647.6. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 2-bromo-4-(tert-butyl)-1-
chlorobenzene (124 mg, 0.500 mmol, 1.0 equiv) to obtain 2-(6-(tert-butoxy)-1-phenylhexyl)-
4-(tert-butyl)-1-chlorobenzene (115 mg, 0.287 mmol, 57%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.18 (1% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.33 (d, J = 2.4 Hz, 1H), 7.27 – 7.22 (m, 4H), 7.22 – 7.14 (m, 
2H), 7.12 (dd, J = 8.4, 2.5 Hz, 1H), 4.42 (t, J = 7.7 Hz, 1H), 3.28 (t, J = 6.6 Hz, 2H), 2.02 (tt, J = 7.7 
Hz, 2H), 1.52 – 1.43 (m, 2H), 1.41 – 1.30 (m, 4H), 1.27 (s, 9H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 149.9, 144.1, 141.7, 131.4, 129.1, 128.4, 128.3, 126.2, 
125.6, 124.4, 72.5, 61.6, 47.0, 35.7, 34.7, 31.5, 30.6, 27.8, 27.7, 26.4. 
IR (neat): ν (cm-1) 2969.5, 1479.0, 1362.8, 1197.2, 1080.4, 907.6, 820.0, 729.7, 648.4. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 2-bromo-1-chloro-4-
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methoxybenzene (68 µL, 0.500 mmol, 1.0 equiv) to obtain 2-(6-(tert-butoxy)-1-phenylhexyl)-
1-chloro-4-methoxybenzene (120 mg, 0.320 mmol, 64%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.35 (5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.29 – 7.25 (m, 4H), 7.23 (d, J = 8.8 Hz, 1H), 7.20 – 7.15 (m, 
1H), 6.84 (d, J = 3.0 Hz, 1H), 6.66 (dd, J = 8.8, 3.0 Hz, 1H), 4.41 (t, J = 7.7 Hz, 1H), 3.75 (s, 3H), 
3.29 (t, J = 6.6 Hz, 2H), 2.05 – 1.96 (m, 2H), 1.53 – 1.46 (m, 2H), 1.41 – 1.29 (m, 4H), 1.16 (s, 
9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.5, 143.8, 143.8, 130.2, 128.5, 128.3, 126.3, 125.9, 
114.9, 112.2, 72.5, 61.6, 55.6, 46.9, 35.5, 30.6, 27.7, 27.7, 26.4. 
IR (neat): ν (cm-1) 2934.2, 2861.1, 1597.6, 1471.9, 1361.6, 1291.0, 1234.6, 1197.4, 1081.1, 
1026.1, 731.5. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 5-Bromo-6-chloro-1,3-
benzodioxole (118 mg, 0.500 mmol, 1.0 equiv) to obtain 5-(6-(tert-butoxy)-1-phenylhexyl)-6-
chlorobenzo-1,3-dioxole (118 mg, 0.304 mmol, 61%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.14 (2.5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.30 – 7.21 (m, 4H), 7.19 – 7.14 (m, 1H), 6.80 (s, 1H), 6.73 
(s, 1H), 5.91 (dd, J = 14.0, 1.4 Hz, 2H), 4.40 (t, J = 7.7 Hz, 1H), 3.28 (t, J = 6.6 Hz, 2H), 2.05 – 1.87 
(m, 2H), 1.52 – 1.45 (m, 2H), 1.40 – 1.27 (m, 4H), 1.16 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.0, 146.3, 144.1, 136.1, 128.5, 128.1, 126.3, 125.6, 
109.9, 108.1, 101.7, 72.5, 61.6, 46.4, 35.5, 30.6, 27.7, 27.6, 26.4. 
IR (neat): ν (cm-1) 2932.9, 1727.4, 1601.2, 1477.5, 1362.0, 1231.7, 1081.4, 1037.9, 934.0, 
863.5. 
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The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 5-bromo-6-chloro-1-methyl-1H-
indole (S1b, 122 mg, 0.500 mmol, 1.0 equiv) to obtain 5-(6-(tert-butoxy)-1-phenylhexyl)-6-
chloro-1-methyl-1H-indole (105 mg, 0.264 mmol, 53%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.18 (5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.52 (s, 1H), 7.32 – 7.30 (m, 1H), 7.28 – 7.21 (m, 4H), 7.16 
– 7.10 (m, 1H), 6.98 (d, J = 3.1 Hz, 1H), 6.40 (dd, J = 3.1, 0.9 Hz, 1H), 4.52 (t, J = 7.7 Hz, 1H), 3.70 
(s, 3H), 3.28 (t, J = 6.6 Hz, 2H), 2.14 – 2.02 (m, 2H), 1.53 – 1.45 (m, 2H), 1.42 – 1.32 (m, 4H), 
1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 145.2, 135.8, 133.5, 129.7, 128.6, 128.4, 128.3, 127.7, 
125.9, 120.2, 110.1, 101.1, 72.5, 61.7, 46.8, 36.4, 33.0, 30.7, 27.9, 27.7, 26.4. 
IR (neat): ν (cm-1) 2932.5, 2860.1, 1482.5, 1453.3, 1361.3, 1239.1, 1197.2, 1081.4, 1018.0, 
909.4, 837.5, 721.7, 643.2. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 2-bromo-3-chloropyridine (96.2 
mg, 0.500 mmol, 1.0 equiv) to obtain 2-(6-(tert-butoxy)-1-phenylhexyl)-3-chloropyridine (67.0 
mg, 0.194 mmol, 39%) as a slightly yellow oil. 
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rr: (benzylic vs. others) 92:8. 
Rf = 0.1 (5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 8.52 (dd, J = 4.6, 1.6 Hz, 1H), 7.58 (dd, J = 8.0, 1.6 Hz, 1H), 
7.42 – 7.36 (m, 2H), 7.28 – 7.23 (m, 2H), 7.19 – 7.14 (m, 1H), 7.05 (dd, J = 8.0, 4.6 Hz, 1H), 4.56 
(t, J = 7.6 Hz, 1H), 3.28 (t, J = 6.6 Hz, 2H), 2.36 – 2.05 (m, 2H), 1.52 – 1.44 (m, 2H), 1.38 – 1.22 
(m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 160.4, 147.4, 143.0, 137.0, 131.7, 128.5, 128.3, 126.5, 
122.2, 72.5, 61.6, 48.5, 35.4, 30.6, 27.7, 27.7, 26.3. 
IR (neat): ν (cm-1) 3028.6, 2931.4, 2858.5, 1573.3, 1421.8, 1361.7, 1197.1, 1081.2, 1028.5, 
794.7, 745.9, 698.5. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 2-bromo-1-chloro-3-
methoxybenzene (S1e, 111 mg, 0.500 mmol, 1.0 equiv) to obtain 2-(6-(tert-butoxy)-1-
phenylhexyl)-1-chloro-3-methoxybenzene (47 mg, 0.126 mmol, 25%) as a colourless oil which 
could not be further purified. 
 
rr: (benzylic vs. others) >95:5. 
Rf = 0.35 (5% EtOAc in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.35 – 7.30 (m, 2H), 7.25 – 7.13 (m, 3H), 7.08 (t, J = 8.1 Hz, 
1H), 6.99 (dd, J = 8.1, 1.3 Hz, 1H), 6.72 (d, J = 8.1 Hz, 1H), 4.86 – 4.74 (m, 1H), 3.63 (s, 3H), 3.29 
(t, J = 6.6 Hz, 2H), 2.36 – 2.15 (m, 2H), 1.53 – 1.48 (m, 2H), 1.42 – 1.31 (m, 4H), 1.17 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 159.4, 144.2, 135.3, 131.6, 128.5, 128.4, 128.1, 127.8, 
127.7, 125.6, 72.5, 61.7, 55.8, 44.0, 35.8, 30.7, 28.1, 27.7, 26.6. 
IR (neat): ν (cm-1) 2932.2, 2861.0, 1584.3, 1461.1, 1258.3, 1197.7, 1081.6, 1039.6, 862.9, 
738.8, 697.6. 
HRMS (ESI): Calcd for C23H31ClO2Na [M+Na]+: 397.1905, found 397.1902. 
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1-(6-(tert-Butoxy)-1-phenylhexyl)-2-methylbenzene (3.3aa) 
 
The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-methylbenzene (60 
µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-phenylhexyl)-2-methylbenzene (130 
mg, 0.400 mmol, 80%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.18 (1% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.31 (d, J = 7.7 Hz, 1H), 7.27 – 7.13 (m, 6H), 7.12 – 7.08 (m, 
2H), 4.07 (t, J = 7.6 Hz, 1H), 3.28 (t, J = 6.6 Hz, 2H), 2.26 (s, 3H), 2.05 – 1.95 (m, 2H), 1.53 – 1.42 
(m, 2H), 1.39 – 1.26 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 145.0, 143.1, 136.4, 130.6, 128.4, 128.3, 126.8, 126.1, 
126.0, 125.9, 72.5, 61.6, 47.0, 36.4, 30.6, 28.0, 27.7, 26.5, 20.1. 
IR (neat): ν (cm-1) 3025.0, 2931.3, 2859.2, 1601.1, 1457.5, 1389.1, 1198.2, 1084.0, 748.5, 
732.5. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-methoxybenzene (62 
µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-phenylhexyl)-2-methoxybenzene (97 
mg, 0.285 mmol, 57%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.4 (5% EtOAc in Cy). 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 7.27 – 7.19 (m, 5H), 7.17 – 7.09 (m, 2H), 6.90 (td, J = 7.5, 
1.2 Hz, 1H), 6.81 (dd, J = 8.3, 1.2 Hz, 1H), 4.37 (t, J = 7.8 Hz, 1H), 3.75 (s, 3H), 3.27 (t, J = 6.7 Hz, 
2H), 2.05 – 1.94 (m, 2H), 1.52 – 1.44 (m, 2H), 1.39 – 1.25 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 157.2, 145.4, 133.9, 128.3, 128.2, 127.7, 127.0, 125.8, 
120.6, 110.8, 72.5, 61.7, 55.6, 43.2, 35.2, 30.6, 28.0, 27.7, 26.4. 
IR (neat): ν (cm-1) 2933.3, 1733.6, 1599.2, 1491.0, 1240.6, 1197.2, 1081.0, 1030.7, 908.9, 
731.0, 648.3. 




The title compound was obtained following general procedure J from (E)-(6-(tert-butoxy)hex-
3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-2-
(trifluoromethyl)benzene (76 µL, 0.500 mmol, 1.0 equiv) to obtain 1-(6-(tert-butoxy)-1-
phenylhexyl)-2-(trifluoromethyl)benzene (122 mg, 0.323 mmol, 65%) as a colourless oil. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.2 (3% Et2O in Cy). 
1H-NMR (500 MHz, CDCl3): δ (ppm) 7.62 (d, J = 7.9 Hz, 1H), 7.48 – 7.39 (m, 2H), 7.30 – 7.25 (m, 
5H), 7.19 – 7.15 (m, 1H), 4.41 (t, J = 7.6 Hz, 1H), 3.27 (t, J = 6.5 Hz, 2H), 2.14 – 1.93 (m, 2H), 
1.51 – 1.45 (m, 2H), 1.40 – 1.27 (m, 4H), 1.15 (s, 9H). 
13C{1H}-NMR (151 MHz, CDCl3): δ (ppm) 144.7, 143.9, 132.1, 129.5, 128.5, 128.3 (q, J = 25.3 
Hz), 128.12, 126.4, 126.0, 125.9 (q, J = 5.9 Hz), 124.8 (q, J = 274.2 Hz), 72.6, 61.5, 45.6, 36.8, 
30.5, 27.8, 27.7, 26.4. 
19F{1H}-NMR (476 MHz, CDCl3): δ (ppm) -57.74. 
IR (neat): ν (cm-1) 2932.6, 2862.7, 1734.6, 1605.5, 1454.5, 1362.1, 1311.2, 1198.2, 1120.2, 
876.9, 766.9, 699.3, 668.3. 
HRMS (ESI): Calcd for C23H29F3OAg [M+Ag]+: 485.1216, found 485.1209. 
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6.3.4. Deprotection and postfunctionalisation 
(5,5-Dimethylhexane-1,1-diyl)dibenzene (3.22) 
 
Prepared following a modified reported procedure.[221] 1-Chloro-2-(5,5-dimethyl-1-
phenylhexyl)benzene (3.3a, 150 mg, 0.500 mmol, 1.0 equiv), NaOtBu (50.5 mg, 0.525 mmol. 
1.05 equiv), [(IPr)Pd(allyl)Cl] (1.43 mg, 2.50 µmol, 0.5 mol%) and technical grade iPrOH (1.0 
mL) were charged in a microwave vial which was flushed with Argon and then sealed with a 
cap fitted with a septum. The vial was then placed in a microwave reactor set at 120 °C for 4 
min. The reaction mixture was filtered over Celite® to obtain (5,5-dimethylhexane-1,1-
diyl)dibenzene (133 mg, 0.500 mmol, quant.) as a colourless oil. 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.30 – 7.19 (m, 8H), 7.19 – 7.11 (m, 2H), 3.91 (t, J = 7.8 Hz, 
1H), 2.07 – 1.92 (m, 2H), 1.25 – 1.17 (m, 4H), 0.80 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 145.5, 128.5, 128.0, 126.1, 51.4, 44.3, 36.8, 30.5, 29.5, 
23.1. 
IR (neat): ν (cm-1) 3026.9, 2950.4, 1600.4, 1469.9, 1364.1, 1249.8, 747.3, 698.7. 




1-(6-(tert-Butoxy)-1-phenylhexyl)-2-chlorobenzene (3.3b, 20.0 mg, 0.058 mmol, 1.0 equiv) 
was dissolved in trifluoroacetic acid (2.0 mL) at 0 °C and the reaction mixture was allowed to 
warm to 25 °C and stirred for 1 h. Water (20 mL) was then slowly added to the reaction 
mixture, and the aqueous phase extracted with DCM (3 x 20 mL). The combined organic layers 
were dried over MgSO4 and the volatiles removed under reduced pressure to obtain 6-(2-
chlorophenyl)-6-phenylhexan-1-ol (17.0 mg, 0.059 mmol, quant.) as a colourless oil. 
 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.41 – 7.15 (m, 8H), 7.15 – 7.05 (m, 1H), 4.47 (t, J = 7.7 Hz, 
1H), 4.30 (t, J = 6.6 Hz, 2H), 2.09 – 1.97 (m, 2H), 1.71 (tt, J = 7.8, 6.6 Hz, 2H), 1.44 – 1.20 (m, 
5H). 
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13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 143.6, 142.4, 134.3, 129.8, 128.5, 128.5, 128.3, 127.5, 
127.1, 126.5, 68.3, 46.6, 35.3, 28.1, 27.4, 25.6. 
IR (neat): ν (cm-1) 3730.4, 2934.0, 1784.6, 1469.6, 1350.3, 1220.1, 1150.8, 1036.0, 751.0. 




Prepared according to a modified procedure.[223] 1-Chloro-2-(5,5-dimethyl-1-
phenylhexyl)benzene (3.3a, 75.2 mg, 0.250 mmol, 1.0 equiv), 4-methoxyphenylboronic acid 
(41.8 mg, 0.275 mmol, 1.1 equiv), Pd(OAc)2 (2.25 mg, 0.010 mmol, 4 mol%), SPhos (10.3 mg, 
0.025 mmol, 10 mol%) and K3PO4 (159 mg, 0.750 mmol, 3.0 equiv) were charged in a vial, 
which was purged and filled with Argon three times. THF (0.9 mL) and water (0.3 mL) were 
added and the septum exchange with a cap. The vial was placed in a heating block set at 60 °C 
for 18 h. The reaction mixture was then filtered over Celite® and the volatiles removed under 
reduced pressure. The crude product was purified by FCC (1% Et2O in cyclohexane) to obtain 
2-(5,5-dimethyl-1-phenylhexyl)-4'-methoxy-1,1'-biphenyl (86.0 mg, 0.231 mmol, 92%) as a 
colourless oil. 
 
Rf = 0.2 (1% Et2O in Cy). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.42 – 7.33 (m, 1H), 7.33 – 7.26 (m, 1H), 7.25 – 7.14 (m, 
4H), 7.14 – 7.03 (m, 5H), 6.95 – 6.87 (m, 2H), 4.10 (t, J = 7.7 Hz, 1H), 3.83 (s, 3H), 1.99 – 1.85 
(m, 2H), 1.16 – 1.01 (m, 4H), 0.75 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 158.7, 145.7, 142.8, 142.2, 134.5, 130.7, 130.4, 128.3, 
128.1, 127.5, 127.4, 125.8, 125.7, 113.4, 55.4, 46.4, 44.1, 37.9, 30.4, 29.5, 23.0. 
IR (neat): ν (cm-1) 2953.1, 1611.6, 1515.5, 1477.9, 1243.0, 1177.1, 1038.2, 906.1, 727.0. 
HRMS (ESI): Calcd for C27H32ONa [M+Na]+: 395.2345, found 395.2342. 
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9-(4,4-Dimethylpentyl)-9H-fluorene (3.25c) 
 
Prepared according to a modified procedure.[224] 1-Chloro-2-(5,5-dimethyl-1-
phenylhexyl)benzene (3.3a, 150 mg, 0.500 mmol, 1.0 equiv), CsOPiv (351 mg, 1.50 mmol, 3.0 
equiv), Pd(OAc)2 (3.37 mg, 0.015 mmol, 3 mol%) and tricyclohexylphospine (8.41 mg, 0.030 
mmol, 6 mol%) were charged in a vial, which was purged and filled with Argon three times. 
THF (2.0 mL) was added and the septum exchanged with a cap. The vial was then placed in a 
heating block set at 120 °C with vigorous stirring for 12 h. The reaction mixture was then 
filtered over Celite® and the volatiles removed under reduced pressure. The crude product 
was then purified by FCC (cyclohexane) to obtain 9-(4,4-dimethylpentyl)-9H-fluorene (132 mg, 
0.500 mmol, quant.) as a colourless oil. 
 
Rf = 0.8 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.72 (d, J = 7.4 Hz, 2H), 7.49 (d, J = 7.4 Hz, 2H), 7.32 (dd, J 
= 7.3 Hz, 2H), 7.27 (dd, J = 7.2 Hz, 2H), 3.92 (t, J = 6.3 Hz, 1H), 1.88 (t, J = 7.8, 7.0 Hz, 2H), 1.37 
– 1.25 (m, 2H), 1.25 – 1.11 (m, 2H), 0.81 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 147.9, 141.2, 127.0, 126.9, 124.5, 119.9, 47.7, 44.6, 
34.6, 30.5, 29.6, 21.6. 
IR (neat): ν (cm-1) 2950.4, 1473.9, 1246.6, 1029.8, 934.9, 735.7, 661.9. 
HRMS (ESI): Calcd for C20H24Ag [M+Ag]+: 371.0923, found 371.0918. 
 
6.3.5. Mechanistic study 




The title compound was obtained following the adapted general procedure J from (Z)-(5,5-
dimethylhex-3-en-1-yl)benzene (1c, 56.5 mg, 0.300 mmol, 0.6 equiv), (Z)-(5,5-dimethylhex-2-
en-1-yl)benzene (3.1l, 56.5 mg, 0.300 mmol, 0.6 equiv), and 1-bromo-2-chlorobenzene (58 µL, 
0.500 mmol, 1.0 equiv) to obtain 1-chloro-2-(5,5-dimethyl-1-phenylhexyl)benzene (150 mg, 
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0.500 mmol, quant.) as a colourless oil. Spectroscopic data are consistent with those reported 
above. 
 
rr: (benzylic vs. others) >99:1. 
Rf = 0.84 (cyclohexane). 
1H-NMR (400 MHz, CDCl3): δ (ppm) 7.35 – 7.26 (m, 5H), 7.26 – 7.14 (m, 3H), 7.14 – 7.06 (m, 
1H), 4.50 (t, J = 7.7 Hz, 1H), 2.07 – 1.91 (m, 2H), 1.29 – 1.18 (m, 4H), 0.82 (s, 9H). 
13C{1H}-NMR (101 MHz, CDCl3): δ (ppm) 144.0, 142.7, 134.4, 129.8, 128.6, 128.4, 128.3, 127.3, 
127.0, 126.3, 46.8, 44.2, 36.5, 30.5, 29.5, 22.9. 
IR (neat): ν (cm-1) 3027.1, 2951.6, 1600.4, 1470.2, 1364.2, 1249.4, 907.4, 731.0, 670.0. 
HRMS (ESI): Calcd for C20H26Ag [M+Ag]+: 373.1080, found 373.1079. 
 
6.3.5.2. Influence on the regioselectivity 
1-(6-(tert-Butoxy)-1-phenylhexyl)-4-(trifluoromethyl)benzene (3.3ad) 
 
The title compound was obtained as a regioisomeric mixture using general procedure J from 
(E)-(6-(tert-butoxy)hex-3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-
4-(trifluoromethyl)benzene (70 µL, 0.500 mmol, 1.0 equiv). The crude product was analyzed 
by GC-MS to determine the regioselectivity.  




The title compound was obtained as a regioisomeric mixture using general procedure J from 
(E)-(6-(tert-butoxy)hex-3-en-1-yl)benzene (3.1b, 157 µL, 0.600 mmol, 1.2 equiv) and 1-bromo-
4-methoxybenzene (63 µL, 0.500 mmol, 1.0 equiv). The crude product was analyzed by GC-MS 
to determine the regioselectivity.  
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rr: (benzylic vs. others) 60:40. 
 
6.3.5.3. Crossover experiment 
1-Chloro-2-(5,5-dimethyl-1-phenylhexyl)benzene (3.3a) 
 
The title compound was obtained following the adapted general procedure J from (Z)-(5,5-
dimethylhex-3-en-1-yl)benzene (1c, 132 µl, 0.600 mmol, 1.2 equiv), and 1-bromo-2-
chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv). (Z)-1-(5,5-dimethylhex-3-en-1-yl)-4-
methoxybenzene (3.1h, 131 mg, 0.600 mmol, 1.2 equiv) was added to the reaction at the same 
time as the aryl bromide. The presence/absence of crossover product and the regioselectivity 
were analyzed by GC-MS. Dibromomethane (17.5 µL, 0.250 mmol, 0.5 equiv) was added as an 
internal standard and the yield determined by 1H-NMR analysis. No crossover product was 
observed. 
 
rr: (benzylic vs. others) >99:1. 
1H-NMR yield: quant. 
 
6.3.5.4. Isotopic labelling experiment 
 
The title compounds were obtained following general procedure J from (Z)-1-methoxy-4-(8-
(4-(trifluoromethyl)phenyl)oct-4-en-1-yl)benzene (3.1r, 217 mg, 0.600 mmol, 1.2 equiv) and 
1-bromo-2-chlorobenzene (58 µL, 0.500 mmol, 1.0 equiv) to obtain a 1 to 1 mixture of 1-
chloro-2-(1-(4-methoxyphenyl)-8-(4-(trifluoromethyl)phenyl)octyl)benzene (3.3af) and 1-
chloro-2-(8-(4-methoxyphenyl)-1-(4-(trifluoromethyl)phenyl)octyl)benzene (3.3ag) (202 mg, 
0.424 mmol, 85%) as an inseparable colourless oil. 
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The same was performed using (Z)-1-methoxy-4-(8-(4-(trifluoromethyl)phenyl)oct-4-en-1-yl-
4,5-d2)benzene (3.1r-D2, 219 mg, 0.600 mmol, 1.2 equiv) to obtain a 1 to 1 mixture of 1-
chloro-2-(1-(4-methoxyphenyl)-8-(4-(trifluoromethyl)phenyl)octyl)benzene (3.3af-D2) and 1-
chloro-2-(8-(4-methoxyphenyl)-1-(4-(trifluoromethyl)phenyl)octyl)benzene (3.3ag-D2) each 
bearing two deuterium atoms along the alkyl chain (185 mg, 0.388 mmol, 78%) as an 
inseparable colourless oil. 
 
rr: >99:1 
Rf = 0.4 (2% Et2O in Cy). 
 
6.3.5.5. Determination of organoborane specie 
 
Identical to general procedure J, (Z)-(5,5-dimethylhex-3-en-1-yl)benzene (1c, 124 mg, 0.600 
mmol, 1.2 equiv) was charged in an oven-dried 10 mL catalysis tube equipped with a stirring 
bar and septum, and then purged and filled with Argon three times. A borane dimethyl sulfide 
complex solution in toluene (2 M, 0.35 mL, 0.700 mmol, 1.4 equiv) was then added and the 
tube placed in a metal heating block set at 60 °C with stirring, fitted with a balloon. After 1 h 
water (0.10 mL, 5.55 mmol, 11.1 equiv) was added to the reaction mixture, which was further 
stirred at 60 °C for 1 h. The balloon was then swapped with a line from the Schlenk and the 
volatiles were removed under high vacuum at 60 °C for 1 h.  
The crude product was then analyzed by 11B-NMR. The range of the peak (19.49 ppm) is within 
the range of RB(OH)2 (35 – 15 ppm), compared to R2B(OH) (40 – 60 ppm) and R3B (80 – 90 
ppm).28 The absence of a second peak slightly upfield of the boronic acid despite using D2O as 
solvent is also indicative for the absence of boroxine. 
11B-NMR (160 MHz, D2O): δ (ppm) 19.49.  
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6.4. Benzylic Selective Migratory SMC – C(sp2)-H Activation Cascade 
6.4.1. General procedure for the screening of the reaction conditions 
General Procedure L: One-Pot Hydroboration – Migratory Suzuki-Miyaura Coupling – C(sp2)-H 
Activation cascade 
The olefin (0.600 mmol, 1.2 equiv) was charged in an oven-dried 10 mL catalysis tube equipped 
with a stirring bar and septum, and then purged and filled with Argon three times. A borane 
dimethyl sulfide complex solution in toluene (2 M, 0.35 mL, 0.700 mmol, 1.4 equiv) was then 
added and the tube placed in a metal heating block set at 60 °C with stirring, fitted with a 
balloon. After 1 h water (0.10 mL, 5.55 mmol, 11.1 equiv) was added to the reaction mixture, 
which was further stirred at 60 °C for 1 h. The balloon was then swapped with a line from the 
Schlenk and the volatiles were removed under high vacuum at 60 °C for 1 h. After allowing the 
tube cool down to 25 °C it was transferred in a glovebox and Pd(TFA)2 (8.31 mg, 0.025 mmol, 
5 mol%), (tBu)2PMe•HBF4 (18.6 mg, 0.075 mmol, 15 mol%), Cs2CO3 (489 mg, 1.50 mmol, 3.0 
equiv) and aryl bromide (0.500 mmol, 1.0 equiv) (if solid) were charged in the catalysis tube. 
Outside of the glovebox, toluene (1.0 mL), water (0.1 mL) and the aryl bromide (0.500 mmol, 
1.0 equiv) (if liquid) were added. The septum was rapidly exchanged for a screw cap, the 
catalysis tube sealed with Teflon-tape and then placed in a heating block set at 120 °C with 
vigorous stirring for 36 h. After this period the reaction mixture was allowed to cool to 25 °C 
and filtered over Celite® with EtOAc. The volatiles were removed under reduced pressure and 
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7. NMR Spectra of Compounds 
7.1. Terminal Selective SMC 
4-Methoxyphenyl trifluoromethanesulfonate (2.21a) 
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2-Chlorophenyl trifluoromethanesulfonate (2.21h) 
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Methyl 4-bromo-3-chlorobenzoate (2.2i) 
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Methyl 2-bromo-3-chlorobenzoate (2.2l) 
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(E)-hex-3-en-1-yl pivalate (2.1c) 
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Dicyclohexyl(neopentyl)phosphine tetrafluoroborate (L2.49) 
  
  
NMR Spectra of Compounds 
- 196 - 
  
Dicyclohexyl(ethyl)phosphine tetrafluoroborate (L2.50) 
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Butyldicyclohexylphosphine tetrafluoroborate (L2.51) 
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sec-Butyldicyclohexylphosphine tetrafluoroborate (L2.52) 
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Dicyclohexyl(isobutyl)phosphine tetrafluoroborate (L2.53) 
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Dicyclopentyl(methyl)phosphine tetrafluoroborate (L2.54) 
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Dicyclopentyl(ethyl)phosphine tetrafluoroborate (L2.55) 
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Butyldicyclopentylphosphine tetrafluoroborate (L2.56) 
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Dicyclopentyl(isopropyl)phosphine tetrafluoroborate (L2.57) 
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7.2. Benzylic Selective SMC 
(Z)-(5,5-Dimethylhex-3-en-1-yl)benzene (3.1a) 
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(E)-6-Phenyl-3-hexenoic acid (3.16) 
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(4-Phenylbutyl)-triphenylphosphonium bromide (3.13b) 
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Methyl 4-bromo-3-chlorobenzoate (S1c) 
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Methyl 4-(6-(tert-Butoxy)-1-phenylhexyl)-3-chlorobenzoate (3.3r) 
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9-(4,4-Dimethylpentyl)-9H-fluorene (3.25c) 
 
 
 
